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Abstract 
Rab proteins are the largest subfamily of the Ras superfamily of small GTPases, with more than 
60 known members, that are involved in a multitude of different processes regulating 
membrane traffic. Rab proteins cycle between the cytosol and association with membranes, 
whereby each Rab exhibits a characteristic and specific subcellular localisation. It remains 
obscure how Rab proteins, in spite of high sequence and structure identity, distinguish between 
different membranes in the cell with such specificity. Membrane biophysical properties, such as 
stored curvature elastic stress and bending rigidity, are increasingly found to be determinants 
for protein recruitment and activity, and other Ras related proteins have recently been shown 
to exhibit sensitivity towards lipid species and elastic membrane properties.  
In this study Rab membrane binding is for the first time correlated to membrane bending 
rigidity, suggesting that biophysical properties of lipid membranes may play a role in the 
regulation of Rab targeting. Furthermore, all Rab proteins tested were observed to bind 
membranes in the absence of other protein factors, questioning the function of protein 
targeting factors for the Rab membrane recruitment process. Another aspect of Rab membrane 
interaction is Rab extraction from membranes by GDI. A large scale in vitro screening of 17 Rab 
proteins revealed a broad range of extractability from membranes with GDI. No correlation was 
found between extractability and the C-terminal prenylation motif, and no difference in 
extractability was observed in direct comparison of the extraction potential with GDIα and β. 
However, Rab proteins that exhibited low extractability from membranes are involved in 
secretory processes, suggesting a functional correlation to extractability. Furthermore, Rab40c 
as the first mammalian Rab protein to date was shown to be palmitoylated.  
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CHAPTER 1 
Introduction 
 
Eukaryotic cells consist of a large variety of membrane compartments that communicate via 
membrane traffic. Stringent spatio-temporal control of these processes is required to ensure 
cellular processes are efficiently regulated. Rab GTPases are key regulators of intracellular 
membrane trafficking events such as organelle motility, endocytosis and exocytosis. They cycle 
between the cytosol and membrane association and their activity is controlled by a GDP/GTP 
switch. More than 60 Rab family members have been identified in humans and they exhibit 
extreme specificity with respect to the membrane surrounded compartment they bind to. It 
remains elusive how these proteins which exhibit substantial sequence and structural similarity 
distinguish between different types of cellular membranes with such enormous specificity. A 
number of mechanisms have been proposed in which Rab targeting is facilitated via the 
interaction with other membrane bound proteins, but not many such proteins have been 
identified and no clear general mechanism has emerged. Membrane elastic properties such as 
curvature elastic stress have been shown to regulate membrane recruitment, activity and 
folding of a number of proteins. Rab proteins target to all types of subcellular membranes, 
which exhibit tightly regulated compartment specific lipid compositions with consequently 
different elastic membrane properties. It is therefore of interest to examine the implication of 
these physical properties on Rab protein membrane targeting. 
 
1.1 The Ras Superfamily of Small GTPases 
The Ras superfamily of small GTPases comprises the majority of small GTP binding proteins (G 
proteins), with molecular masses of 20-40 kDa [1]. According to structural and functional 
similarities the Ras superfamily is classified into five families, Ras, Rho/Rac, Rab, Arf, and Ran 
[2,3]. All Ras superfamily proteins act as molecular switches (Figure 1), being inactive in the 
GDP bound state but rendered active when GDP is exchanged for GTP, accompanied by a 
conformational change. In their active state they interact with a multitude effector proteins 
which stimulate a range of further cellular processes. GTP is then hydrolysed to GDP returning 
the protein into its inactive conformation.  
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Figure 1: Ras activity cycle [4]. Active GTP bound Ras proteins interact with a multitude of effector 
proteins that implement cellular processes. Upon GTP hydrolysis, facilitated by GAP, the conformation 
changes and the Ras protein is inactivated. Re-activation is facilitated by GEFs that accelerate nucleotide 
exchange to GTP. 
 
Intrinsic GTPase activity and nucleotide exchange rates are generally slow, therefore additional 
proteins enhance and regulate these steps in the Ras cycle. GTP hydrolysis is facilitated by GAPs 
(GTPase activating protein) and nucleotide exchange by GEFs (Guanine nucleotide exchange 
factor) respectively. Another common feature of most Ras superfamily proteins is post-
translational lipidation, which facilitates membrane association. Isoprenylation with farnesyl or 
geranylgeranyl groups at the C-terminus is a general feature of most Ras, Rho and Rab proteins. 
Furthermore, palmitoylation is observed for Ras and Rho family proteins, often near the C-
terminus. N-terminal myristoylation occurs in the Arf family. 
The Ras (Rat sarcoma) family is involved in regulating gene expression by facilitating signal 
transduction from the extracellular side to intracellular targets, as well as cell proliferation and 
differentiation, morphology and apoptosis [1]. Ras proteins are important oncogenes, and 
therefore a key target in the field of cancer research [5]. Rho (Ras homology) proteins are 
closely related to the Ras family. They regulate cytoskeletal reorganisation and gene 
expression. Rac and CDC42 are important Rho subfamily members. Arf (ADP-ribosylation factor) 
family proteins are involved in the regulation of vesicle budding and trafficking. Ran (Ras-
related nuclear protein) family proteins play an important role in nucleoplasmic transport and 
microtubule organisation.  
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1.1.1 Rab GTPases 
The largest branch of the Ras superfamily is formed by Rab proteins. The first Rab gene (YPT1) 
was  identified in yeast in 1983, as a protein with 30% homology to mammalian Ras [6]. Later a 
number of Ras-related genes were cloned from a rat brain library and the term Rab for “Ras-like 
in rat brain” emerged [7]. Rab proteins are highly conserved between different species and are 
present in all eukaryotes, highlighting their importance for cellular processes. Currently, more 
than 60 Rab family members have been identified in humans [8] (Rab1 – Rab44), most of them 
ranging between 20 – 30 KDa, but some are up to 37 kDa large. Human Rab proteins share less 
than 35% sequence identity. Rab proteins regulate a myriad of intracellular membrane 
trafficking processes, such as vesicle formation, organelle and vesicle motility along cytoskeletal 
filaments, vesicle tethering and fusion. This versatility is also reflected in their ability to interact 
with a large number of effectors in their GTP bound conformation. Rab5a for example interacts 
with at least 30 effector proteins [9]. A characteristic feature of Rab proteins is their 
exceedingly specific localisation to subcellular membranes. Rab5a regulates endocytic events 
from the plasma membrane to early endosomes and hence is only found on the plasma 
membrane, early endosomes and vesicles communicating between those two membranes. 
Accordingly, Rab5a was found to be involved in vesicle formation on clathrin-coated pits on the 
plasma membrane [10] and also in endocytic membrane fusion [11]. Figure 2 shows a summary 
of the localisation and function of the majority of Rab proteins. Many Rabs are expressed 
ubiquitously in all cells, but a few Rab proteins exhibit tissues specificity. An example is Rab3a 
which is only expressed in cell types that exhibit regulated secretion, such as synaptic vesicles, 
where Rab3a is involved in the regulation of neurotransmitter release [12,13], or Rab27a, which 
regulates movement of lytic granules and melanosomes towards the plasma membrane in 
melanosomes and granules [14,15]. 
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Figure 2: Localisation and function of Rab GTPases [8] 
 
 
1.2 Post-translational prenylation of Rab proteins 
Prenylated proteins play important roles in the cell and constitute up to 2% of the total cellular 
proteins [16]. More than 100 different proteins with prenylation motifs are known and they are 
required for eukaryotic cell growth, differentiation and morphology. The prenyl groups, which 
are either farnesyl or geranylgeranyl moieties, serve as lipid anchors for the association with 
membranes. These isoprenoids are covalently attached to distinct carboxy-terminal prenylation 
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motifs by protein prenyltransferases. Depending on these motifs, prenylated proteins can be 
classified into two major groups [16]. The CAAX motif (where “A” stands for aliphatic and “X” 
for any amino acid) is prenylated by two different enzymes. Farnesyltransferase (FTase) 
attaches the C15 farnesyl group to the cysteine residue and geranylgeranyltransferase I 
(GGTase I) attaches the C20 geranylgeranyl group, which is like the farnesyl group an 
unsaturated lipid. These C20 prenyl moieties are derived from geranylgeranyl pyrophosphate, 
(Figure 3). Rab proteins are usually geranylgeranylated by a third type of prenyltransferase, 
termed Rab geranylgeranyltransferase (RGGTase or GGTase II) and in most cases carry two GG 
groups instead [17]. These are attached to conserved cysteine residues at or near the C-
terminus, which exhibits a number of typical motifs such as XXCC, XCXC, CCXX or the Ras family 
typical CAAX box. 
 
 
Figure 3: Chemical structure of geranylgeranyl pyrophosphate (GGPP) 
 
All three types of protein prenyltransferases consist of heterodimers with related subunits [18] 
and require additional cofactors. RGGTase requires millimolar amounts of Mg2+ while it is 
inhibited by micromolar levels of Zn2+ [17]. 
 
1.2.1 Rab geranylgeranyl transferase and Rab escort protein 
All Rab proteins are post-translationally prenylated in order to bind to membranes. The 
prenylation reaction is mediated by RGGTase, which is a heterodimer of a 60 kDa α subunit and 
a 38 kDa β subunit [17-20]. Unlike FTase and GGTase I, RGGTase alone is not functionally active 
but requires another co-factor for the prenylation reaction [21]. This is a 75 kDa protein called 
Rab escort protein (REP) [17,22,23], which binds newly synthesised non-prenylated Rab 
precursors and presents them to the catalytic component of the RGGTase. REP stays bound to 
the Rab until it is diprenylated and delivered to its target membrane [18]. This reflects its role 
as a chaperone, similar to Guanine nucleotide dissociation inhibitor (GDI). Two REP isoforms 
have been identified, sharing 75% identity, REP-1 and REP-2 [17]. REP-1 was discovered due to 
its link to Choroideremia (CHM) an X-linked form of retinal degeneration. REP-2 was discovered 
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subsequently to REP-1 and was designated as CHM-like (CHML) [19]. Genetic defects in REP-1 
are responsible for this disease. Lack of REP-1 leads to incorrect geranylgeranylation of Rab27a 
in the retina. In all other tissues, REP-1 deficiency can be overcome by REP-2, while this is 
exclusively not possible in the retina, leading to blindness. Other diseases linked to specific 
Rab27a depletion are the Griscelli and the Hermansky-Pudlak syndromes [24]. 
In most cases, two cysteine residues at the carboxy terminal region of the protein are linked 
with a geranylgeranyl group via a stable thioether linkage, but in some Rabs carrying the CAAX 
motif, only one GG-anchor is added [17,23,24]. The type and number of the attached prenyl 
groups has an effect on the extent and strength of membrane association. For farnesylated 
proteins the membrane association is also strongly influenced by the methylation of the prenyl 
cysteine residue. However this has only a weak impact on geranylgeranylated proteins [16].  
In some cases further processing of the prenylated proteins is necessary for their final 
maturation. Rab proteins ending on the CAAX motif are post-translationally modified by 
proteolytic cleavage of the three terminal amino acids (-AAX), leaving the negatively charged 
carboxy group. This C-terminal prenyl cysteine and also the one in Rab proteins ending on a CXC 
motif are furthermore post-translationally methylated by a methyltransferase [16], which 
minimises electrostatic repulsion during the insertion of the prenyl groups into a lipid 
membrane.  
 
1.2.2 The prenylation reaction 
Two pathways for the RGGTase reaction have been proposed (Figure 4). The classical pathway 
arose from early studies, which indicated that newly synthesised Rab proteins associate with 
REP, followed by binding of the resulting binary complex by RGGTase [20,25]. Based on the 
observation that GGPP promotes interaction between REP and RGGTase in the absence of Rab 
proteins [26] the alternative pathway was proposed, stating that first GGPP binds to RGGTase 
which in turn increases its binding affinity for REP-1, leading to eventual recruitment of the Rab 
protein and the isoprenoid transfer reaction. While GGPP enhances REP and RGGTase 
association in the absence of Rab,  it promotes dissociation of the ternary complex after double 
prenylation of the Rab protein, suggesting an allosteric regulation of the prenylation reaction 
[27,28] . 
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Figure 4: Two proposed pathways of Rab prenylation [29]. In the classical pathway newly expressed 
Rab proteins are initially bound by REP, prior to formation of the ternary RGGT:REP:Rab complex. The 
alternative pathway proposes formation of a RGGT:REP complex, which binds the Rab to form the 
ternary complex.  
 
Despite its single active site [30], RGGTase is capable of transferring two GG groups to the Rab 
protein consecutively without dissociation of REP, implicating a fourfold decrease of the 
reaction rate for the second prenylation reaction in comparison to the first GG addition [26]. 
The alternative pathway has recently been suggested to prevail in vivo by showing that REP 
mutants defective in RGGTase association were unable to compete with wild type REP for Rab 
binding [28]. 
 
1.2.3 Post prenylation processing of Ras proteins with a CAAX motif 
Small GTPases ending with a CAAX motif undergo further modification steps after the 
prenylation reaction.  “A” are aliphatic amino acids and “X” can be any amino acid , but the 
type of residue determines whether a farnesyl or geranylgeranyl group is attached [17].  
Usually, after prenylation, the CAAX box undergoes further processing on the ER membrane. 
First, the three terminal amino acids (-AAX) are cleaved proteolytically by Rce1 (Ras-converting 
enzyme 1 [31]) followed by carboxyl methylation of the prenylated cysteine by Icmt 
(isoprenylcysteine carboxylmethyltransferase, [32]). It has recently been revealed that these 
processing steps also occur for Rab proteins ending in CAAX, with the exception of Rab38 [33]. 
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1.3 Rab structure 
Rab proteins share around 35% amino acid sequence homology and a common core structure 
with other members of the Ras superfamily and other G proteins. This 20 kDa G domain 
consists of a six-stranded ß-sheet, surrounded by five α-helices [34]. It contains the guanine 
nucleotide binding site and catalyses GTP hydrolysis. Guanine nucleotide binding proteins 
(GNBPs) contain four conserved regions lined up along the nucleotide binding site: Switch I and 
II, the P-loop  (phosphate binding loop) and the guanine binding motif. Superimposition of Ras 
related GNBPs in the GTP and GDP bound form (Figure 5) shows that the conformational 
change affects mainly two regions, termed switch I and switch II, which exhibit increased 
flexibility. The GTP bound form is remarkably similar between different GNBPs, whereas the 
GDP bound conformation underlies much more variation [35].The switch I polypeptide 
sequence contains a Serine or Threonine residue essential for GTPase activity by ligation of a 
Mg2+ ion [36]. The switch II region consists of a loop followed by a helix. The peptide amide 
groups of the loop bind the GTP γ-phosphate and a conserved Aspartate residue serves as a 
water mediated ligand [36]. Release of the γ-phosphate upon GTP hydrolysis leads to relaxation 
of the switch regions via the conformational change, destabilising the GTPase-effector complex. 
 
 
Figure 5: Canonical GTP conformation of GNBPs. Superimposition of a selection of Ras-related proteins 
on the G domain shows that the switch I and II regions are much more divergent in the GDP-bound 
form. Extra elements in the structures of Rho, Arf, and Ran are highlighted:  COOH-terminus of Ran 
(red), Rho insert (purple) and Arf N-terminal helix (blue) [35]. 
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In spite of sharing the common structural features of other G proteins, Rab proteins exhibit Rab 
specific sequences, termed Rab family (RabF) motifs [37]. Five of these motifs have been 
identified based on sequence conservation and they are clustered around the two switch 
regions. Phylogenetic analysis of all Rab proteins furthermore revealed that Rab proteins 
cluster into related groups. Four specific stretches were observed to exhibit much higher amino 
acid conservation than compared to the overall sequence and were termed Rab subfamily-
specific sequences (RabSF1-RabSF4) [37], based upon which Rab proteins were grouped into 10 
subfamilies. RabF and RabSF regions of GTP bound Rab3a are shown in Figure 6. 
 
 
Figure 6: Cartoon representing the Rab3a-GTP 3D structure. RabF regions are shown in red, RabSF in 
yellow and the conserved nucleotide binding (PM/G) motifs in green. The nucleotide and Mg2+ ion are 
presented in blue [37]. 
 
RabF and RabSF regions were proposed to confer specificity to interaction with nucleotide 
sensitive Rab effectors and regulators. RabSF motifs may confer specificity regarding effector 
binding and RabF regions may be recognition sites for nucleotide sensitive GDI and REP, which 
bind all Rab proteins [37]. The fact that the RabSF regions are localised to two distinct surfaces 
of the protein argues for this hypothesis. It was further confirmed by crystal structures of 
Ypt1:RabGDI and Rab7:REP1 complexes revealing that RabF1, RabF2, RabF3 and RabF4 are 
indeed part of the binding interface [38,39].  
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1.4 GDI and the GDI-Rab cycle 
Once delivered to the membrane by REP, Rab proteins do not remain permanently membrane 
associated. Membrane association is reversible and Rab proteins dynamically cycle between 
membranes and the cytoplasm. Due to their high hydrophobicity Rab proteins require a 
chaperoning protein when they are not membrane bound. This protein, GDI (Guanine 
nucleotide dissociation inhibitor) was first identified in 1990 as an inhibitor for GDP dissociation 
of Rab3a in bovine brain [40]. It was then recognised to retrieve Rab proteins from membrane 
bilayers [41], but only interacts with Rabs in the GDP bound state [42]. The affinity of Rab:GDI 
interaction was shown to be high with Kd values in the range of 20 – 500 nM [43,44].  
GDI extracts Rab proteins from the membrane, generating a readily available pool of inactive 
Rab proteins. Similarly, GDI redelivers Rab proteins to their site of action and releases the Rab 
upon membrane binding. This Rab cycle (Figure 7) poses a means of controlling the amount of 
membrane bound, active Rab. Furthermore, Rab proteins that regulate one-directional 
membrane transport can be extracted from the acceptor compartment and recycled to the 
donor compartment, to catalyse a new round of Rab regulated membrane traffic [40].  
 
 
Figure 7: Rab cycle controlling vesicular transport. Cytosolic Rab in complex with GDI is delivered to the 
donor membrane and nucleotide exchange to GTP is catalysed by a GEF (guanine nucleotide exchange 
factor) activating the Rab. Rab is then involved in vesicle budding, vesicular motility and vesicle docking 
and fusion to the acceptor compartment.  Once Rab function is not required anymore GTP hydrolysis to 
GDP and Pi (inorganic phosphate) is facilitated by a GAP (GTPase activating protein). The inactive, GDP 
bound Rab is then available for extraction into the cytosol by GDI and may start a new cycle of 
membrane traffic [45]. 
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1.4.1 GDI structural features 
 While yeast only expresses one GDI isoform (GDI1/Sec19), which is essential for cell survival 
[46], two GDI isoforms have been cloned from rat brain [47]. Similarly, in humans two isoforms 
are expressed, GDIα and ß, which share 85% identity. These two isoforms are capable of 
interaction with the majority of Rab proteins in vitro, but their different functions remain 
unclear. In vivo the proportion of Rab proteins found in complex with either GDI isoform is 
tissue and cell type dependent [48]. For example in CHO (Chinese hamster ovary) cells, Rab 
proteins mainly bind GDIβ, but in rat brain, the predominant association partner is GDIα. In rat 
liver cytosol the distribution of Rab proteins in complex with GDIα and ß is balanced. In general, 
the ratio of each GDI isoform in complex with Rab roughly represents the ratio of isoform 
expression. GDIα is much higher expressed in brain than in other tissues, but GDIβ is abundant 
in all cell types [47]. Non redundant function of the two GDI isoforms, at least in brain, is 
indicated by the fact that mutations in GDIα lead to X-linked mental retardation [49]. 
 
X-ray crystallography revealed that bovine GDIα (Figure 8) is composed of two major domains 
[44]: a large cylindrical 340 amino acid domain I, resembling that of FAD containing 
monooxygenases and oxidases, and a smaller 100 amino acid α-helical domain II. GDI shares 5 
sequence conserved regions (SCRs) with REP in the N-terminal and central portions, mainly part 
of domain I. All of these SCRs are localised to one face of the molecule. SCR1 and SCR3B form a 
compact structure at the apex of the protein with highly conserved tri- and tetrapeptide motifs 
and site directed mutagenesis showed that these are required for Rab binding [44]. In addition, 
a mobile effector loop (MEL) in SCR 3A was shown to be crucial for binding of GDIα to 
membrane receptors and normal vesicle trafficking [50]. Studies of GDI mutants in yeast 
revealed that mutations in the Rab binding domain did not interfere with GDI membrane 
association [51], indicating that GDI directly associates with membranes or membrane bound 
factors. However, mutations in the MEL led to a distinct defect in vesicular traffic and inhibition 
of cell growth. As a consequence, the existence of membrane bound Rab recycling factors 
(RRFs) was suggested, for example GDI displacement factors (GDFs) involved in the regulation 
of Rab cycling between membrane and cytosol. Hsp90 was shown to function as a Rab recycling 
factor for Rab3a in the synapse by Sakisaka et al. [52]. Hsp90 was shown to be required for 
efficient retrieval of Rab3a from synaptic membranes and Ca2+ dependent neurotransmitter 
release. Furthermore, formation of the GDIα:Hsp90 complex was dependent on a functional 
MEL. 
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Figure 8: Structure of GDIα. (A) Backbone tube representation of GDI shows that the SCRs are all 
localised to one face of the protein, indicating that this side is involved in interaction with Rab proteins 
and/or surface membrane receptors [44]. (B) Rab-binding platforms are highlighted and boxed in 
orange, as are SCR1 and 3B. Domain II mobile effector loop (MEL) is highlighted and boxed in red, as is 
SRC 3A. SCR 2 is highlighted in green, non-conserved residues in gray. Positions Met 250 and Arg248 
(bovine GDIα) in ß-strand a3 define the upper edge of the Rab-binding platform and effector loop. 
Arg218 and Tyr219 are involved in function of the mobile effector loop [50]. 
 
It is furthermore possible that phosphorylation of GDI plays a role in the regulation of its 
activity. Studies showed that p38 MAPK (mitogen activated protein kinase) promotes 
association of GDI with Rab5a and leads to stimulation of endocytosis  [53,54]. However, these 
observations were limited to Rab5a and no further indications for a regulatory role of 
phophorylation have been found. 
 
Using expressed protein ligation to obtain semisynthetic prenylated Ypt1 the crystal structures 
of mono- and diprenylated Ypt1 in complex with GDI were elucidated [38,55]. Figure 9 shows 
that the two proteins mainly interact at the switch regions and the C-terminus Ypt and the Rab 
binding platform (RBP) and mobile effector loop (MEL) of GDI. In addition, a C-terminal binding 
region on GDI was identified that interacts with conserved hydrophobic residues on Ypt. These 
structures of GDI bound, diprenylated Ypt1 revealed that the first GG moiety is located to a 
cavity in the hydrophobic core of domain II of GDI surrounded by helices D, E H and F. This 
cavity only opens up upon GG binding, by outward movement of helix D. The second GG group 
is more exposed to solvent and skewed across several atoms of the first moiety. The structure 
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furthermore demonstrates that the Switch I and II regions of YptI are strongly involved in GDI 
binding. These regions undergo structural changes upon GTP hydrolysis leading to stabilisation 
of the water molecule that coordinates the essential Mg2+ ion, which in turn interacts with the 
ß-phosphate of GDP. These interactions explain the inhibition of GDP dissociation in the 
Ypt1:GDI complex.  
 
Figure 9: Structure of the doubly prenylated Ypt1:GDI complex (ribbon representation) (PDB 1UKV). 
GDI is shown in dark blue (domain I) and light blue (domain II, helices are marked by letters) with the 
RBP (Rab binding platform) of GDI in red, the MEL (mobile effector loop) in green and the CBR (C-
terminus binding region) in orange.  Ypt1  is shown in yellow with its switch I and II regions in green and 
grey respectively. The geranylgeranyl moieties 1 and 2 are shown as ball-and-stick representations in 
red and orange respectively. GDP (atomic colours) and Mg2+ (magenta) are shown in the nucleotide 
binding pocket in ball-and-stick and space filling representations [55]. 
 
Furthermore, the structure of the Rab:GDI complex with one GG group [38] revealed that the 
MEL undergoes a considerable rearrangement from an open to a closed conformation upon GG 
binding. This is accompanied by opening of a GG binding cavity, into which the two GG moieties 
of the Rab protein are sequentially transferred. These findings led to the proposal of a 
structural model of Rab extraction by GDI (Figure 10). 
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Figure 10: Structural model proposed for GDI function during Rab recycling.  GDI interacts with a 
membrane bound GDI receptor through MEL in domain II in the open conformation. GDI binds to Rab 
(GDP bound) through the Rab binding platform in domain I, which triggers interaction and transfer of 
the GG group from the lipid bilayer to GDI, mediated for example by Hsp90, followed by Rab extraction 
into the cytosol. Association with GG allosterically regulates the release of the Rab:GDI complex into the 
cytosol by collapsing MEL into the closed conformation. The SCRs are colour coded and conformation of 
GG is shown as a ball and stick representation in brown (first GG) and orange (potential site for a second 
GG). 
 
1.4.2 The Rab:REP:RGGT complex 
Crystal structures of the ternary Rab:REP:RGGT complex are not yet available but a composite 
model was generated by superimposition of the known structures of the Rab7:REP and 
REP1:RGGT sub-complexes [56]. This predicted structure (Figure 11) in combination with 
biochemical experiments suggests that REP binds Rab7 at the RBP (Rab binding platform). A 
specific hydrophobic region of the flexible C-terminal region of Rabs termed CIM (CBR 
interacting motif) then associates with the CBR (C-terminal binding region) of REP which leads 
to positioning of the prenylation motif into the active site of RGGT. A minimum of 9 amino acids 
was shown to be required between the CIM and the prenylation motif in the flexible C-terminal 
sequence of Rab7 in order for the prenylation motif to reach the active site of RGGT.  
Furthermore, evidence was found that prenylation activity may be largely independent of exact 
identity of these amino acids. This finding explains the broad Rab GTPase substrate acceptance 
of the REP:RGGT complex.  
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Figure 11: Model of the ternary Rab7:REP1:RGGT complex resulting from Computer based prediction 
using known structures of subcomplexes [56]. The C-terminus is based on the calculated lowest energy 
conformation. REP1 (Rab Escort protein 1) is shown in grey surface representation; Rab7 is shown as 
ribbons and coloured according to secondary structure; RGGT (Rab geranylgeranyl transferase) is shown 
as a ribbon with the α subunit in orange and the ß subunit in blue. The flexible C-terminus of Rab7 is 
shown as a space filling representation and coloured in green. 
 
1.5 Membrane targeting of Rab proteins 
Many proteins that are destined for specific subcellular compartment contain N-terminal or 
internal sorting signals, that direct them from their site of synthesis at the ER to their specific 
target organelle. This can occur by different mechanisms. Proteins enter the nuclear envelope 
through nuclear pore complexes, which is termed gated transport.  Many proteins that are 
transported to internal site of other organelles enter by migrating through protein translocators 
by transmembrane transport in their unfolded state and refold in the organelle interior. A third 
common type of protein sorting is vesicular transport from the ER to different compartments or 
the cell exterior, using the secretory pathway. A common question in the field of Rab targeting 
is their initial targeting post-prenylation. As Rab proteins are located to the cytosolic side of 
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membranes, they could potentially use vesicular transport for directed delivery to their target 
membranes. An indication for this was the observation that monoprenylated Rab mutants 
accumulated in the ER and Golgi, while diprenylated C-terminal mutants were shown to target 
correctly to their parent organelles [57]. In addition Rab proteins with mutated RabF and RabSF 
regions targeted to the ER and Golgi [58]. This led to the suggestion that the ER and Golgi serve 
as the default location for Rab proteins that have lost their targeting information [57,58]. In 
order to check if Rab proteins are sorted via the secretory pathway temperature shift 
experiments were conducted. Decreasing the temperature of cultured cells to 20˚C for 3 h leads 
to impairment of protein exit from the Golgi apparatus and a massive accumulation of 
secretory proteins to the Golgi. While HRas and NRas protein membrane targeting is affected 
by this temperature shift as they pass through the secretory pathway, correct targeting of 
Rab5a to endosomes was unaffected, indicating that Rab proteins are not sorted via this 
mechanism. Furthermore, Rab proteins have been shown to correctly target their respective 
organelles in permeabilised, cytosol free cells (Rab5, Rab7) [39,59] and exhibit activity in cell 
free environment (Rab9) [60], which further supports the hypothesis that Rab proteins are 
directly targeted to membranes by REP and GDI. 
 
While Rab retrieval from membranes by GDI may be explained by its structural features and 
interaction with GDI receptors, such as Hsp90 (see 1.4.1), the recruitment of Rab proteins to 
their target membranes is more complicated due to the required specificity of the process. As it 
is the case for all Ras related proteins, the C-terminus of Rab proteins contains the most 
divergent sequence and is called the hypervariable domain. The C-terminal 10 -17 amino acids, 
of HRas and KRas, containing the post-translational lipidation sites and a polybasic stretch (K-
Ras), were shown to be sufficient for plasma membrane targeting of H-Ras and K-Ras [61], 
raising the question whether the hypervariable region contains all required targeting signals for 
Rab proteins. However, exchange of the hypervariable domain between Rab proteins localised 
to different organelles had no effect on their localisation and they remained on their parent 
organelle [62]. Therefore it was concluded, that the hypervariable stretch is not a sufficient 
targeting signal, as initially proposed [58].  Instead a combination of protein regions, including 
RabSF regions, is required for specific Rab targeting, as it was shown for Rab27a [58]. It was 
concluded, that the signal for Rab specific targeting is complex and Rab dependent. 
Typical motifs present in most small GTPases are the hypervariable C-terminal domain, C-
terminal lipidation and the two switch regions. They are required for correct targeting and may 
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at least partially serve as stabilisers of membrane association, but they cannot confer specificity 
to the targeting process. Rab phosphorylation may play a role in targeting or activation of 
certain Rab proteins, but only the Rab5 isoforms have been shown to undergo phosphorylation 
[63].  The Rab cycle (Figure 12), suggests different possibilities, where targeting specificity may 
be conveyed. The Rab:GDI complex may interact with targeting factors (TF), exhibiting 
membrane specificity. However, no such proteins have been identified yet.  A number of  
potential membrane recruitment models exist, which will be presented in the following 
subsections. 
 
Figure 12: Schematic representation of the Rab cycle showing possibilities of membrane recruitment 
factors and Rab activation. (a) GDP-bound Rab proteins form a cytosolic complex with RabGDI, (b) 
membrane delivery and GDI displacement are mediated by a GDF, probably aided by unidentified 
targeting factors (TF), followed by (c) Rab activation through GEF-catalysed nucleotide exchange, (d) 
GTP-bound Rab recruits effector molecules to the membrane, (e) GAP-mediated GTP hydrolysis returns 
Rabs to its inactive state, followed by Rab re-extraction from the membrane by GDI [64]. 
 
1.5.1 GDI Displacement Factors  
Rab binding to GDI and the membrane underlies an equilibrium. Since the affinity of Rab 
proteins for GDI is very high, GDI displacement factors (GDF) were proposed as a means of 
shifting this equilibrium and locking Rab proteins in the membrane, as they cannot disscociate 
from membranes without GDI interaction, due to the hydrophobicity of the GG groups. Moya et 
al. first reported the requirement for a Rab GDF in 1993, when they discovered that Dss4p, a 
nucleotide exchange factor of the yeast Rab GTPase Sec4p, could not use the Sec4p:GDI 
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complex as a substrate. They suggested that an additional factor acts in concert with Dss4p as 
part of the membrane recruitment process [65]. Yip3 was then shown to induce the release of 
GDI from endosomal Rabs (Rab5, 7 and 9) [66] and a broader range of Yips was found to 
interact with a number Rab proteins [67-69]. The fact that Yips exhibit organelle specific 
localisations supports the hypothesis that they might act as recruitment factors. However only 
1 of 16 human Yips has been shown to promote GDI displacement. 
 
1.5.2 GEFs for Rab membrane targeting 
The intrinsic guanine nucelotide exchange rate of Rab proteins is relatively low and significantly 
increased by Guanine nucleotide exchange factors (GEFs), which promote release of GDP and 
binding of GTP. GEFs with specific membrane localisation may act as Rab membrane targeting 
factors by locking the Rab in its active GTP bound and hence membrane associated state.  
Within one family of Ras related small GTPases GEFs are widely conserved and generally exhibit 
multidomain structures or even associate into complexes. Most Ras superfamily GEFs have 200-
300 amino acid catalytic domains which are flanked by oligomerisation, protein-protein and 
membrane interaction domains [70]. 
In-between different Ras families GEF sequence and structure are highly divergent. Ras GEFs 
contain a Cdc25, Arf GEFs a Sec7 and Rho GEFs a DH (dibble homology) domain [70]. In spite of 
their unrelated structures, all GEFs are thought to share common mechanistic principles. 
Nucleotide binding of Ras related proteins is promoted by interaction of the nucleotide 
phosphate groups with Mg2+ and the P-loop. In a series of fast reaction steps GEFs are believed 
to initiate nucleotide release by a combination of direct interaction with the Mg2+ ion and 
indirectly changing the GTPase conformation to decrease interaction with Mg2+ and the 
phosphate binding to the P-loop [35].  Until recently, only few RabGEFs had been identified, 
and unlike GEFs for other Ras family members, RabGEFs seemed highly divergent. Examples for 
known RabGEFs are the TRAPP-I complex activating Ypt1p/Rab1, Vsp9 domain proteins 
activating Ypt51/Rab5, Sec2p/Rabin proteins activating Sec4p, Ric1p-Rgp1p complex activating 
Ypt6p and the Mon1p-Ccz1p complex activating Ypt7p and Rab7. Recently the list of identified 
RabGEFs has been extended considerably by identification of specific DENN (differentially 
expressed normal neoplastic) domain proteins. In humans seven subgroups of DENN domains 
exist: DENND1-5, MTMR5/13 (myotubularin-related proteins 5 and 13) and MADD (MAP kinase 
activating death domain protein) [71]. A summary of identified human Rab GEFs and their 
target proteins is presented in Table 1. 
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Table 1: Summary of human RabGEF domains and their target Rab proteins [72] 
RabGEF Domain Affected Rab proteins 
DENND1A-B Rab35 
DENND1C Rab13 
DENND2 Rab9a,b 
DENND3D Rab12 
DENND4A-C Rab10 
DENND5A-B Rab39a, b 
MADD Rab3a,b c d, Rab27a,b 
Mon1/Ccz1 Rab7 
MTMR5-13 Rab28 
Ric1-Rgp1 Rab6a,b,c, Rab6d/41  
SEC2 Rab8a,b 
TRAPP I Rab1a,b 
VSP9 domain GEFs Rab5a,b c, Rab17, Rab21, Rab22a, Rab22b/31, Rab24  
 
1.5.3 Rab cascades 
Rab cascades were proposed as a  maturation model, regulating Rab localisation and activity, as 
well as directionality of membrane transport from one Rab defined compartment to another. 
Only few examples of Rab cascades have been discovered, and it remains unclear if Rab 
cascades are a universal mechanism of Rab function. The first Rab GEF cascade was discovered 
in yeast. The redundant yeast Rab proteins Ypt31/Ypt32 (Rab11 homologs) are found on late 
Golgi compartments. From these compartments, secretory vesicles marked with Sec4p (Rab8 
homolog) are generated and traffic to the plasma membrane. The Rab cascade is initiated by 
activation of Ypt31/32, which in its active form recruits Sec2. Sec2 then acts in two ways as 
follows. It is a GEF for Sec4, leading to activation of Sec4 and thereby promoting stable 
membrane association of Sec4 and execution of its function of delivering secretory vesicles to 
the plasma membrane. Sec2 concomitantly associates with Sec15, an effector of Sec4 and 
component of the exocyst, thereby enhancing Sec4 recruitment to secretory vesicles [73,74]. In 
order to inactivate upstream Rabs after recruitment of the downstream Rab, GAPs may play an 
important role in counteracting GEF cascades. As shown in Figure 13, after recruitment of a 
downstream Rab GEF and its activation, this Rab recruits a GAP of the upstream Rab, thereby 
inactivating it. Connecting each step of a trafficking process with the following step in such a 
coordinated manner makes the process highly efficient and conveys spatio-temporal control.  
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Figure 13: The Rab GEF and GAP cascade [75]. Membrane insertion of RabA is followed by activation by 
its respective GEF (1). Active RabA then recruits a GEF for RabB, the downstream Rab in the pathway (2). 
RabB in turn recruits a GAP for RabA, thereby inactivating it (3). In addition RabB also recruits a GEF for 
the next downstream Rab, RabC. RabC recruits a GAP to inactivate RabB (5).  
 
1.5.4 Rab Effectors for Rab membrane targeting 
Rab effectors interact with Rab proteins in their GTP bound, active form [76] and may promote 
stable membrane association. Consequently, the interaction with a Rab effector may confer 
specificity to the Rab membrane binding process, provided that the effector exhibits membrane 
specificity. Rab effectors often form complexes with exchange factors of the GTPase they 
activate [77]. One example is the Rabex5/Rababtin5 complex, which functions early in the 
endocytic pathway [78]. Rabex5 is a GEF and Rabaptin5 an effector for Rab5. Rabex5 is involved 
in Rab5 dependent recruitment of Rabaptin5 to early endosomes, Rabaptin5 in turn increases 
exchange activity of Rabex5 [79]. Similar positive feedback loops have been reported in other 
systems. Divalent Rab effectors, such as Rabenosyn-5, which binds Rab5 and Rab4, have been 
suggested to connect Rab domains and thereby regulate protein sorting and recycling [80]. 
 
1.6 Lipid Membrane Properties 
Cellular membranes are composed of a multitude of different lipids. Thousands of different 
lipid species exist [81] and mammalian cell membranes contain more than 1000 lipid species 
[82]. 5% of genes are required for their production [83]. In spite of the immense variety of lipid 
species, biological membranes exhibit extremely distinct lipid compositions, depending on the 
organism, tissue type and membrane enclosed compartment. The regulation of the lipid 
composition necessitates tight spatio-temporal control by the cellular machinery. For example 
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the mycoplasma Acholeplasma laidlawii adjusts the lipid headgroup composition in response to 
alterations in the levels of acyl chain saturation, in order to maintain the PM elastic stress 
constant [84,85]. The cellular effort of maintaining a homeostatic membrane dependent lipid 
composition highlights the importance of biological membrane composition for cellular 
function. Figure 14 shows a comparison of the phospholipid composition in different 
membrane compartments in mammals and yeast, and the site of lipid synthesis for selected 
important lipids.  
 
Due to their high caloric density, lipids are used for energy storage. Furthermore, they self-
assemble into aggregates forming a membrane barrier which serves as the structural matrix for 
cellular compartmentalisation. Self-assembly is a consequence of the amphiphilic structure of 
lipids and the hydrophobic effect in water. Initially, membranes were regarded as a two 
dimensional solvent in which membrane proteins can freely diffuse. This fluid mosaic 
membrane model, proposed by Singer and Nicholson almost 40 years ago [86], has long been 
expanded. It is now accepted that membrane lipids play a much wider role as modulators of 
protein activity and regulators of cellular processes [87]. Membrane lipids can influence protein 
activity, by regulating membrane physical parameters, such as hydrocarbon thickness, surface 
charge density, lipid headgroup hydration etc. 
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Figure 14: Lipid synthesis and steady state composition of cell membranes. The lipid composition is 
expressed as percentage of the total phospholipid PL in mammals (blue) and yeast (light blue) for PC 
(phosphatidylcholine), PE (phosphatidylethanolamine), PI (phosphatidylinositol), PS (phosphatidyl-
serine), SM (sphingomyelin), CL (Cardiolipin), ISL (yeast inositol sphingolipid), BMP (bis(monoacyl-
glycero)phosphate) and R (remaining lipids). The sterol content was determined as the molar ratio of 
cholesterol (CHOL) or ergosterol (ERG) to phospholipid. The localisation of lipid synthesis of the major 
phospholipids (blue) and signalling and organelle recognition pathways (red) is indicated for PC, PE, PI, 
PS, SM, CL, PA (phosphatidic acid), PG (phosphatidylglycerol) GalSer (galactosylceramide), TG 
(triacylglycerol), GlcSer (glucosylceramide), complex glycosphingolipids (GSL), yeast inositol 
sphingolipids (ISL), PG (phosphatidylglycerol), PI(3,5)P2 (phosphatidylinositol-(3,5)-bisphosphate), 
PI(4,5)P2 (phosphatidylinositol-(4,5)-bisphosphate), PI(3,4,5)P3 (phosphatidylinositol-(3,4,5)-
trisphosphate), PI4P (phosphatidylinositol-4-phosphate), Sph (sphingosine) and S1P (sphingosine-1-
phosphate). Signalling and recognition lipid levels are significantly below 1% of total phospholipid, 
except ceramide (Cer) [83].  
 
Another global membrane parameter is the elastic stress, which results from the packing of 
non-lamellar lipid molecules into planar bilayer structures. This was first noted by Luzzati and 
Husson in 1962 [88], who discovered non-bilayer lipids in the plasma membrane that prefer 
packing into inverted hexagonal phases. This led to the hypothesis that these lipids are 
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important for biological regulation [89,90]. Furthermore, the membrane itself can be employed 
as a reaction compartment which regulates cellular processes through its physical properties. 
Lateral segregation of lipids within a membrane bilayer into microdomains can also drive and 
enhance chemical and enzymatic processes in membranes. A third function of specific lipids 
such as phosphoinositols, cardiolipin and arachidonic acid is signal transduction as first and 
second messengers.  
 
1.6.1 Lipid geometry and packing parameter 
Lipids are classified according to chemical structure. There are three general classes of 
biological lipids, which are neutral lipids (e.g. cholesterol), glycolipids and phospholipids. 
Phospholipids are the major component of biological membranes and are composed of a 
glycerol backbone with usually two distinct fatty acid acyl chains esterified to the sn-1 and sn-2 
positions and a polar headgroup attached to the sn-3 position. Depending on the choice of the 
apolar lipid chains and headgroups, a variety of different phospholipids can be created, with 
different physical properties. Of the total phospholipid fraction in mammalian cells about 40-
50% are phosphatidylcholine (PC) and the second largest fraction is constituted by 
phosphatidylethanolamine (PE) with 20-50% [82]. The chemical structure of both lipids is 
shown in Figure 15.  
 
 
Figure 15: Chemical structure of (A) DOPC and (B) DOPE 
 
The length and degree of unsaturation of the hydrocarbon tail and the headgroup determine 
the ratio between the cross sectional area between the headgroup and lipid chains. 
Accordingly, lipids exhibit three general geometric types, shown in Figure 16. Cone-shaped 
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(type I) and inverted-cone shaped (type II) lipids are non-bilayer lipids, meaning they prefer 
assembly into curved phases such as hexagonal structures rather than planar lamellar bilayers. 
Cylindrical lipids are bilayer lipids and spontaneously assemble into planar lamellar structures in 
aqueous solutions. 
 
 
Figure 16: Lipid geometry and membrane curvature. Lipids are classified into three types depending on 
their geometric shape. Type I lipids such as lysophospholipids are cone shaped and assemble into 
membranes with positive curvature. Type 0 lipids such as PC lipids are cylindrical and exhibit no or very 
low curvature when they self assemble. Type II lipids such as PE are inverted cones and exhibit negative 
curvature when assembled into a monolayer (modified from [91]).   
 
1.6.2 Membrane curvature 
Curvature is defined by the principal curvatures c1 and c2 which are perpendicular to each 
other. They can be obtained by the two perpendicular radii of a curved surface as illustrated in 
Figure 17. The two principal curvatures are reciprocal to these radii: 
 
   
 
  
     
 
  
 
Eq. 1 
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Figure 17: Curvature. A normal through the surface at any point can be extended to obtain the two 
perpendicular radii R1 and R2. The two principal curvatures are defined as the reciprocal values of these 
radii. 
 
The mean curvature H and the Gaussian curvature K are defined as: 
 
  
 
 
        
       
Eq. 2 
 
For a flat surface both principal curvatures are zero, but for a cylinder, only one of the principle 
curvatures is zero. Consequently, the Gaussian curvature K is zero for a cylinder but not for the 
mean curvature H. A convention when dealing with lipid monolayers is that curvature of the 
headgroups towards water is negative and when the headgroups curve away from the water 
the sign of the curvature is positive. As a result, a saddle shaped monolayer has zero mean 
curvature (when c1 = -c2), but a negative Gaussian curvature. 
 
1.7 Membrane elastic energy  
1.7.1 Stored curvature elastic energy and lateral stress 
What happens when a bilayer is formed from two monolayers? If both monolayers are 
intrinsically flat, forming a bilayer will not affect their packing, however if the monolayers 
exhibit a negative spontaneous curvature due to the incorporation of type II lipids forming a 
bilayer will force the chains to pack tight under energetic cost. Leaving voids between the 
monolayers to allow maintenance of their curvature would be energetically even more 
unfavourable due to the hydrophobic effect (see Figure 18). The energy required to force the 
curved monolayers into a bilayer is called stored curvature frustration, curvature elastic energy 
or lipid packing stress [87,92]. This stress can reach 50 atm [93], indicating that relief of this 
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stress is highly favoured and may be used in biological systems as a means of protein 
regulation. 
 
 
Figure 18: Curvature frustration in a bilayer formed from two symmetrically curved monolayers [91]. 
Voids between the monolayers are energetically unfavourable and therefore they are forced into a flat 
bilayer containing stored curvature elastic stress. 
 
Curvature frustration is an elastic stress that causes a lateral pressure which varies across the 
membrane depth [94,95]. The pressure profile is determined by the contributions of the 
headgroup repulsion, the outward chain pressure and the compensating attractive interfacial 
tension (or hydrophobic free energy density) (Figure 19).  
 
 
Figure 19: Distribution of lateral pressure π along the axis z of a flat monolayer [95]. 
When the interfacial tension fully compensates the repulsive forces, the overall membrane 
tension is zero. The first moment of the lateral pressure, the torque tension    is defined as 
follows and is general nonzero. 
 
            
Eq. 3 
 The torque tension is related to the bending rigidity and spontaneous curvature via 
 
        
Eq. 4 
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The extent of the membrane pressure is also determined by the lipid packing parameters, 
which is schematically clarified in Figure 20. Lamellar membrane bilayers exhibit low pressures 
in the lipid chain region when they are composed of lipids with low spontaneous curvature, 
whereas lipids with negative spontaneous curvature cause high pressures. 
 
 
Figure 20: Lateral pressure (here designated p) in a planar bilayer membrane changes along the 
membrane depth z and depends on the lipid nature. Left: membrane assembled from bilayer lipids 
with small spontaneous curvature leads to low pressure in the hydrocarbon tail area. Right: Lipids of 
high negative spontaneous curvature leads to higher pressures in the lipid chain area (modified from 
[87]). 
 
The transmembrane profile of the lateral pressure and its components are not accessible 
experimentally. This necessitates the determination of closely related elastic parameters such 
as the spontaneous curvature [90] and bending modulus [96] (see section 1.7.3). Lateral 
pressure is linked to protein function and has been suggested to be important for the 
conformational change of membrane proteins [97]. It is predicted to only influence protein 
activity when the conformational change of the protein is accompanied by a depth dependent 
change in its cross sectional area [98]. 
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1.7.2 Membrane deformation energy 
Mechanical deformation of lipid bilayers is a superposition of three principle elastic 
deformations: stretching/compression with an isometric area change, bending and shear 
deformation with constant area (Figure 21). 
 
 
Figure 21: Elastic deformation of membranes. (A) Stretching/compression, (B) bending, (C) shear 
deformation. 
 
Isometric stretching and compression of a membrane can be described by the elastic area 
dilation energy gdil per unit area: 
      
 
 
   
  
 
 
 
 
Eq. 5, 
 
where Kc is the lateral compressibility or area dilation modulus (energy per unit area)  and 
  
 
 is 
the relative change in area. 
Shear deformation energy can be expressed as follows: 
 
       
 
 
            
Eq. 6, 
where μ is the shear elastic modulus and  the strain λ depends on the relative elongation  
 
  
     
  
 
Eq. 7 
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1.7.3 Membrane elastic energy and the Helfrich model 
The total free energy of a lipid membrane is composed of three terms: membrane curvature 
elasticity gC, packing frustration of the hydrocarbon chains gP, and the sum of interaction forces 
ginter which include hydration force, electrostatic contributions and other forces [91]. The total 
free energy gtot can therefore be written as 
 
                  
  Eq. 8 
 
Helfrich recognised, that for the determination of membrane elasticity, a membrane bilayer 
may be treated as an infinitely thin elastic sheet under the assumption of unrestricted internal 
fluidity, using the established theory of thin elastic shells developed by Frank [99,100]. The 
curvature elasticity of the monolayer may then be expressed as the bending energy per unit 
area, gc: 
           
      
Eq. 9, 
 
where H is the mean curvature, H0 the spontaneous mean curvature, K the Gaussian curvature 
and κ and κG are the bending modulus and Gaussian bending modulus, respectively. The latter 
two are constants with units of energy. The two main parameters determining the elastic 
properties of membrane bilayers are the bending modulus (κ) and the apparent area 
compressibility modulus (Ka) [101]. The area dilation energy is large in comparison to thermal 
energies, thus the membrane area is assumed to be constant. The compressibility modulus lies 
roughly in the range of 0.1-1 J/m2 which equals 107-108 kBT/μm
2 and the bending rigidity of lipid 
membranes generally lies in the range of 1 -100 kBT. The bending rigidity describes the 
resistance of the membrane to changes in curvature. It is composed of two parts [102]: the 
intrinsic stiffness of each monolayer to changes in curvature, leading to a localised resistance 
and local bending stiffness, which is described by the curvature elastic modulus according to 
Helfrich. The second part of the bending rigidity arises from the different strain caused in the 
two monolayers upon bending, as one leaflet is compressed while the other is stretched. This is 
referred to as the nonlocal bending energy or global curvature energy [103]. There is a close 
correlation between this nonlocal bending energy and the bilayer couple hypothesis and the 
area difference elasticity model (see section 1.7.4) which predict the morphology of 
membranes. The bending rigidity is proportional to the compressibility modulus: 
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Eq. 10 
where  dm is the bilayer thickness. 
 
1.7.4 Area difference elasticity model 
The morphology of vesicles is very diverse and not simply spherical. Shapes of vesicles can be 
determined by the area difference elasticity (ADE) model [104] depending on their bending 
moduli, reduced volume and area difference between the two leaflets of a bilayer. The ADE 
model is a result of the combination of the bilayer couple (or area difference) model proposed 
by Sheetz et al. [105] and the Helfrich elasticity. According to this model vesicle shape can be 
predicted by only two parameters, the reduced volume of the vesicle  , and the preferred 
differential area          [106]. A vesicle shape phase diagram can be created, which predicts the 
vesicle morphology, see Figure 22. The reduced volume   is the ratio of volume to area and 
equals 1 for a sphere. 
 
  
  
    
  
Eq. 11, 
where the basic length scale via the membrane area A is 
  
    
 
  
 
 
 
 
Eq. 12 
The preferred differential area is 
 
             
 
   
   
Eq. 13, 
 
where     is the dimensionless relaxed area difference     between the two monolayers of 
the bilayer with thickness D, 
 
    
   
     
 
Eq. 14  
 
α is the ratio of the two bending moduli  
  
 
, and         denotes the dimensionless 
spontaneous curvature of the membrane. 
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Figure 22:  Vesicle shape phase diagram according to the ADE model. Preferred differential area          
and reduced volume   determine the vesicle shape with minimal elastic energy [100]. A selection of 
vesicle shapes is shown in the diagram, with their centre of gravity at the respective position. Solid lines 
in the diagram show first-order transitions between different principle shapes. 
 
1.7.5 Lipid mesophases 
Cellular membranes are usually lamellar bilayers exhibiting different degrees of curvature. The 
plasma membrane is generally planar and curvature can be neglected. On the contrary, 
organelle membranes can exhibit extreme curvature, such as the inner mitochondrial 
membrane or the ER. This curvature is induced by mechanisms discussed in section 1.8.1. In 
pure form highly curved lipids do not assemble into lamellar phases. Instead they aggregate 
into a number of polymorphic liquid crystalline mesophases, depending on the lipid species and 
composition. It is now widely accepted that the lipid composition of cellular membranes is 
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tightly controlled to adjust their curvature [108]. Furthermore, lipid mesophases other than the 
lamellar bilayer phase are biologically relevant. In membrane trafficking events such as fusion, 
fission and pore formation lipids transiently aggregate to non-bilayer phases, such as the 
inverse hexagonal phase and cubic phases [109].  The lyotropic phase behaviour of one specific 
composition of lipids is dependent on temperature, pressure, and type and amount of solvent. 
Liquid crystals have a long range order with a periodicity on one or more dimensions. This is 
employed by the determination of phase behaviour by X-ray diffraction. Other methods that 
are typically used to determine the lyotropic phase behaviour of lipids are polarising 
microscopy, NMR and differential scanning calorimetry [110]. 
 
1.7.6 Lamellar phases and membrane microdomains 
Depending on the fluidity of the lipid chains, the lamellar phase is distinguished into liquid 
crystalline Lα (also liquid-disordered, Ld), solid gel Lß and liquid-ordered Lo phase. In the L α 
phase the chains are completely free to move and the lipids freely diffuse laterally. The Lo phase 
exhibits no lateral diffusion, but rotational freedom of the lipid molecules around their axis with 
low lipid chain motility. In the Lß phase the lipid chains are ordered into regular crystalline 
patterns without movement [111]. 
Unsaturated hydrocarbon chains tend to form liquid-disordered phases, while long saturated 
chains, as they occur for example in sphingomyelins, prefer liquid-ordered phases.  
Model membranes composed of a mixture of lipids with preferential disordered and ordered 
behaviour exhibit lateral segregation into liquid crystalline and ordered microdomains, 
especially in the presence of cholesterol [112-116].  Due to technical difficulties in the detection 
of such microdomains (or “rafts”, 10-200 nm [117]) the biological functions and even existence 
of lateral lipid segregation are still discussed [118,119].   Sphingolipids and cholesterol are 
enriched in the late Golgi, plasma membrane and endosomes [120]. It is believed that 
cholesterol serves as a regulator of membrane fluidity in cellular membranes. It decreases 
fluidity in conjunction with fluid phase lipids, but increases fluidity in the presence of gel-phase 
lipids, by forming the liquid ordered (Lo) phase. This phase exhibits close membrane packing, 
while the phospholipid headgroups are pushed apart by the inserted cholesterol, which is 
thought to act as a spacer molecule. In spite of this high cohesion, there is no long-range order 
resulting in a certain extent of lateral fluidity [121]. Biologically, cholesterol may be relevant as 
an anti-freezing agent, as it lowers the freezing point of saturated lipid mixtures. Compared to 
unsaturated lipids, which also exhibit lower freezing points, cholesterol has the advantage of 
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not being prone to oxidation [122]. Proteins have been found to specifically partition into the 
liquid ordered phase, indicating that microdomains may serve as concentrators of potential 
interaction partners [123]. Rafts have been also suggested to play a role in signal transduction 
[124,125] and intracellular trafficking [126], by changing membrane mechanical properties. 
10% incorporation of cholesterol into DMPC bilayers is sufficient for an 80% increase in bending 
rigidity [127], and a 30% incorporation leads to a 2.5-fold increase [128]. Furthermore, 
cholesterol drastically increases the area expansion modulus Ka [129] of DMPC bilayers and the 
lysis tension [128,130]. 
 
1.8 Protein-lipid interactions 
Lipids and proteins closely interact to regulate cellular processes. This regulation works both 
ways: Proteins regulate membrane curvature (see 1.8.1) which in turn has an impact on 
membrane trafficking and organelle morphology, for example. Vice versa, single lipid species 
regulate protein activity and serve as signalling molecules. Furthermore, global membrane 
properties also modulate protein function, which will be focussed on in section 1.8.1. 
 
1.8.1 Inducing membrane curvature 
Membrane curvature is important for membrane fusion and fission, organelle morphology and 
the regulation of protein activity. Membrane deformation can be achieved by extrinsic forces, 
for example the actin cytoskeleton [131], or by pulling on membranes with motor proteins to 
create tubules. Three mechanisms may be used to intrinsically induce and stabilise membrane 
curvature (Figure 23). Protein scaffolds are formed by polymerising transmembrane proteins 
which induce curvature. Due to the rigidity of the protein scaffold the membrane bilayer 
conforms to this curvature. Examples for protein scaffolds are the vesicle coat complexes COPI, 
COPII and clathrin which are important in intracellular membrane traffic.  
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Figure 23: Mechanisms of inducing high curvature in organelle membranes. (A) Scaffolds of integral 
membrane proteins with their transmembrane domains inserted into the bilayer, oligomerise to form a 
rigid curved protein scaffold to which the membrane bilayer conforms. (B) The bilayer couple effect 
arises from insertion of peptides (e.g. amphipathic helices) into one bilayer. (C) Lipid asymmetry caused 
by sorting of lipids or lipid modification (modified from [132]). 
 
Proteins that only insert into one bilayer increase the surface area of this bilayer significantly, 
causing the membrane to bend according to the bilayer couple hypothesis [105].  Interestingly, 
coat protein recruitment also requires small G-proteins Arf1 (clathrin and COPI) and Sar1p 
(COPII) (among other co-factors), which induce curvature by insertion of amphipathic helices 
into one bilayer [133,134]. A number of proteins have been identified that induce curvature by 
inserting amphipathic helices into one bilayer. Examples are amphiphysin, epsin (ENTH 
domain), ARF GTPases [134], melittin, and the pleckstrin homology domain (PLCδ) [135]. An 
amphipathic helix exhibits separation of the helix into an apolar and a polar face. The helix 
inserts horizontally into the lipid plane at the level of the glycerol group with the apolar side 
facing towards the lipid chains [136]. A combination of the scaffold and bilayer couple 
mechanism is employed by the BAR domain which often occurs in combination with other 
domains, such as the pleckstrin homology domain. The BAR domain is part of many proteins 
(such as amphiphysin and some small GTPases). When it dimerises it exhibits a curved banana 
like structure with amphipathic helices at either end which insert into the membrane.  
Another way of controlling bilayer curvature is transmembrane leaflet asymmetry. This 
principle is visualised in Figure 24. In the plasma membrane, 80% of the aminophospholipid (PS 
and PE) are distributed on the inner leaflet, whereas PC and sphingomyelin (SM) are enriched 
on the outer leaflet [82]. Enzymes, such as Flippases and Scramblases regulate the spatial lipid 
composition on both monolayers [137].  Furthermore, de novo lipid synthesis and lipid 
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conversion regulate curvature. An important example is the balance of phosphatidic acid and 
lysophosphatidic acid controlled by phospholipase D, Brefeldin A ribosylated substrate (BARS) 
and LPA acyltransferase [138,139]. Bilayer asymmetry is important for vesicle budding and 
fission, in order to induce regions of high curvature. In addition, organelle morphology may be 
controlled in such a way.  
 
 
Figure 24: Effect of lipid shape and bilayer asymmetry on membrane curvature. Sorting of type II lipids 
into the outer leaflet and type I and type 0 lipids into the inner leaflet of a bilayer creates regions of high 
curvature which facilitate vesicle budding [140]. 
 
1.8.2 Lipid membranes as protein activity modulators 
Collective physical membrane properties, such as lateral stress, curvature and bending rigidity, 
increasingly emerge as regulators of protein activity and function. For example, folding of 
membrane proteins has been shown to be affected by membrane stress [141-143] and bending 
rigidity [144]. An example for activity modulation by membrane curvature is ArfGAP1, which 
promotes GTP hydrolysis of Arf1 leading to COPI disassembly. It senses membrane curvature 
and binds to membranes inserting a myristate moiety and an amphipathic helix. Its activity 
increases with membrane curvature [145,146] suggesting a negative feedback loop for COPI 
coating. In general, protein activity is expected to be sensitive to membrane mechanics when 
its function is involved in membrane modulation, for example proteins involved in conversion 
of non-bilayer lipids to bilayer lipids and vice versa. Also channel or pore forming proteins have 
been implicated in sensing membrane properties. For example membrane partitioning and 
pore formation of the pore forming protein Melittin is sensitive to lipid composition and 
leakage is dependent on the area compressibility modulus Ka, the spontaneous monolayer 
curvature R0 and the presence of polymer lipids [147]. Furthermore, the ion channel gramicidin 
is sensitive to membrane rigidity [147-149]. A more detailed discussion of two specific proteins 
with sensitivity towards membrane elastic properties is presented below (1.8.2.1 and 1.8.2.2). 
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1.8.2.1 CTP:Phosphocholine cytidylyltransferase  
CTP:Phosphocholine cytidylyltransferase (CCT) catalyses the formation of the PC headgroup 
CDPcholine from phosphocholine, which represents a rate-limiting step in the biosynthesis of 
PC. PC is the major lipid headgroup in cell membranes and also a precursor to many other 
lipids, therefore regulation of CCT is of crucial importance for the control of membrane 
composition and membrane physical properties. CCT reversibly associates with membranes via 
insertion of an amphipathic helix and binding induces a conformational change in the protein, 
allowing CTP binding. CCT membrane association and activity are dependent on the lipid 
composition. Anionic lipids such as fatty acids and PS stimulate binding through interaction with 
cationic helix residues [150,151] , but also uncharged type II lipids promote activity [152-155]. It 
was shown that non-bilayer lipids are of crucial importance for CCT activity [156]. Systematic 
studies of CCT binding to binary lipid membranes revealed that CCT activity increases 
proportionally with increasing lateral stress [153], see Figure 25. Binary mixtures of DOPC with 
different mole fractions of either DMPC or DOPC were subjected to CCT partitioning and the 
activity was quantified. Assuming that in these mixtures electrostatic contributions for CCT 
membrane binding and folding energetics are negligible, only stored curvature elastic stress of 
the lipid mixtures effects CCT recruitment and activation. 
 
 
Figure 25: Relative activity, S, of CCT as a function of the mol fraction of DOPC, x, in DMPC/DOPC 
(solid circles) and DOPC/DOPE (open circles) vesicles [153]. 
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The stored curvature elastic energy for each DOPE molecule in a flat monolayer is estimated to 
1 kBT and according to the size of the CCT binding domain 19 lipid chains are estimated to relax 
upon CCT insertion [153]. This is a major energetic contribution, favouring CCT binding and 
possibly promoting CCT activity in membranes with type II lipids.  
 
1.8.2.2 Alamethicin 
Another pore forming peptide, the 20 amino acid voltage-gated ion channel alamethicin is 
sensitive to membrane elasticity. Membrane partitioning monotonously decreases with 
increasing DOPE in binary DOPC/DOPE mixtures [157] (Figure 26). Additionally, also its 
conductance state is dependent on membrane curvature [158]. Using DOPE derivatives DOPE-
Me and DOPE-Me2 had the same effect on membrane binding, showing that the lipid 
headgroup or electrostatic interactions are not responsible for the observed data. Furthermore, 
using lipids of different chain length and degree of saturation confirmed a decrease of 
membrane binding with increasing membrane curvature stress [157]. 
 
 
Figure 26: Partition coefficient Kp of alamethicin into membranes of DOPC/DOPE mixtures as a 
function of the DOPE mole fraction, X(DOPE) (from [97], data from [157]). 
 
1.8.3 Membrane binding of small GTPases 
The membrane binding mechanism of Rab proteins is poorly understood and it is worth taking a 
look at the lipid-protein interplay of other Ras superfamily GTPases and the membrane 
interaction of their lipid anchors. 
 
53 
 
1.8.3.1 Ras GTPase membrane binding 
Ras GTPases are targeted to the plasma membrane. In the past decade fluorescence 
microscopy has revealed that different Ras family members exhibit distinct microlocalisation 
patterns. The farnesylated and palmitoylated H-Ras and N-Ras target specifically to liquid 
ordered cholesterol dependent membrane microdomains. K-Ras is only farnesylated at the C-
terminus, but exhibits a nearby polybasic sequence for electrostatic association with the lipid 
headgroups. It is predominantly localised to liquid-disordered domains, which is expected, as 
prenyl anchors are too bulky for insertion into the liquid-ordered phase [159], while saturated 
fatty acids such as myristate and palmitate favour segregation into raft domains. Analysis of Ras 
microlocalisation at the plasma membrane revealed that active H-Ras and K-Ras are 
predominantly targeted to spatially distinct cholesterol-independent non-raft microdomains. 
Conversely, inactive HRas localises between lipid rafts and microdomains [160]. 
Structural data on the insertion of lipidated proteins is hard to obtain due to a lack of 
experimental methods.  A MAS NMR study of membrane insertion of the N-Ras C-terminus 
revealed that the two lipid chains (farnesyl and palmitate) insert vertically into one monolayer 
and the peptide backbone into the headgroup area [161]. Surface Plasmon Resonance was 
employed to study the influence of the lipid anchor motif of N-Ras on the interaction with lipid 
membranes [162]. Membrane binding of N-Ras with different combinations of lipid motifs 
(Farnesyl and hexadecyl thioethers, which are non-cleavable palmitoyl analogues) was 
investigated. For this purpose different membrane compositions of DOPC, DPPC and 
cholesterol were employed to yield pure Ld, pure Lo and Ld/Lo  phase coexistence. In addition 
the influence of negatively charged headgroups and stored curvature elastic stress was 
examined. The association of monofarnesylated H-Ras with pure DOPC Ld phase exhibited the 
highest association and dissociation rates, compared to other lipid motifs and DPPC Lo phases. 
This may be explained by the strong hydrophobic mismatch between the hydrophobic length of 
the farnesyl anchor and the all-trans DPPC chains. Double lipidation led to a 5-fold decrease of 
binding kinetics in Ld phases, but stronger association. The dissociation of doubly lipidated N-
Ras from Ld is also delayed. These results confirm findings that mono-farnesylated peptides 
display reduced kinetic stability on membranes. Introduction of charged and negatively curved 
lipids did not notably affect membrane interaction [162]. 
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1.8.3.2 Arf GTPase membrane binding 
Like Rab proteins, Arf (ADP-ribosylation factor) GTPases also function in various membrane 
trafficking events, by interacting with a multitude of effectors. However, they feature 
momentous structural differences to Rabs and other Ras family proteins [163]. They do not 
require GDI, instead membrane association is regulated by the nucleotide state. Arf proteins 
can dissociate from the membrane upon GTP hydrolysis. Furthermore, Arf proteins are 
myristoylated at the N-terminus which is also an amphipathic helix, serving as a membrane 
anchor. Recent structural studies revealed that Arf proteins and their effectors are tightly 
membrane associated, in contrast to Rab proteins that are more loosely bound due to the 
flexible C-terminal hypervariable region, which extends 7-8 nm from the membrane (Figure 27) 
[164]. Having an amphipathic helix, it is not surprising that in recent years Arf proteins have 
been identified as sensors and modulators of membrane curvature [146]. Examples for such Arf 
proteins are Arf1 [134] and  Sar1p [133]. In addition to directly sensing membrane stress, Arf 
GTPase effector proteins are also modulated by membrane properties [146], highlighting the 
importance of regulating vesicular trafficking steps via membrane curvature.  
 
 
Figure 27: Membrane association of Arf and Rab GTPases in comparison [163]. 
 
1.8.3.3 Rho/Rac GTPase membrane binding 
It has also been demonstrated for members of the Rho GTPase family, Rac1 and 2, that they 
only target to membranes containing anionic phospholipids [165,166]. Neutral lipids did not 
cause dissociation of the Rac:RhoGDI complex and binding. Rac1 contains a stretch of 6 basic 
residues, Rac2 a stretch of 3, which explains their preferred interaction with anionic lipids. 
Rac:RhoGDI dissociation was also dependent on the presence of GEF and GTP. Optimal 
dissociation and binding was observed when using vesicles containing PtdIns(3,4,5)P3 
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1.8.4 Lipids and membrane properties regulating Rab membrane targeting 
Unlike other Ras families, Rab protein membrane association has only vaguely been linked to 
the presence of specific lipids or membrane elasticity. Studies on this topic are scarce and 
inconclusive, but will be presented below. 
 
1.8.4.1 Phosphoinositols 
In a large scale study, 125 small GTPases were investigated with respect to plasma membrane 
localisation. Of 48 PM localised proteins, 37 contained polybasic clusters and it was shown that 
these proteins specifically bind to PI(3,4,5)P3 and PI(4,5)P2 [167]. Six Rab GTPases were among 
these proteins, Rab8, Rab8b, Rab13, Rab22A, Rab23, Rab35. Interestingly, four of these Rabs 
are only singly prenylated in vivo (Rab8, Rab8b, Rab13 and Rab23) indicating the importance of 
enhancing membrane interaction through this alternative mechanism. 
Membrane binding of the yeast Rab exchange factor and effector Sec2p has recently been 
demonstrated to depend on the presence of PI4P. Sec2p is first recruited to the Golgi by PI4P 
and Ypt32 (see Rab cascade, 1.5.3). Vesicles bud off the Golgi, containing the interacting Ypt32 
and Sec2p, but reduced concentration of PI4P. Sec2p then activates Sec4p via its function as a 
GEF, leading to Sec15p recruitment, which in turn competitively replaces Ypt32 in binding to 
Sec2p [168]. 
 
1.8.4.2 Rab domains and cholesterol 
Rab proteins, even when bound to the same organelle membrane can be localised to distinct 
membrane domains, for example Rab4 and Rab5a on early endosomes and Rab7 and Rab9 on 
late endosomes [169-171] (Figure 28). Late endosome motility is affected by membrane 
content of cholesterol. Increasing levels of cholesterol were shown to promote Rab7 
recruitment, decrease Rab7 re-extraction by GDI and impair vesicle motility [172]. Similarly, 
stabilisation of Rab9 membrane binding by cholesterol has recently been shown, however this 
is accompanied by decrease in Rab9 function, i.e. a disruption of late endosomal export of 
Mannose-6-phosphate receptors [173].  Conversely, Rab3a membrane recruitment in sperm 
acrosomal membranes was shown to increase upon cholesterol depletion. However, its activity 
was not influenced [174]. Due to the impact of cholesterol on membrane elasticity, these 
examples could indicate a functional role of membrane mechanics on Rab protein recruitment. 
An overview of Rab membrane binding studies will be given in section 5.1.1. 
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Figure 28: Rab domains [8]. The occurrence of microdomains enriched for specific Rab GTPases, as 
exemplified with endosomes. Early endosomes contain separate domains enriched in Rab5 (blue) and 
Rab4 (red) which are involved in endosome fusion and endocytic recycling respectively. The recycling 
endosome contains domains enriched in Rab4 and Rab11 (green), which are involved in vesicle 
trafficking from the early endosome to the plasma membrane, respectively. Late endosomes contain 
domains enriched in Rab7 (yellow) and Rab9 (purple), which mediate trafficking to lysosomes and the 
trans-golgi network (TGN), respectively. 
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1.9 Aims of the project 
The aim of this project is the investigation of the molecular mechanisms of Rab membrane 
interaction at the level of membrane delivery and extraction by GDI. Eukaryotic cells are highly 
compartmentalised and require mechanisms to communicate between different 
compartments. Rab proteins are key regulators of these communication pathways and need to 
be targeted correctly to membranes. Protein factors are thought to be implicated in regulating 
Rab membrane targeting specificity, but other small GTPases have been shown to implicate 
lipid and membrane properties in this process. Given the high sensitivity of other members of 
the Ras superfamily of GTPases, and the function of Rab proteins in membrane traffic, involving 
processes of extreme membrane curvature, it is likely that Rab proteins can also sense 
membrane stress.  
 
 Chapter 2 presents the expression and purification of different proteins required for further 
experiments. 
 In chapter 3 assays for the formation and purification of Rab:GDI complexes, subsequently 
used in Rab membrane delivery studies, are developed. This involves implementing a 
method for obtaining high concentrations of sufficiently pure Rab:GDI complex with 
fluorescently labelled Rab protein to enhance later detection. Rab fluorescence allows Rab 
detection and adjustment of the complex to identical starting concentrations in the 
membrane binding assay. Not all Rab proteins are suitable for complex formation with GDI, 
therefore a study is presented investigating the extractability of a broad range of Rab 
proteins. Furthermore, the implications of differences in extractability with GDI on Rab 
function are discussed.  
 Chapter 4 establishes the phase behaviour of complex synthetic organelle mimetic 
membrane compositions to determine their suitability as model membrane systems for Rab 
delivery experiments. Methods used are X-ray scattering techniques and differential 
scanning calorimetry. Furthermore, membrane fluctuation analysis of giant unilamellar 
vesicles consisting of binary lipid mixtures is applied to determine their bending rigidity. This 
is necessary in order to correlate Rab binding to these mixtures to their biophysical 
properties. It is shown that the bending rigidity of DOPC/DOPE mixtures is dependent on the 
mol fraction of DOPE, indicating that phospholipid headgroups have a considerable effect on 
the bending rigidity. 
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 Chapter 5 shows data of Rab delivery to membranes of different lipid compositions, with 
defined biophysical properties, previously determined in Chapter 4. This assay involved the 
development of a method for separating membranes from a surrounding solution, followed 
by detection of membrane bound and free Rab. It is revealed  that there is a linear 
correlation between membrane biophysical properties and membrane partitioning of Rab1a. 
Furthermore, Rab binding is shown to be not strictly dependent on other protein factors.  
 The Rab lipid motif modulates membrane association. Rab proteins are generally believed to 
be exclusively prenylated, however recent indications of potential palmitoylation of Rab 
proteins has questioned this. In chapter 6 a number of Rab proteins are subjected to 
metabolic labelling, in order to identify palmitoylated Rab proteins.  
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CHAPTER 2 
Protein Expression and Purification 
 
This chapter presents the exogenous expression and purification of E. coli and Sf9 derived 
(His)6-Rab5a, and Sf9 (His)6-GDIα and (His)6-GDIβ. Unprenylated (His)6-Rab5a from E. coli was 
purified by Nickel affinity chromatography. The total yield from 5 L E. coli culture was 102 mg, 
the main pool having a concentration of 2.6 mg/mL of which 30 mL were obtained. Prenylated 
(His)6-Rab5a was expressed in Sf9 cells and the expression time optimised with respect to yield 
of total prenylated protein. 2 mL of 0.6 mg/mL (His)6-Rab5a were obtained from 500 mL Sf9 cell 
culture by batch wise Nickel affinity purification. 
GDIα and β were also overexpressed in Sf9 and purified by batch purification on NiNTA agarose 
beads. A total amount of 21.9 mg for GDIα and 8.3 mg for GDIβ was obtained from 500 mL Sf9 
suspension. RGGTase was purified from Sf9 cells co-expressing both subunits using ion-
exchange followed by size exclusion chromatography. 1 L cell culture yielded 26 mg of RGGTase 
in two separate pools, the main pool exhibiting a concentration of 10 mg/mL and a volume of 
2 mL. This sample was sent for crystallisation with a novel phosphonocarboxylate RGGTase 
inhibitor. Rab5a and both GDI isoforms were purified for Rab:GDI complex formation (see 
Chapter 3) 
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2.1 Materials and Methods 
2.1.1 Media and Chemicals 
Media and supplements were purchased from Gibco (Invitrogen) unless otherwise specified. 
Chemicals were obtained from Sigma-Aldrich unless otherwise specified. 
Protease inhibitor tablets were procured from Roche. 
 
2.1.2 Tissue Culture Methods 
2.1.2.1 Passaging of adherent mammalian cell lines  
COS7 (African green monkey kidney) and HEK293 (Human embryonic kidney) cells were 
maintained at 37°C in DMEM (Dulbecco’s modified Eagle’s medium) supplemented with 2 mM 
L-Glutamine, 10% FBS (foetal bovine serum), 100 U/mL penicillin and streptomycin under a 
humidified atmosphere containing 10% (v/v) CO2.  
Cells grown in 10cm dishes were passaged when they reached 90% confluency as follows: The 
medium was removed and the cells were washed once with 5 mL DPBS (Dulbecco’s phosphate 
buffered saline) before 2.5 mL 2.5% trypsin-EDTA solution was administered to the cell layer 
and immediately removed. The cells were incubated at 37°C for 3 - 5 minutes to detach the 
cells, followed by inactivation of the remaining trypsin by resuspending the cells in complete 
medium. The cells were split in ratios between 1:5 and 1:10 and grown to 90% confluency. 
 
2.1.2.2 Passaging of Sf9 cells in monolayer and suspension 
Spodoptera frugiperda (Sf9) cells were grown in monolayer and suspension at 27°C using 
Sf900II SFM supplemented with 100 U/mL streptomycin and 100 U/mL penicillin. Adherent Sf9 
cells were scraped when reaching 90% confluency. The cells were resuspended in complete 
medium and diluted 1:10. Sf9 cells in suspension were grown under 100 rpm agitation until 
they reached a density of 8x106 cells/mL and were then diluted to a density of 2x106 cells/mL in 
complete media. 
 
2.1.2.3 Freezing and thawing cells 
Sf9 cells were grown in 250 mL T-flasks to 90% confluency. They were scraped and pelleted at 
800g for 5 min, followed by washing the pellet in 10 mL SF900II SFM and resuspension in 4 mL 
Sf900II SFM supplemented with 10% (v/v) DMSO (dimethylsulfoxide). The cells were aliquoted 
into cryo tubes and immediately frozen in liquid nitrogen. To grow Sf9 cells from frozen stocks 
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they were quickly thawed at 37°C and immediately resuspended in 10 mL Sf900II SFM medium 
supplemented with 10% FBS. The medium was exchanged daily until the cells started 
replicating, at which point the FBS concentration was gradually decreased in steps of 1-2%  until 
the cells were adjusted to serum free medium.  COS7 and HEK293 cells were quickly thawed 
and resuspended in 4 mL complete medium in a T12.5 flask. The medium was exchanged after 
cell attachment to remove toxic DMSO.  
 
2.1.3 Microbial methods and molecular biology 
2.1.3.1 Antibiotics 
The following table shows the antibiotics used in cloning techniques and their stock and 
working concentrations. 
 
Table 2: Antibiotics and respective concentrations used for E. coli cultivation 
 Stock concentrations 
Concentration  
range *μg/mL+ 
Ampicillin 10% (w/v) in dH2O 50 to 100 
Kanamycin 3.4% (w/v) in dH2O 34 to 50 
Chloramphenicol 2.5% (w/v) in ethanol 25 
Tetracycline 10% in 50% (w/v) ethanol 10 
Gentamycin 5% (w/v) in dH2O 7 
 
 
2.1.3.2 Standard Escherichia coli and DNA techniques 
For the transformation of E. coli with plasmid DNA, preparation of E. coli glycerol stocks, 
isolation of plasmid DNA from E. coli and gel extraction of DNA from agarose gels Qiagen kits or 
standard techniques were used, as described in Sambrook and Russel [175] and are described 
in detail below. A summary of the E. coli genotypes used for different applications is provided in 
Table 3. 
 
Table 3: E. coli gentotypes and respective applications 
E. coli species Supplier Application 
DH5α, subcloning efficiency Invitrogen Subcloning of plasmid DNA, DNA amplification 
XL10 –Gold Ultracompetent Stratagene Plasmid amplification after site directed 
mutagenesis 
BL21-codon plus (DE3) RILP Stratagene Protein expression 
MAX Efficiency DH10Bac Invitrogen Bacmid formation and amplification 
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2.1.3.2.1 Transformation of competent E. coli 
50 μL ultracompetent DH5α cells were thawed on ice for 10 min. 1 – 100 ng plasmid DNA was 
added to the cells and mixed by gently tapping the tube. After 30 min on ice, DNA uptake was 
initiated by heat shock for 30 s at 42 °C. The cells were incubated on ice for 2 min followed by 
addition of 0.5 – 1 mL LB medium to the cells. The cells were incubated at 37°C for 1 h with 
agitation at 180 rpm and plated onto agar plates containing the appropriate antibiotic. Plates 
were inverted and incubated overnight at 37°C for 12-16 h.  The following day, colonies were 
picked to inoculate 5 ml LB media cultures which were grown overnight at 37°C with agitation 
at 230 rpm.  Cultures were subsequently used for production of DNA or glycerol stocks. 
 
2.1.3.2.2 Production of E. coli glycerol stocks 
E. coli cell cultures grown overnight were diluted two fold in sterile 20% glyercol, snap frozen in 
liquid nitrogen and stored at -80°C. 
 
2.1.3.3 DNA quantification by spectrophotometry 
DNA was quantified by measuring the optical density (OD) at 260 nm using a Nanodrop ND-
1000 spectrophotometer. An OD260 of 1 was assumed to be equivalent to a DNA concentration 
of 50 ng/μL. 
 
2.1.3.4 Separation of DNA by agarose gel electrophoresis 
DNA was electrophoretically separated on Tris/Boric acid/EDTA (TBE) agarose gels containing 
0.2 μg/mL ethidium bromide. The agarose concentration varied between 0.7 and 1.2%, 
depending of the size of the fragments to be separated. Before loading, the samples were 
mixed with DNA loading buffer. A voltage of 100 V was applied and the samples were 
electrophoresed until the dye approached the bottom of the gel. DNA bands were visualised 
under UV illumination. 
 
TBE 
90 mM Tris 
90 mM boric acid 
3.2 mM EDTA 
6xDNA loading buffer 
In TBE: 
0.25% bromophenol blue 
40% sucrose 
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2.1.3.5 Standard Polymerase Chain Reaction (PCR) 
Polymerase chain reaction was applied to amplify DNA fragments. The standard procedure was 
used as follows unless stated otherwise. For amplification of fragments used for subcloning, 
PfuTurbo DNA polymerase (Stratagene) was used instead of Taq polymerase including the 
appropriate 10xPfu-buffer and no magnesium chloride was added. The extension temperature 
for Pfu polymerase was reduced to 68°C. 
 
Table 4: Composition of standard PCR reaction mix 
Component  
( stock concentration) 
Volume *μL+ Final amount or conc. 
10xTaq-Buffer -Mg (Invitrogen) 5 1x 
MgCl2 [50 mM] 1.5 1.5 mM 
dNTP mix [10 mM each] 1 0.2 mM (each) 
1:1 Primer mix *10 μM each+ 1 0.2 μM (each) 
Template [10-100 ng/μL+ 1 10-100 ng 
Taq DNA polymerase (5 U/ μL) 1 5 U 
dH2O to  50  
 
Table 5: Standard PCR temperature profile  
Temperature [°C] Time  Cycles 
94 3:00 min 1 
94 0:45 min  
55 0:45 min 30 
72 1 min/kb  
72 10:00 min 1 
 
 
2.1.4 Bacmid DNA and virus production 
2.1.4.1 Production of bacmid DNA 
Bacmid DNA for the transfection of Sf9 cells was produced from pFastBacHtb vectors containing 
the gene to be expressed. 1 – 10 ng of the recombinant pFastBacHtb vector was transformed 
into E. coli DH10Bac cells. This strain contains bacmid DNA and a helper plasmid that acts in the 
transposition of the DNA fragment from the recombinant pFastBac vector to the bacmid. The 
transformation was performed as described previously (see section 2.1.3.2.1), except that the 
cells were recovered in Luria Bertani (LB) medium for 4 hours instead of one hour. To select for 
recombinant bacmids, transformed cells were plated on LB agar plates (1.5% (w/v) agar) 
containing 50 µg/ml kanamycin, 7 µg/ml gentamicin, 10 µg/ml tetracycline, 100 µg/ml Bluo-gal, 
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and 40 µg/ml IPTG and grown at 37°C for 48 hours. White colonies were selected and 
restreaked on fresh plates containing the same supplements to confirm their white phenotype. 
White colonies were grown in 100 mL LB medium containing 50 µg/ml kanamycin, 7 µg/ml 
gentamicin and 10 µg/ml tetracycline and the bacmid DNA was isolated using a Qiagen Midi 
prep kit following the manufacturer’s instructions.  
 
2.1.4.2 Analysis of recombinant bacmid DNA by PCR 
To ascertain whether the correct insert was present, purified bacmid DNA was used as template 
in a PCR reaction with the primers M13 forward (-40) and M13 reverse. The expected size of 
the product was the sum of 2430 bp plus the size of the insert.  
 
2.1.4.3 Production and amplification of recombinant baculovirus 
Recombinant bacmid DNA was transfected into Sf9 cells to produce recombinant baculovirus. 
The transfection was achieved using Cellfectin Reagent (Gibco), which is a liposome mixture 
containing TM-TPS and DOPE (1:1.5 (M/M)). 
The following procedure based on the protocol supplied by Invitrogen (Bac-to-Bac® Baculovirus 
Expression System) was used. 1x106 cells/well were seeded in a 6-well tissue culture plate in 
2 mL Sf-900IISFM and incubated for 1 hour at 27°C to allow attachment of the cells. In parallel 
2 μg bacmid DNA and 10 μL Cellfectin reagent were separately diluted in 100 μL each of 
unsupplemented Grace’s medium. Both solutions were then combined, gently mixed and 
incubated at room temperature for 45 min.  
After attachment of the cells in the 6-well plate they were washed once with unsupplemented 
Grace’s medium. 0.8 mL of unsupplemented Grace’s medium was added to the DNA:lipid 
mixture and this mixture transferred into the well. After incubation for 5 hours at 27°C the 
medium was exchanged for 3 mL complete growth medium. The cells were incubated 96 hours 
until signs of viral infection were apparent. The P1 viral stock was isolated by centrifuging the 
supernatant for 10 min at 800g. The P2 and P3 viral stocks were produced by infecting 10 - 50 
mL Sf9 suspension (2x106 cells/mL) with viral stocks P1 and P2 respectively in dilutions of 1:10 
to 1:100 depending on their titre. After incubation for 96 hours at 27°C and agitation at 
100 rpm the cell supernatant was collected by centrifugation of the cells for 10 min at 800g. 
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2.1.5 Protein techniques 
2.1.5.1 Bradford assay 
The Bradford assay served as the means of choice for determining the protein concentration for 
membrane containing samples and for the measurement of samples with low protein 
concentration. The Bradford assay was performed using the Pierce Coomassie Plus Reagent 
(Thermo Scientific) according to the manufacturer’s instructions. Briefly, the protein sample 
was diluted to a concentration within the range of a bovine serum albumin (BSA) standard. 
33 μL protein sample was pipetted into a plastic cuvette and 1 mL Coomassie Reagent was 
added subsequently. After 10 min incubation at room temperature the absorption at 595 nm 
was measured. Water alone was used as a reference.  
 
2.1.5.2 Spectrophotometric measurement of protein concentration from absorption at 
280 nm  
Protein concentration was measured by determining the absorption at 280 nm using the 
Nanodrop ND-1000 spectrophotometer. For protein mixtures an OD of 1 was assumed to be 
equivalent to 1 mg/mL and for purified protein the molar extinction coefficient and molecular 
weight was calculated based on their amino acid sequence using internet based programs 
provided on the ExPASy proteomics server. 
 
2.1.5.3 Separation of proteins by SDS-Polyacrylamide gel electrophoresis 
Proteins were electrophoretically separated on 12.5% polyacrylamide gels based on the 
method described by Laemmli 1970 [176]. Electrophoresis was performed using a “Mighty 
Small” apparatus (Hoefer) under a voltage of 160 - 200 V. Pre-stained broad range or low range 
SDS-PAGE markers (Bio-Rad) were used as molecular weight standards. 
 
SDS-PAGE stacking gel 
5.5 % (v/v) acryl amide 
124 mM Tris pH 6.8 
0.1% (w/v) SDS 
0.05% (w/v) APS 
0.5% (v/v) TEMED 
 
 
 
 
SDS-PAGE resolving gel 
12.5% (v/v) acryl amide 
372 mM Tris pH 8.8 
0.1% (w/v) SDS 
0.05% (w/v) APS 
0.25% (v/v) TEMED 
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1xSDS-PAGE running buffer 
30 mM Tris pH 6.8 
192 mM glycine 
0.1% (w/v) SDS 
 
 
 
6xSDS-PAGE loading buffer 
0.3 M Tris pH 6.8 
10% (w/v) SDS 
40% (v/v) glycerol 
0.02% (w/v) bromophenol Blue 
9% (v/v) β-mercaptoethanol
 
2.1.5.4 Separation of proteins on urea acrylamide gradient gels by electrophoresis 
Prenylated Rab proteins can be separated from unprenylated ones on urea-acrylamide gradient 
gels [177]. 7.5% and 12.5% acryl amide mixtures were prepared as described in section 2.1.5.3, 
but the 7.5% gel was supplemented with 24% (w/v) urea and the 12.5% gel with 48% (w/v) 
urea.  
The two gel solutions were mixed in a gradient mixer (Hoefer) and cast into a 1.5 mm x 10 x 
10 cm gel mould with the higher percentage gel on the bottom. The stacking gel was the same 
as for usual SDS-Page gels (see 2.1.5.3). Electrophoresis was performed as described in section 
2.1.5.3. 
 
2.1.5.5 Detection of proteins on SDS-PAGE gels by Coomassie staining 
Staining of proteins was achieved by gently shaking the gels for 30 - 60 min in 50 mL Coomassie 
stain solution. Subsequently, the gels were destained overnight in destaining solution until the 
gel background became clear. 
 
Coomassie stain solution 
0.25% (w/v) Coomassie brilliant blue R250 
45% (v/v) methanol 
10% (v/v)acetic acid 
Destaining solution 
30% (v/v) methanol 
10% (v/v) acetic acid 
 
2.1.5.6 Detection of proteins on SDS-PAGE gels by silver staining 
In order to detect proteins on the nanogram scale below the sensitivity detectable by 
coomassie staining, the gels were stained by silver staining. All solutions were freshly made up 
with milliQ water. After electrophoresis, the gel was washed twice in fixation solution (40% 
ethanol, 10% acetic acid), either for 30 min each or incubating the second time overnight. The 
gel was then agitated for 2x 15 min in 20% (v/v) ethanol, followed by two 15 min washes in 
milliQ water. Sensitisation was achieved by incubating the gel in 0.03% (w/v) sodium dithionite 
(Na2S2O4) for 1 min. The gel was twice washed in milliQ water for 1 min and then stained in a 
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0.2% (w/v) silver nitrate solution for 20 to 60 min. The gel was then washed briefly in milliQ 
water for 10 to 20 s and subjected to development (3% (w/v) K2CO3, 250 μg/L formaldehyde, 
0.001% (w/v) sodium thiosulfate (Na2S2O3)) for 5 to 20 min until the staining was sufficient. To 
stop the reaction, gels were incubated in 5% (w/v) Tris pH 7.5, 2% (v/v) acetic acid for 30 min 
and finally washed in milliQ water for at least 1 h.  
 
2.1.5.7 Western immunoblotting 
Proteins were transferred from SDS-gels onto PVDF membranes (polyvinylidene fluoride, 
Millipore ImmobilonTM-P) using a Hoefer TE2 mini tank transfer unit at 500 mA for 75 min. Prior 
to transferring, the PVDF membrane surface was hydrated by consecutive equilibration in 
methanol and transfer buffer. A sandwich of two Whatman filter papers, membrane, SDS gel 
and another Whatman filter paper was assembled and the cathode connected to the side 
corresponding to the PVDF membrane side. After the transfer, the membrane surface was 
blocked in PBST supplemented with 5% (w/v) skimmed milk powder for 1 hour, followed by 
incubation overnight at 4°C with the appropriate primary antibody in PBST supplemented with 
1% milk powder. The membrane was subsequently washed 3x10 min with PBST and incubated 
1 hour with the appropriate secondary antibody (conjugated to horseradish peroxidase, HRP) at 
room temperature. After another 3 washes with PBST (10 min each) the proteins were detected 
using either SuperSignal West Pico Chemiluminescent substrate (Pierce) or the ECL Plus 
Western Blotting detection system (GE Healthcare, Amersham) according to the manufacturer’s 
instructions. 
 
Transfer buffer 
40 mM glycine 
48 mM Tris 
1.25 mM SDS 
20% (v/v) methanol 
 
PBST 
140 mM NaCl 
2.7 mM KCl 
10 mM NaH2PO4 
1.8 mM K2HPO4 pH 7.4 
0.1% (v/v) Tween20 
 
Chemiluminescent detection was performed by exposing a sheet of Amersham hyperfilm ECL 
(GE Healthcare) to the membrane. The films were developed in a Compact X4 developer 
(Xograph Imaging Systems). For quantitative analysis (densitometry) of the signals, 
chemiluminescence was detected using a Fuji Film LAS-3000 imager and AIDA Image analyse 
3.52 software.  
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2.1.5.7.1 Antibodies used for immunoblotting 
Primary antibodies used for immunoblotting are summarised in Table 6. 
 
Table 6: Antibodies used for immunoblotting  
Antigen Antibody Working 
dilution 
Source 
Histidine-tag αPolyhistidine (mouse monoclonal) 1/7000 Sigma H1029 
hRab5a αRab5a (mouse monoclonal) 1/2000 Transduction Labs 
610725 
hGDI αGDI (rabbit polyclonal) 1/2000 Zymed 71-0300 
GFP αGFP (mouse monoclonal) 1/2000 Roche Applied 
Science 11814460001 
GFP αGFP (rabbit polyclonal) 1/2000 Abcam ab290 
Calnexin αCalnexin (rabbit polyclonal) 1/5000 Stressgen SPA-860 
 
 
2.1.5.8 Expression of recombinant proteins in E. coli 
100 mL BL21-codon plus (DE3) RILP cells containing the plasmid of interest were grown 
overnight in LB medium containing the appropriate antibiotic (see Table 2) at 37°C and with 
agitation at 210 rpm. This culture was used the next day to inoculate 5 L of fresh LB medium at 
a dilution of 1:40. These cultures were grown to an OD600 of 0.6 to 0.9, at which point the 
expression was induced by the addition of 200 μM IPTG (isopropyl-β-D-thiogalactopyranoside). 
After an induction time of 2 - 3 hours at 37°C the bacterial cultures were harvested by 
centrifugation at 6000g for 15 min at 4°C.  
 
2.1.5.9 Purification of (His)6-Rab5a from E. coli by affinity chromatography 
Cell pellets were lysed by resuspending in ice-cold lysis buffer (10 mL per 1 L cell culture) and 
sonicating three times for 30 s each at 20 μm (Branson Sonifier 450) before incubating the 
lysate on ice for 30 min. The lysate was centrifuged at 100000g, 4°C for 1 h and the resulting 
supernatant was adjusted to 500 mM NaCl. The supernatant was then loaded onto a 5 mL 
Nickel-sepharose column (GE Healthcare) previously equilibrated in buffer A and connected to 
a Fast protein liquid chromatography system (FPLC, Pharmacia Biotech). The column was 
washed with 50 mL buffer A and elution was performed with a linear imidazole gradient ranging 
from 0 to 40% buffer B (imidazole 0 – 200 mM). Eluates were collected in 4 mL fractions and 
each fraction was analysed by SDS-PAGE followed by Coomassie staining to determine the 
fractions containing the desired protein. The respective fractions were pooled and dialysed in 
dialysis buffer overnight.
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Lysis Buffer 
50 mM Tris pH 7.5 
150 mM NaCl 
5 mM MgCl2 
1 mM β-mercaptoethanol 
1x Complete protease inhibitor (Roche) 
1 mg/mL lysozyme 
 
Buffer A 
50 mM Tris pH 7.5 
500 mM NaCl 
5 mM MgCl2 
1 mM β-mercaptoethanol 
10 mM imidazole 
Buffer B 
50 mM Tris pH 7.5 
500 mM NaCl 
5 mM MgCl2 
1 mM β-mercaptoethanol 
500 mM imidazole 
 
 
Dialysis Buffer 
50 mM Tris pH 7.5 
150 mM NaCl 
5 mM MgCl2 
1 mM β-mercaptoethanol 
1 mM GDP 
 
2.1.5.10 Expression of proteins in Sf9 cells 
Prior to the large scale expression of proteins in Sf9 cells, expression was verified and optimised 
by time course protein expression analysis. For this purpose, 20 mL Sf9 cultures were infected 
with baculovirus stocks in dilutions of 1:100 to 1:1000. 1 to 5 mL samples were taken every 24 h 
for 4 to 5 days and analysed by Western blotting. For the large scale expression of proteins, 
400 mL to 1 L Sf9 cultures containing 2x106 cells/mL were used. Infection was performed with 
baculovirus dilutions that were shown to be adequate for expression on a small scale and 
harvested after the respective optimal times. The cells were harvested by centrifugation at 
800g for 30 min at room temperature and the pellet either stored at -80°C or used for protein 
purification immediately.  
 
2.1.5.11 Purification of recombinant (His)6-Rab5a from Sf9 
Recombinant (His)6-Rab5a was purified from Sf9 based on the protocol described by Horiuchi et 
al. [178] as follows. An Sf9 pellet from 500 mL culture (approximately 3 mL pellet) was lysed by 
resuspending in 40 mL lysis buffer followed by sonication three times for 30 sec each with an 
amplitude of 20 μm (Branson Sonifier 450). The total lysate was centrifuged at 100000g, 4°C for 
1 h to obtain the P100/S100 fractions. The P100 should contain only prenylated Rab and was 
therefore used for further purification steps. The membrane pellet (P100) was resuspended in 
40 mL buffer A by sonicating three times  for 10 s each and then supplemented with 0.6% 
CHAPS. The detergent is required to minimise precipitation of hydrophobic prenylated Rab5a.  
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The resuspended membrane fraction was rotated at 4°C for 1 - 2 h to allow solubilisation of 
prenylated Rab5a into solution. The sample was centrifuged again at 100000g, 4°C for 1 h and 
the supernatant containing solubilised prenylated Rab5a was used for further purification. 
In order to purify the solubilised, prenylated Rab5a, 2 mL NiNTA agarose beads (Qiagen) were 
washed three times in lysis buffer supplemented with 10 mM imidazole and 0.6% CHAPS. The 
supernatant was adjusted to 300 mM NaCl and added to the beads. After rotation at 4°C for 2 - 
3 hours the supernatant was removed from the beads. The beads were washed twice in 50 mL 
wash buffer (lysis buffer + 10 mM imidazole + 300 mM NaCl) and the proteins were then eluted 
from the beads with a stepwise gradient of 25/50/75/125/150/175 mM imidazole. The protein 
content of each fraction was assessed using Pierce Coomassie Plus reagent (Thermo Scientific) 
and the imidazole concentration was only continued to the next gradient step after a decrease 
of protein concentration was visualised. The fractions were analysed by SDS-PAGE followed by 
Coomassie staining. Appropriate fractions were combined and concentrated on Viva spin 
columns (10 kDa cut off). Imidazole and high salt concentration was then removed by buffer 
exchange  using a PD10 column (Pierce) following the manufacturer’s protocol using lysis buffer 
(without PI), followed by another round of concentration until 0.5 to 3 mg/mL were reached. 
 
Lysis buffer 
20 mM HEPES pH 7.2 
150 mM NaCl 
5 mM MgCl2 
2 mM β-mercaptoethanol 
1xPI 
 
2.1.5.12 Purification of RabGDIα and β from Sf9 cells using affinity chromatography 
An Sf9 pellet from 500 mL culture was lysed by resuspending in 30 mL lysis buffer and 
sonicating the cells for 30 sec at 20 μm (Branson Sonifier 450). The total lysate was then 
centrifuged for 1 h at 100000g and 4°C. Meantime, 5 mL NiNTA agarose resin were equilibrated 
by washing three times in 50 mL lysis buffer (without PI). The supernatant fraction (S100) of the 
total lysate was added to the equilibrated NiNTA beads and incubated 2 - 3 hours at 4°C under 
gentle end over end agitation. This was followed by centrifugation at 4000g, 4°C for 10 min to 
pellet the beads and washing them once in 50 mL lysis buffer (without PI) and twice in lysis 
buffer with 0.2% (w/v) CHAPS instead of Triton X-100. The beads were transferred into a 
column and the proteins were eluted with a stepwise gradient of imidazole in lysis buffer 
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(+0.2% (w/v) CHAPS) starting at a concentration of 10 mM to 200 mM. The fractions were 
analysed by SDS-PAGE followed by Coomassie staining. Fractions containing the protein of 
interest were pooled and concentrated using 30 KDa cut off Vivaspin columns (GE Healthcare) 
to a concentration of 1-3 mg/mL followed by buffer exchange on a PD10 column (Pierce) which 
was used according to the manufacturer’s instructions. The fractions were pooled and 
concentrated once more if the concentration was lower than 1 mg/mL. The protein was 
aliquoted, snap frozen in liquid nitrogen and stored at -80°C. 
 
Lysis buffer 
50 mM Tris pH 7.5  
150 mM NaCl 
5 mM MgCl2 
1 mM β-mercaptoethanol 
0.2% Triton X-100 
1x PI (Roche) 
 
2.1.5.13 Purification of RGGTase from Sf9 using ion exchange chromatography and 
subsequent size exclusion chromatography 
Preparation of recombinant RGGTase from Sf9 cells and subsequent purification was based on 
the protocol described by Armstrong et al. [179]. Cells obtained from 1 L Sf9 cell culture were 
resuspended in 40 mL lysis buffer and lysed by sonication for 2x30s at 20 μm (Branson Sonifier 
450) . The lysate was subjected to ultracentrifugation for 1 h at 100000g, 4°C and the 
supernatant was bound to a miniQ column (HiLoad Q-sepharose FF (16/10), GE Healthcare, 
20 mL column volume) using an FPLC system. The column was washed with 2 column volumes 
(CVs) buffer A (50 mM Tris pH 7.5, 1 mM DTT), followed by a linear gradient reaching 15% 
buffer B (buffer A supplemented with 1 M NaCl) over 1.5 CVs. The column was washed with 
15% buffer B for 2 CVs before a linear gradient reaching 60% buffer B was applied over 7 CVs. 
5 mL fractions were collected and analysed by SDS-PAGE followed by Coomassie staining. 
Finally, a step to 100% buffer B was performed to wash the column. 
 
Lysis Buffer 
50 mM HEPES pH 7.2 
10 mM NaCl 
1 mM β-mercaptoethanol 
0.1 mM IGEPAL 
1xComplete protease inhibitor (Roche) 
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Fractions containing RGGTase were pooled, concentrated on 50 KDa cut-off Vivaspin columns 
to 2 mL and loaded onto a S200 (16/60) column for size exclusion chromatography. Protein was 
eluted with a flow rate of 1 mL/min and 1 mL fractions were collected starting after 40 mL 
elution volume, followed by analysis of the fractions by SDS-PAGE followed by Coomassie 
staining. Fractions containing RGGTase were pooled, dialysed against 5 L dialysis buffer, 
followed by concentrating using 50 KDa cut-off Vivaspin columns. 
 
S200 elution buffer 
20 mM HEPES, pH 7.2 
0.1 mM Igepal 
0.5 M NaCl 
1 mM DTT 
Dialysis buffer 
20 mM HEPES, pH 7.2 
0.1 mM Igepal 
10 mM NaCl 
1 mM DTT 
 
2.1.5.14 Size exclusion chromatography using a SMART system 
Size exclusion chromatography was performed on a SMART system (Amersham Pharmacia 
Biotech Inc.) using a Superdex 200 PC 3.2/30 column. The column was equilibrated with size 
exclusion buffer at a flow rate of 40 μL/min. 50 μL of sample was injected into a 100 μl loop and 
applied to the column at  a flow rate of 40 μl/min. Proteins were eluted with the same buffer 
and flow rate in fractions of 100 μL.  
 
Size exclusion buffer 
50 mM Tris pH 7.5 
150 mM NaCl 
5 mM MgCl2 
1 mM DTE 
  
2.1.5.15 Subcellular fractionation 
In order to separate cellular membranes including membrane associated proteins from 
cytosolic components, a subcellular fractionation was conducted. The cells of choice (Sf9, COS7 
or HEK293) were harvested and lysed as described in 2.1.5.11 and 3.2.7, followed by 
centrifugation at 600g at 4°C for 10 min to remove large cell debris. The resulting post-nuclear 
supernatant (PNS) was subjected to ultracentrifugation at 100000g, 4°C for 1 h in a Beckman 
TLA-45 rotor. The resulting P100 (membrane pellet, abbreviated to “P”) and S100 (supernatant, 
abbreviated to “S”) fractions were immediately separated. The membrane pellet was 
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resuspended to the same volume as the S100 fraction with lysis buffer containing 200 mM 
sucrose by 10 s sonication with an amplitude of 5 μm (MSE Soniprep 150). 
 
2.1.5.16 Triton-X114 extraction of prenylated proteins 
Prenylated Rab proteins were extracted from the cytosolic fraction (S100) using a Triton X-114 
extraction assay. Triton X-114 was added to the S100 fraction to a final concentration of 1% 
(v/v) from a 10% stock. The sample was then incubated at 37°C for 5 min until the solution 
became cloudy and subsequently centrifuged for 1h at 100000g, 4°C to separate the Triton X-
114 detergent fraction from the soluble fraction. The soluble fraction was adjusted to 1% (v/v) 
Triton X-114 as before and separated again, pooling the detergent phases. The detergent phase 
was adjusted to the same volume of buffer as the soluble phase and equal volumes were 
separated by SDS-PAGE for comparison of the prenylated and unprenylated fraction of Rab 
protein in the cytosol.  
 
2.1.5.17 In vitro prenylation assay 
In order to determine the activity of purified RGGTase an in vitro prenylation assay using 
[3H]GGPP was conducted, based on the protocol described in [180], preparing duplicates of 
each sample. The reaction volume was 20 μL, each containing 50 mM HEPES pH 7.2, 150 mM 
NaCl, 5 mM MgCl2, 1 mM DTE, 2 μM REP1, 5 μM Rab1a, 5 μM GGPP, 0.05 μL/reaction [
3H]GGPP 
(Amersham) and varying concentrations of RGGTase (0/6.125/12.5/25/50/100 nM). 
The reaction mixes were incubated at 37°C for 30 min and stopped by the addition of 1 mL 
EtOH/HCl (9:1). The samples were then incubated for at least 30 min at room temperature to 
precipitate proteins, followed by filtering the precipitates with a vacuum manifold device on 
Whatman glass microfiber filters, which were previously soaked in dH2O and washed twice with 
2 mL ethanol. 2 mL ethanol were added to each reaction and transferred to the filters. Each 
filter was washed three times with 2 mL ethanol followed by transfer to a scintillation vial. 4 mL 
scintillation fluid was added and the samples vortexed briefly. As a reference scintillation fluid 
alone was used. The scintillation was measured with a scintillation counter (Beckman LS 6000SC 
counter). 
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2.2 Results 
2.2.1 Expression and purification of unprenylated (His)6-Rab5a 
Expression of Rab proteins in E. coli generates unprenylated proteins because prokaryotic cells 
do not possess post-translational modification machinery. N-terminally histidine tagged human 
(His)6-Rab5a (234 aa, 25.68 kDa) was expressed in BL21-CodonPlus-RIL cells (Stratagene) and 
purified by affinity chromatography on NiNTA agarose using an FPLC system. The fractions were 
analysed by SDS-PAGE followed by Coomassie staining. Figure 29 shows the resulting 
Coomassie stained SDS-gels with the total lysate, flow through and respective fractions 
containing (His)6-Rab5a. Fractions 24 to 31 were combined to the main pool, and fractions 21 to 
23, 32 and 33 formed the second pool. Both pools exhibit very little protein degradation and 
are purified to homogeneity. The pools were dialysed and the protein concentration was 
determined by measuring absorption at 280 nm and calculating the concentration according to 
Beer-Lambert’s law: 
 
         
 Eq. 15, 
 
where A is the absorption, d the distance of the sample through which absorption is measured 
and ε the molar extinction coefficient of the respective protein, which was calculated from the 
amino acid sequence using the ExPASy ProtParam software. For (His)6-Rab5a the molar 
extinction coefficient was calculated as ε280nm = 18700 M
-1cm-1 and the resulting concentrations 
were 2.6 mg/mL (pool 1, 30 mL) and 2 mg/mL (pool 2, 12 mL). The total amount of purified 
Rab5a was therefore 102 mg. 
 
 
Figure 29: Purification of (His)6-Rab5a from E. coli. Coomassie stained SDS gels showing the total lysate 
(TL), flow through (FT) and fractions 17 to 38 of the NiNTA eluate containing (His)6-Rab5a. 
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2.2.2 Expression and purification of prenylated Rab5a from Sf9 
2.2.2.1 Optimisation of (His)6-Rab5a expression conditions 
In order to study membrane association of Rab proteins, they need to be prenylated 
[11,181,182]. The expression of proteins in Sf9 is more elaborate and costly than in bacteria. 
However, as bacterial expression systems do not exhibit the necessary post-translational 
modification machinery for prenylation, eukaryotic organisms had to be employed for the 
exogenous expression and purification of prenylated Rab proteins. Histidine-tagged human 
Rab5a was expressed in Sf9 after production of the respective bacmids from pFastBacHtb-
Rab5a (249 aa, 27.68 kDa). The bacmids were transfected into Sf9 cells and the resulting 
baculovirus was amplified to a P3 stock as described in section 2.1.4.3. For expression, Sf9 cells 
were infected with a viral dilution of 1/1000. Determination of the optimal expression time was 
accomplished by a time course expression study which revealed detectable expression at 48 h, 
which increases over time, peaking at 96 h. No expression could be detected after 24 h or in Sf9 
that were not infected with baculovirus (Figure 30). 
 
 
Figure 30: Western blot showing the expression of His-Rab5a in Sf9 at different time points post-
infection. Detection was performed with monoclonal anti-polyhistidine antibody (1/2000).(+) denotes 
samples infected with (His)6-Rab5a baculovirus, (-) denotes negative controls with uninfected Sf9 cells. 
 
However, if exogenous Rab proteins are highly overexpressed, the prenylation reaction can 
become limiting. In order to optimise the yield of prenylated Rab protein, the ratio of 
prenylated versus unprenylated Rabs was determined for different expression times during the 
over expression of Rab5a.The relative amounts of membrane associated exogenous and 
endogenous Rab proteins in Sf9 cells were determined by subcellular fractionation and Western 
blotting analysis. As can be seen in Figure 31, Rab5a expression can be detected after 48 h and 
the expression increases with time. After 48 h no Rab5a is detected in the membrane fraction, 
but after 72 h membrane bound Rab5a can be detected. The relative amount of Rab5a in the 
S100 and P100 at 72 h and 120 h was determined by densitometry using AIDA software, 
dividing the intensity of the pellet signal by the total amount of detected His-Rab5a. Even 
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though the total amount of Rab5a in the membrane fraction increases, the relative amount is 
slightly lower after 120 h expression (27.9%) time than after 72h (30.2%).  
 
A 
                
B 
 
Figure 31: Distribution of overexpressed His-Rab5a into the soluble (S) and membrane (P) fraction of 
Sf9 cells at different time points post-infection. (A) Western blots, (+) denotes virus infected samples,  
(-) denotes the negative control, uninfected Sf9 cells. (B) Densitometry of Western blots using AIDA 
software showing the percentage of Rab5a associated with membranes.  
 
Not all prenylated Rabs are bound to the membrane. The supernatant contains a pool of 
prenylated Rabs that are bound to GDI or REP. At high expression levels, when membranes are 
saturated with Rab protein, Rabs may possibly even be free in the cytosol. To investigate the 
fraction of prenylated Rab5a in the supernatant at different times post-transfection, the 
supernatant samples used in the subcellular fractionation were subsequently submitted to a 
Triton-X114 extraction assay , which is based on the fact that prenylated proteins partition into 
the detergent phase [183]. With increasing expression time the overall amount of Rab5a in the 
supernatant fraction increases, but also the fraction of prenylated Rab5a in the cytosolic 
fraction (supernatant) increases (Figure 32). 
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A 
                
B 
 
Figure 32: Distribution of prenylated and unprenylated overexpressed His-Rab5a at different time 
points post-infection. (A) TritonX-114 extraction of prenylated Rabs into the detergent phase (D), while 
unprenylated soluble Rabs remain in the aqueous (A) phase. +/- denotes samples + baculovirus and -
baculovirus controls respectively. (B) Densitometry of Western blots using AIDA software showing 
percentage of prenylated Rab5a. 
 
From the time course expression and prenylation studies it was concluded that Rab5a is 
sufficiently expressed in Sf9 cells. The optimal expression time lies between 72 h and 120 h and 
therefore Rab proteins were expressed for 96 h in large scale expressions.  
 
2.2.2.2 Purification of (His)6-Rab5a from Sf9 
Purification of recombinant histidine tagged Rab5a from 500 mL Sf9 cell culture was performed 
by batch affinity purification on NiNTA agarose beads. Elution commenced at 50 mM imidazole. 
The resulting fractions (Figure 33) show a sufficiently high expression of (His)6-Rab5a at 
approximately 31 kDa. Fractions 50 mM (3) to 125 mM (2) were pooled, concentrated, buffer 
exchanged using a PD10 column and finally concentrated again to obtain 2 mL of 0.6 mg/mL 
His-Rab5a with low degree of degradation and low amount of contaminating proteins. 
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Figure 33: NiNTA eluates of Sf9 derived overexpressed (His)6-Rab5a 
 
To assess the fraction of prenylated Rab5a the purified protein was separated by urea 
polyacrylamide gradient gel electrophoresis and compared to unprenylated Rab5a from E. coli, 
(Figure 34). Prenylated Rab proteins exhibit a higher electrophoretic mobility than 
unprenylated ones on urea polyacrylamide gradient gels [184]. Rab5a from Sf9 and E. coli run at 
slightly different heights, which may be due to their different polylinker lengths. Rab5a from Sf9 
is a 27.7 kDa protein, while E.coli derived Rab5a weighs 25.7 kDa, explaining its lower position 
on the SDS gel. The gel shows, that the purity of both proteins is very high. From the intensities 
of the prenylated and unprenylated His-Rab5a bands it is estimated that 50% of the purified 
Rab5a is prenylated. 
 
 
Figure 34: Coomassie stained urea-polyacrylamide gel of recombinant (His)6-Rab5a derived from E. 
coli (E) and Sf9 (S). 
 
2.2.3 Expression and purification of RabGDIα 
(His)6-RabGDIα was purified from a 500 mL Sf9 cell culture by a batch wise approach using 
NiNTA agarose beads. The protein was eluted with a step wise imidazole gradient. 1.5 mL 
fractions were collected and analysed by SDS-PAGE followed by Coomassie staining as shown in 
Figure 35. GDIα runs at approximately 60 kDa.  
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Elution of RabGDIα commenced at 25 mM imidazole, but the majority of the protein is eluted at 
50 mM imidazole. Three pools were prepared and concentrated on 30 kDa Vivaspin columns, 
followed by buffer exchange on a PD10 column. The resulting protein containing fractions were 
pooled and concentrated again. See Table 7 for a summary of the purification. 
 
Table 7: GDIα purification summary 
 
Pool 
Fractions from 
NiNTA elution 
Final volume 
(mL) 
Final concentration 
(mg/mL) 
Total protein 
mass (mg) 
A 25 mM (3-8) 
50 mM (10-12) 
75 mM (1) 
4.4 1.75 7.7 
B 25 mM (9-13) 
50 mM (1) 
2 1.14 2.28 
C 50 mM (2-9) 7 1.7 11.9 
 
In order to check the purity and quality of the three RabGDIα pools, they were analysed by SDS-
PAGE followed by Coomassie staining. 10 µg of each sample were loaded on the gel (Figure 35 
B). The main pool (C) is purified to homogeneity with little apparent degradation. Pool A and B 
contain minor contaminants but are nevertheless suitable for optimisation and trial 
experiments.  
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Figure 35: Purification of GDIα. Coomassie stained SDS gels of (A) elution fractions of GDIα from NiNTA 
beads, (B) final pools of GDIα. 
 
 
2.2.4 Expression and Purification of RabGDIβ 
GDIβ was purified using the same protocol as for GDIα (see 2.2.3). Figure 36 shows the 
Coomassie stained SDS gels of the resulting eluted fractions. GDIβ is highly expressed. All pools 
were concentrated to 0.5 – 1.5 mL and imidazole, salt and detergent removed on a PD10 
column, followed by another round of concentration. The final protein concentration was 
determined by absorbance at 280 nm assuming that the extinction coefficient is 
ε =39930 cm1M-1, as computationally calculated from the amino acid sequence (M = 50661 Da).  
The final pools of GDIβ are presented in Table 8, showing that they are all very pure, with little 
apparent contamination or degradation. Pool A exhibited a slightly higher level of 
contamination with other proteins. 
81 
 
Table 8: Summary of GDIβ purification 
 
Pool 
Fractions from 
NiNTA elution 
Final volume 
(mL) 
Final concentration 
(mg/mL) 
Total protein 
mass (mg) 
A 25 mM (7-9) 
50 mM (1-7) 
3 1.34 4 
B 50 mM (8-13) 
75 mM (1-2) 
2 1.4 2.8 
C 75 mM (3—7) 
100 mM (1) 
2 0.75 1.5 
 
 
 
Figure 36: Purification of GDIβ. Coomassie stained SDS gels of (A) elution fractions of GDIβ from NiNTA 
beads, (B) Final pools of GDIβ. 
 
2.2.5 Expression and purification of Rab geranylgeranyltransferase 
RGGTase was overexpressed in Sf9 cells and purified from 1 L of Sf9 cell culture. The first 
purification step consisted of ion exchange chromatography on a Q-sepharose column. The 
resulting Coomassie stained eluate fractions are shown in Figure 37. The two subunits of 
RGGTase, RGGTase α  (60 KDa) and ß (38 KDa) [17], are present in high concentrations and in 
approximately equimolar amounts in fractions C12 and D12. These two fractions were pooled 
and concentrated to 2 mL, followed by a second purification step by size exclusion 
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chromatography on a S200 column. Fractions C8 and C9 contain the α-subunit alone and D11 
the ß-subunit. 
 
 
Figure 37: Ion-exchange chromatography of RGGTase. Coomassie stained SDS gels of selected 
fractions. 
 
The respective eluate fractions from the S200 column are shown on the Coomassie stained SDS 
gels in Figure 38. It shows, that the protein is present in very high concentration and high 
purity. Two pools were generated, pool 1 containing fractions D14 -  D10 and pool 2 containing 
fractions C10 - C13 plus D8 - D9. 
 
 
Figure 38: Purification of RGGTase by size exclusion chromatography. Coomassie stained SDS gels of 
selected fractions. 
83 
 
The two RGGTase pools were concentrated to 2 mL each reaching a concentration of 10 mg/mL 
for the main pool 1 and 3 mg/mL for pool 2.  
Different amounts were analysed on a silver stained SDS gel (Figure 39), showing that both 
pools are purified to homogeneity with no apparent degradation. Pool 1 is completely pure, 
while in pool 2 a band at 30 KDa indicates a low amount of contamination. 
 
 
Figure 39: Final purified RGGTase pools. Silver stained SDS gel showing the main pool 1 and pool2 in 
increasing loaded amount. 
 
RGGTase activity of both protein pools was confirmed by in vitro prenylation of Rab1a with 
[3H]GGPP, see Figure 40. The prenylation curve shows comparable activity of all three samples. 
The previously purified RGGTase sample exhibits a slightly lower activity, which may be due to 
prolonged storage at -80°C for several years. Furthermore, the concentractions of pool 1 and 2 
may be underestimated. This would explain the lack of data points in the region of RGGT 
concentration dependence of prenylation. Pool 1 exhibits a slightly higher activity than pool 2 
as expected from its higher purity. It may be concluded that both purified RGGTase samples 
exhibit very high purity and prenylation activity. 
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Figure 40: In vitro prenylation assay of the two RGGTase pools compared to a previously purified 
RGGTase sample (from Sf9). Error bars indicate standard deviation from two measurements. 
 
1 mL of Pool 1 was sent for crystallography in association with a novel RGGTase inhibitor (see 
[185] for further information) in collaboration with Margarida Archer at the Institute of 
Technical Chemistry and Biology (ITQB) of the New University of Lisbon. No results have been 
obtained at the point of submission of this thesis. 
 
2.3 Chapter Summary 
This chapter presents the protein purification of E.coli and Sf9 derived recombinant (His)6-
Rab5a and Sf9 derived (His)6-GDIα and β and Sf9 derived RGGTase. All purified proteins were 
shown to exhibit high purity and low amount of apparent degradation. Sf9 expression of Rab5a 
was analysed with respect to extent of prenylation as a function of expression time. RGGTase 
activity was confirmed relative to a previously purified RGGTase protein and sent away for 
crystallisation studies. 
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CHAPTER 3 
Rab:GDI Complex Formation and  
GDI Extractability Comparison of Rab Proteins 
 
This chapter comprises two parts. The first presents attempts to produce and purify Rab:GDI 
complexes for Rab membrane partitioning studies. In the second part  a comprehensive study 
on Rab extractability from membranes with GDI is presented.  
We started by fluorescently labelling Rab proteins, using two different approaches. These were 
the utilisation of EGFP fusion proteins and loading of Rab proteins with the fluorescent GDP 
analogue MantGDP. Furthermore, different strategies for complex formation and purification 
were tested. These included dialysis of a mixture of purified Rab and GDI, extraction of Rab 
proteins from endogenous membranes with purified GDI followed by different purification 
strategies such as affinity purification on NiNTA beads, size exclusion chromatography, and 
glycerol gradient ultracentrifugation. Ultimately, the most successful Rab:GDI complex 
formation method was extraction of overexpressed EGFP-Rab from HEK293 membranes with 
purified recombinant GDI. Further purification of the complex by NiNTA affinity purification was 
not successful, due to an apparent instability of the complex upon imidazole elution. However, 
NiNTA pull down served to prove the existence of the complex. In addition, freeze-thawing was 
shown to disrupt the complex. Therefore it was decided to use the freshly produced crude 
EGFP-Rab:GDI extract for membrane partitioning studies.  
In the second part of this chapter, a large number of Rab proteins were screened for their 
extractability with GDIα and β. It was found that the maximum concentration of Rab proteins 
that was extractable into the soluble fraction ranges broadly between different Rab proteins, 
and they can be classified into low, medium and high extractability. While the C-terminus 
(prenylation motif and number of prenyl groups) did not apparently influence extractability, 
Rab proteins with low extractability are mostly secretory Rabs, potentially indicating a 
functionality underlying the extractability of Rab proteins.  
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3.1 Introduction 
A number of important criteria need consideration for the study of Rab-membrane interaction. 
Prenylated Rab proteins are hydrophobic and precipitate in aqueous solution, unless they are 
chaperoned by their in vivo binding partners GDI or REP [186]. For the purification of Rab 
proteins it is possible to add detergent as a means of solubilising and stabilising Rab proteins in 
solution [178]. However, the presence of detergent could interfere with subsequent Rab-
membrane binding assays. In addition, it is desirable not to merely study the binding of Rab 
proteins to membranes, but their delivery by GDI which is a more physiological process. 
Therefore, the first step towards membrane binding assays was the formation and purification 
of Rab:GDI complexes. Furthermore, it was intended to use fluorescence as a means of 
detecting the Rab proteins, in order to quantify the relative amounts partitioning into the 
membrane. Preparative formation of the Rab:GDI complex  requires the determination of 
optimal Rab proteins for this purpose, as Rabs display differential affinities for GDI and hence 
different extractability from membranes. GDI extractability studies utilising a range of Rab 
proteins were performed to identify optimal Rabs to produce the maximal Rab:GDI complex 
yield. Furthermore, the investigation of Rab extractability with GDI is also of great interest from 
a physiological point of view. The mechanism of GDI extraction of Rab proteins from 
membranes has been investigated in recent years [55,186,187], but its regulation and 
differentiation between Rab proteins remains obscure. Phosphorylation has been identified as 
a potential means of regulating GDI activity, when it was found that GDI is activated by p38 
MAPK, promoting association with Rab5a and stimulating endocytosis [53,54]. However, it is 
unclear whether GDI plays a role in the regulation of Rab function, or if it merely serves to 
maintain an available cytosolic Rab pool by acting  as a recycling factor for Rab proteins. A 
comprehensive screening of a variety of Rab proteins has not been conducted to date, partly 
due to the lack of a suitable comparative assay. Differential extractability of Rab proteins by GDI 
would indicate a possible regulating role of GDI for Rab function, through the modulation of 
Rab-membrane interaction.  
The implementation of a Rab membrane extraction assay that normalises conditions for all Rab 
proteins assayed made it possible to study a broad selection of Rab proteins with respect to the 
influence of the C-terminal prenylation motif on GDI extraction. Furthermore a comparison of 
the affinity of GDIα and β for a selection of different Rab proteins was performed. Analysis of 
Rab proteins based on their sequence homology has suggested a classification into functional 
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groups that share sequence identity, structural and also functional similarity [188] (Figure 41). 
Consequently, a range of Rab proteins representing a variety of C-terminal prenylation motifs 
from several functional families were assayed for their extractability by GDI. 
 
Figure 41: Neighbour joining dendrogram of the human, nematode, fly and fission yeast Rab families. 
The roman numerals represent the functional groups [188].  
 
3.1.1 Fluorescence labelling of Rab proteins 
Rab membrane extraction assays (and subsequent Rab membrane binding assays, see Chapter 
5) require a means of facilitating Rab protein detection. An ideal method is fluorescent 
labelling, as it enables rapid and sensitive detection, as well as precise quantification.  
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Several possibilities exist for fluorescent labelling of Rab proteins. The fluorescent GDP 
analogue MantGDP (2'-/3'-O-(N'-Methylanthraniloyl)guanosine-5'-O-diphosphate (Figure 42) 
has been used extensively in small GTPase studies to track membrane interaction [165,166,189] 
or study nucleotide release [190,191] and may be used to load Rab proteins [192-194]. Upon 
binding, MantGDP fluorescence yield increases by 100%, allowing the detection of nucleotide 
binding or release. Nucleotide exchange (GDP to MantGDP) must be performed prior to GDI 
complex formation, as GDI binding inhibits nucleotide exchange. Rab proteins generally exhibit 
a higher affinity for GDP than other small GTPases and therefore quantitative nucleotide 
exchange of Rabs requires a more elaborate protocol. First, the bound nucleotide is removed in 
the absence of Magnesium ions (addition of EDTA) and under mild denaturing conditions using 
ammonium sulphate as the denaturing agent to open the nucleotide binding pocket and allow 
dissociation of the bound nucleotide [180]. Agarose-bead conjugated alkaline phosphatase is 
added to degrade GDP and GTP present in solution, followed by addition of the non-
hydrolysable GTP analogue GMPPNP (Guanosine 5′-*β,γ-imido]triphosphate). The alkaline 
phosphatase beads are separated by filtration, followed by addition of excess MantGDP, which 
competes with GMPPNP for Rab binding. 
 
 
Figure 42: Structure of the fluorescent GDP analogue MantGDP. The mant moiety is highlighted in red. 
 
Another method of fluorescent labelling is fusion with a fluorescent protein such as green 
fluorescent protein (GFP). This method was applied by overexpressing EGFP-Rabs in HEK293 
cells and extracting the EGFP-Rabs from the membrane fraction with purified GDI. Figure 43 
shows that the location of the N-terminus of Ypt1 is on the same face as its C-terminal in the 
GDI bound orientation. As EGFP is relatively big with a similar size as Rab proteins and 
furthermore bound via a flexible linker sequence, it may impair interaction between the switch 
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regions and hypervariable C-terminus of Rabs with GDI. However, EGFP-tagged Rab proteins 
have been shown to target correctly to cellular membranes [169,195,196], indicating that EGFP-
Rab proteins are fully functional. In addition, prenylation of Rab proteins should not be 
impaired by EGFP-tags, as RGGTase binds the REP:Rab complex from a different angle. 
 
 
Figure 43: Structure of the doubly prenylated Ypt1:GDI complex (ribbon representation) (PDB 1UKV) 
showing the N-and C-termini of Ypt1 and the C-terminus of GDI. Ypt1 is shown in purple and GDI in 
blue. The N-termini of both proteins are often modified by EGFP or polyhistidine tags. 
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3.2 Materials and Methods 
3.2.1 TEV cleavage  
AcTEV protease ( Invitrogen) was used according to the manufacturer’s protocol. Briefly, 10 μg 
of GDI were mixed with different amounts of AcTEV protease (0/1/5/10/20 U) and incubated 
overnight at 4°C. 800 μL equilibrated NiNTA agarose bead slurry was then added to the mixture 
and rotated for 3 h at 4°C, in order to bind AcTEV protease. The supernatant containing cleaved 
GDI was removed, the beads were washed in 2x 500 μL GDI lysis buffer (see section 2.1.5.12) 
and supernatant and bead fractions were analysed by immunoblotting.  
 
3.2.2 Rab:GDI Complex formation by dialysis 
Based on the protocol described in [198], 1.2 mM purified (His)6-Rab5a and 0.3 mM (His)6-GDIβ  
(4:1 molar ratio with Rab in excess) were mixed in mixing buffer and dialysed against a 500-fold 
volume of dialysis buffer for 2 h at room temperature to allow complex formation.  
The protein mixture was then centrifuged at 20000g for 10 min at 4°C to remove aggregated 
Rab protein. The supernatant was processed in further purification or analysis steps (see 
sections 3.2.4 and 3.2.5).  
 
Mixing buffer 
25 mM HEPES pH 7.2 
125 mM Potassium acetate 
1 mM GDP 
2 mM MgCl2 
0.6 % CHAPS  
Dialysis buffer 
25 mM HEPES pH 7.2 
125 mM Potassium acetate 
0.18% (w/v) CHAPS 
 
 
 
3.2.3 Nickel affinity purification of Rab:GDI complex 
50 μL of EGFP-Rab:(His)6-GDI complex were prepared by extraction from membranes (see 
section 3.2.9) with 1 μM GDI. 200 μL NiNTA beads were equilibrated in 3 x 1 mL pull down 
buffer and resuspended in 200 μL buffer. 120 μL beads were added to the complex and rotated 
at 4°C for 2 hours or overnight. The beads were then pelleted at 200g for 1 min and washed 
twice in 900 μL pull down buffer after removal of the supernatant. Elution was performed with 
2 x 250 μL buffer supplemented with 200 mM imidazole. Alternatively, elution was performed 
with EGTA instead of imidazole. In this case, 2x 500 μL buffer supplemented with 50 mM EGTA, 
0.1% CHAPS and 10 mM imidazole were used for elution.  
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Pull down buffer 
50 mM HEPES pH 7.2 
500 mM NaCl 
5 mM MgCl2 
10 mM imidazole 
1x PI 
1 mM GDP 
1 mM β-mercaptoethanol 
1% detergent (CHAPS, NP40 or TX100) 
 
3.2.4 Purification of Rab:GDI complex by glycerol gradient ultracentrifugation 
4.5 mL each of 25% and 5% (v/v) glycerol containing gradient buffer was prepared and carefully 
transferred into a Beckman tube (#344059) using a gradient mixer with the glycerol 
concentration increasing from the top to the bottom of the tubes. 75 μL of complex 
supplemented with 5% (v/v) glycerol were loaded carefully on top of the buffer. The tubes were 
centrifuged at 100 000g for 18 h at 4°C in a swinging bucket rotor. 250 μL fractions were 
carefully removed from the top of the tube without perturbing the buffer. 20 μL of each 
fraction were analysed by immunoblotting for their content of Rab and GDI.  
 
Gradient buffer 
20 mM Tris pH 7.5 
54 mM MgCl2 
1 mM DTE 
5%/25% (v/v) glycerol 
 
3.2.5 Purification of Rab:GDI complex by size exclusion chromatography 
Superdex 200 PC 3.2/30 and Superdex 75 PC 3.2/30 columns connected to a SMART system 
(Amersham Pharmacia Biotech Inc., now GE Healthcare) were equilibrated with sterile filtered 
size exclusion buffer at a flow rate of 40 μl/min. 25 - 30 μL sample was loaded into a loop, 
subsequently injected onto the column, followed by elution with a flow rate of 40 μl/min. 40 μl 
fractions were collected and analysed by SDS-PAGE and Western blotting. The columns were 
calibrated with Gel filtration standard from Bio-Rad. 
 
Size exclusion buffer 
50 mM Tris pH 7.5 
150 mM NaCl 
5 mM MgCl2 
1 mM DTT 
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3.2.6 Transient transfection of HEK293 and COS7 cells with plasmid DNA 
10 cm dishes were transfected at 70 - 90% confluency. Per dish 485 μL Optimem was mixed 
with 15 μL Fugene6 (Roche) and incubated at room temperature for 5 min. 3 - 6 μg plasmid 
DNA was added to the mixture and the DNA-lipid complexes allowed to form for 30 - 40 min at 
room temperature. The mixture was then added to the cell medium in a drop wise manner and 
the dish was gently swirled. Cells were harvested after 40 - 48 hours.  
 
3.2.7 Preparation of EGFP-Rab containing membranes from mammalian cells 
HEK293 or COS7 overexpressing EGFP-Rab cells were harvested by aspiration of the medium, 
washing the cells in 5 mL ice cold PBS and scraping them into 10 mL ice cold PBS. The cells were 
pelleted at 800g for 5 min at 4°C, resuspended in 1 mL ice cold PBS and transferred to a 
microspin tube. The cells were recovered again by centrifugation for 1 min at 800g, followed by 
removal of the supernatant and immediate snap freezing of the cell pellet in liquid nitrogen and 
storage at -80°C until use. For the preparation of the membrane fraction (P100) for subsequent 
Rab extraction assays each pellet was lysed in 750 μL lysis buffer by vortexing and 30 s 
sonication at 5 μm amplitude with a titanium tip sonicator (MSE Soniprep 150). The PNS (post 
nuclear supernatant) was prepared by centrifugation of the total lysate at 2000g for 5 min at 
4°C. The pellet contains large debris and DNA, while the supernatant contains cytosolic proteins 
and cellular membranes. The cellular membranes were purified by ultracentrifugation at 100 
000g and 4°C for 45 - 60 min. The supernatant was discarded and the resulting membrane 
pellet re-solubilised in 750 μL extraction buffer by 30 s sonication at 5 μm (MSE Soniprep 150). 
In order to remove soluble EGFP-Rab proteins loosely bound to the membrane fraction, the 
membranes were again recovered by the same ultracentrifugation step. This second “washing” 
step notably decreased background fluorescence in GDI-free negative controls in the Rab 
extraction assay. The resulting P100 membrane fraction was sonicated again in 750 μL EB for 
30 s at 5 μm to solubilise the membranes.  
 
Lysis buffer 
50 mM Tris pH 7.5 
150 mM NaCl 
5 mM MgCl2 
1 mM DTE 
1x PI  
 
 
Extraction buffer (EB) 
50 mM HEPES pH 7.2 
150 mM NaCl 
5 mM MgCl2 
1 mM GDP 
1 mM DTE 
1x PI 
200 mM sucrose  
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3.2.8 Fluorescence standard curve of Slp1(aa-1-116)-EGFP 
A fluorescence standard curve of purified Slp1(aa-1-116)-EGFP (abbreviated hereafter to Slp-
EGFP) was generated using a dilution range with protein concentrations of 
0/0.05/0.1/0.2/0.4/0.8 mg/mL. 55 μL of each sample was pipetted into a white flat bottom NSB 
384-well plate (Corning, #3574). The EGFP fluorescence emission at 509 nm (approximate 
maximum) was detected using a Variant Cary Eclipse fluorescence spectrophotometer and the 
background fluorescence of the buffer was subtracted from each sample.  The standard curve is 
obtained by plotting and linearly fitting the resulting fluorescence intensity values depending 
on the respective Slp-EGFP concentration 
 
3.2.9 Complex formation by Rab extraction from membranes with GDI 
The fluorescence emission at 509 nm of washed P100 fractions containing EGFP-Rab proteins 
(see 3.2.7) was quantified (λex = 488 nm) and the samples were diluted to a concentration 
equivalent to 0.25 mg/mL Slp-EGFP using a standard curve (see 3.2.8). For Rab extractions with 
increasing amount of GDI 25 μL, concentration adjusted P100 was mixed in an ultracentrifuge 
tube (Beckman) with 25 μL GDI to final GDI concentrations of 0/0.1/0.2/0.5/1.0/2.0 μM and 
incubated at 37°C for 20 min. The tubes were immediately transferred to a pre-cooled TL45 
rotor and centrifuged at 100 000g for 30 – 45 min at 4°C.  
The supernatant was removed and the pellet resuspended in 50 μL EB in a water bath sonicator 
(Fisherbrand FB11021) for 10 min at room temperature. The complete volume of the soluble 
(S100) and membrane (P100) fraction was transferred into a white flat bottom NSB 384-well 
plate (Corning, #3574) and the fluorescence emission quantified (λex = 488 nm, λem = 509 nm) 
using a fluorescence spectrophotometer (Varian, Cary Eclipse). The background fluorescence of 
the buffer was measured and subtracted from each sample. The proportion of EGFP-Rab 
present in the supernatant fraction was calculated as follows (Eq. 16), with FI being the 
fluorescence emission intensity at 509 nm (after background subtraction) and S representing 
the supernatant and P the pellet fraction. 
 
       
   
       
 
  Eq. 16 
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3.3 Results 
Several strategies were explored for the formation and purification of Rab:GDI complexes on a 
preparative scale. A number of criteria have to be fulfilled in order for the complex to be 
suitable for subsequent Rab-membrane binding assays. It should contain a fluorescently 
labelled Rab protein to facilitate detection in the membrane binding studies. Furthermore, the 
amount and concentration of complex should be sufficient for detection in these assays. Finally, 
excess GDI needs to be removed or minimised as free GDI would shift the equilibrium of Rab 
membrane binding towards Rab:GDI in solution. Figure 44 shows a flow chart representation of 
the attempted combinations of Rab labelling, Rab:GDI complex formation and complex 
purification.  
 
 
Figure 44: Flow chart of attempted Rab:GDI complex formation and purification strategies. 
 
Size exclusion chromatography was attempted as a means of purifying Rab5a:GDI complexes, 
which were previously prepared using different methods, such as co-incubation of Rab5a and 
GDI, dialysis or extraction of EGFP-Rabs from mammalian cell membranes with GDI  (orange, 
red, yellow strategies, Figure 44). The complex should be separable from free Rab5a and GDI, 
but analysis of size exclusion eluates by SDS-PAGE followed by Coomassie staining gave 
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ambiguous results. No signal was detected at the expected elution volume of the complex and 
it could not be determined if the reason for this was that the complex concentration was below 
the detection limit by Western blotting, if the column resolution was insufficient, or if the prior 
complex formation failed. 
Glycerol gradient ultracentrifugation (purple path, Figure 44) was attempted next as a means of 
separating the complex from free protein based on their different sedimentation speeds. 
Proteins sediment in the centrifugation tube to the point, where their density equals the 
density of the solution. The larger complex molecule is expected further down in the 
centrifugation tube than free Rab and GDI. However, this method was also not suitable for 
separating the complex from free proteins as the detection limit was too low, due to high 
dilution of the complex.  
Affinity purification on Nickel beads (light green and blue paths, Figure 44) proved the existence 
of the complex, but was not suitable as a method of purification, as the complex was not 
sufficiently stable and dissociated during elution from the beads, using imidazole, EDTA or the 
gentler EGTA. Two approaches will be presented in detail, both of which utilise Nickel affinity 
chromatography (blue, green paths, Figure 44). 
 
3.3.1 Approach 1 – Rab:GDI complex formation by dialysis and subsequent Nickel 
affinity purification 
The first approach uses MantGDP-loaded Rab proteins. The complex was formed between 
purified prenylated (His)6-Rab (from Sf9) and GDI. The purified recombinant GDI was initially 
His-tagged, but this tag was cleaved with TEV protease prior to complex formation. Thus, during 
the subsequent purification step on NiNTA beads, free GDI is removed from the complex 
solution. The amount of free Rab can be assumed to be negligible, as free prenylated Rab is not 
stable in solution and the aggregate may be removed by a centrifugation step. Figure 45 shows 
a schematic description of this approach. 
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Figure 45: Schematic representation of complex purification approach using purified GDI and Rab 
proteins. The GDI His-tag is cleaved and removed, followed by complex formation with His-tagged Rab 
purified Rab protein by dialysis or mixing. Free GDI is removed on NiNTA resin and the complex is eluted 
with imidazole. This complex may be subjected to a further purifications step by size exclusion 
chromatography to remove excess Rab protein. 
 
Several methods are potentially applicable for the formation of the Rab:GDI complex. Complex 
formation was attempted by dialysis of a mixture of purified His-tagged Rab5a and His-tagged 
GDIβ based on the procedure for formation of Rab1a:GDI described by Peter et al. [198] . This 
method is based on the gradual decrease of detergent concentration by dialysis to promote 
complex formation. It is reported that 0.25% CHAPS is required to maintain prenylated Rab 
stable in aqueous solution, but high concentrations of detergent inhibit complex formation. 
For Rab1a 50% of the Rab is incorporated into complex with GDI, but detergent conditions and 
complex yield may vary for different Rab proteins [198]. In addition to complex formation by 
dialysis, also simple mixing of purified Rab and GDI was employed. 
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3.3.1.1 TEV Cleavage of His-GDIs 
The purified GDI proteins (see section 2.2.3 and 2.2.4) exhibit a TEV cleavage site between the 
(His)6-tag and the protein, which was employed for the removal of the tag. In order to 
determine the optimal amount of AcTEV protease for cleavage of the histidine-tags, GDIα was 
incubated with increasing amounts of AcTEV. Since AcTEV is also histidine-tagged, NiNTA 
agarose beads were used to separate AcTEV and remaining (His)6-GDI from his-tag free GDIα. 
The resulting supernatant and bead fractions were analysed by SDS-PAGE and Western blotting 
(Figure 46). Without the addition of AcTEV protease, GDIα was completely bound to the NiNTA 
beads. However, on addition of 1 U AcTEV no GDIα was bound to the beads,  suggesting the 
majority of his-GDI had been cleaved. Addition of higher concentrations of AcTEV protease did 
not result in increased efficiency of cleavage, but at 10 U AcTEV protease the NiNTA beads were 
saturated and AcTEV removal became insufficient. Panel B shows the TEV cleavage of GDI on a 
larger, preparative scale with an AcTEV concentration of 5 U and confirms the initial results. 
Without the addition of AcTEV protease GDI was completely bound to the NiNTA beads, but 
after TEV cleavage of the His-tag the majority of the protein was detected in the supernatant, 
while only very little remained on the beads.  
 
 
Figure 46: Western blots of AcTEV cleavage of GDIα. (A) Optimisation of AcTEV protease concentration, 
(B) TEV cleavage to produce His-tag free GDIα on a preparative scale. 
  
3.3.1.2 His-Rab5a:GDIβ purification by NiNTA pull down and S200 size exclusion 
chromatography 
TEV cleaved GDIβ was used for complex formation with purified (His)6-Rab5a. 1 nM (His)6-
Rab5a was mixed with 2 nM GDIβ in buffer containing 0.18% CHAPS and 1 mM GDP, incubated 
10 min at 30°C and then subjected to affinity purification with 150 μL NiNTA beads by rotating 
2 h at 4°C. The elution with increasing concentration of imidazole was analysed by Western 
blotting (Figure 47). The Western blots in panel A show that 100% of (His)6-Rab5a is bound to 
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the beads and elutes with imidazole. Conversely, GDIβ is mainly found in the supernatant and 
also in the wash fractions. Very faint signals of GDIβ in the imidazole elution fractions indicate 
that a small amount of GDIβ has been pulled down to the beads in complex with Rab5a. Panel B 
shows a silver stained SDS gel of the same samples as panel A. It shows that only GDIβ is 
detected due to a large excess, even though it should only be a twofold molar excess compared 
to Rab5a. Fraction 1 of 100 mM imidazole was further purified by size exclusion 
chromatography on an S200 column. Western blot analysis (Figure 47 C) only detected Rab5a, 
while GDIβ is below the sensitivity threshold after extended exposure times of the film. In  
conclusion, a small fraction of complex was formed by this approach, but the concentration was 
too low to be used in further membrane binding assays.  
 
 
 
Figure 47: NiNTA pull down of His-Rab5a:GDIβ. (A) Western blots, (B) Silver staining, (C) Western blot 
of S200 fractions. SN=Supernatant of beads, W1,W2= wash fractions of beads. 
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Figure 48: Gel filtration standard (Bio-Rad) separated on a S200 PC 3.2/30 column. Fractions 9 - 20 
cover protein sizes from 158 – 17 kDa. 
 
3.3.2 Rab:GDI Complex formation by dialysis and size exclusion chromatography 
The lack of complex detected in the S200 fractions (section 3.3.1.2) may indicate that elution 
from the NiNTA resin with imidazole disrupts the complex. In order to test this, complex was 
formed by dialysis and immediately separated by size exclusion chromatography, without prior 
purification by NiNTA pull down. In detail, dialysis was performed as described in [198], using 
His-tagged prenylated Rab5a (0.55 nmol) and a 4-fold molar excess of His-tagged GDIβ 
(2.2 nmol) in 1.3 mL, for 2 h, followed by S75 size exclusion chromatography in order to 
separate the complex from free protein. Comparing the signals of the Western blots (Figure 49) 
obtained after complex formation (top two panels) to the controls of GDI and Rab5a alone 
(bottom two panels) shows that GDI elutes in the same fractions (9-13) in the presence and 
absence of Rab5a. For Rab5a however a slight shift in the elution fraction is observed. Without 
the presence of GDI, Rab5a elutes in fractions 12 to 17. In the presence of GDI, Rab5a is 
detected in fractions 11 to 16. It may therefore be speculated that fraction 11 contains 
Rab5a:GDIβ complex. However, the complex would be expected to elute in earlier fractions 
than GDIβ alone. Western blotting of fractions 1 – 7 detected neither GDIβ nor Rab5a.  
It is furthermore noted that the amount of Rab5a in the presence of GDI is much lower 
compared to the control. This might be due to a large fraction of Rab5a aggregating and 
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precipitating in the course of dialysis, as the controls were not dialysed. Additionally, the ratio 
of Rab5a in complex to free Rab5a is very low. The presented data results from 2 h dialysis. In 
order to increase the degree of complex formation the experiment was repeated with dialysis 
overnight, but gave the same result. 
 
 
Figure 49: Rab5a:GDIß complex formation by 2h dialysis followed by S75 size exclusion 
chromatography. Western blots of the S75 eluate fractions 8 – 21 are shown. The bottom two panels 
present the elution profiles of (His)6-Rab5a and (His)6-GDIß alone respectively. 
 
3.3.3 MantGDP loading of Rab proteins 
The previously described attempts to purify Rab:GDI complexes omitted MantGDP loading of 
the Rab in order simplify the optimisation process. However, MantGDP loading can serve as a 
means of Rab detection and quantification. Therefore, Rab proteins were loaded with MantGDP 
prior to complex formation, with the purpose of utilising MantGDP fluorescence as a readout of 
complex formation.  This assay would also determine whether MantGDP fluorescence is 
actually sufficient for detection in subsequent membrane delivery assays.  
(His)6-Rab5a was loaded with MantGDP by incubating the Rab with a twofold molar excess of 
MantGDP for 20 min at 30°C. (His)6-GDIβ was then added to form the complex and also lock 
MantGDP onto the Rab. After another 20 min incubation at 30°C separation of free proteins 
and free MantGDP from the complex was attempted by size exclusion chromatography on an 
S75 column. As a control, MantGDP loaded (His)6-Rab5a was separated on the column. Each 
fraction was also subjected to fluorescence spectroscopy (λex = 355 nm, λem = 448 nm), the data 
is presented in Figure 50. As the Rab:GDI complex is a little larger than GDI alone, elution of the 
complex would be expected in fractions 9 or 10. This is indeed observed by a small peak of 
MantGDP fluorescence in fraction 10, however in this fraction the protein signal of GDI is very 
faint and no signal for Rab5a is observed by immunoblotting. A stronger fluorescence signal is 
detected for the MantGDP-Rab5a control in fraction 21. It is unclear if this peak results from 
Rab-bound or free MantGDP. MantGDP is a small molecule and would be expected in the 
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elution volume. The fact that MantGDP fluorescence strongly decreases upon Rab binding [199] 
supports the hypothesis that fraction 21 contains free MantGDP. MantGDP on its own was not 
subjected to S75 size exclusion chromatography, but this control experiment would be required 
to answer this question. 
In conclusion, a small amount of Rab:GDI complex was formed and elutes in fraction 10. 
However, protein concentration and fluorescence intensity both are too low for application of 
the complex in membrane binding studies.  
 
         A 
 
 B 
 
Figure 50: MantGDP-Rab5a:GDI complex formation and purification by S75 size exclusion 
chromatography. (A) MantGDP fluorescence intensity of S75 fractions at 448 nm, (B) Western blots of 
fractions 8 to 21 of MantGDP-(His)6-Rab/(His)6-GDI mixture (top panel) and (His)6-Rab5a elution profile 
(bottom panel). 
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3.3.4 Approach 2 – EGFP-Rab:GDI complex formation by extraction and subsequent 
Nickel affinity purification 
As complex formation and purification attempts by dialysis and size exclusion chromatography 
(section 3.3.1) were largely unsuccessful due to the low yields of complex obtained a second 
approach was undertaken, employing  EGFP-fused Rab proteins. Complex formation was 
performed by extraction of membrane bound EGFP-Rabs with GDI from the P100 membrane 
fraction of overexpressing HEK293 or COS7 cells. As the EGFP-Rab constructs do not exhibit a 
His-tag they can be separated from free GDI and complex by Nickel affinity purification, as GDI 
is his-tagged. Figure 51 shows a schematic representation of this method. Excess GDI is not 
removed by this approach and therefore further purification steps are potentially necessary, for 
example size exclusion chromatography.  
 
 
Figure 51: Schematic depiction of complex purification approach using EGFP-Rab proteins. His-tagged 
GDI is used to extract overexpressed EGFP-Rab from the membrane fraction. Excess free EGFP-Rab 
protein is removed by NiNTA affinity purification.  
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3.3.4.1 EGFP-Rab extraction from membranes with GDI 
Rab extraction from membranes with GDI has been previously reported and the basic protocol 
for extraction was adapted from Leung et al. [33]. However, the affinity of EGFP-tagged Rab 
proteins for membranes and GDI were unknown. Therefore, the optimal conditions for Rab 
extraction from mammalian membranes with GDI were established by titrating increasing 
concentrations of GDIα and β and assessing extraction of Rabs from the membrane by Western 
blotting and densitometry. Using αRab5a antibody for the Western blots allowed detection of 
both, recombinant EGFP-Rab5a and endogenous Rab5a, see Figure 52 panel A and B. Using 
densitometry extraction curves were generated, see panel C and D (Figure 52). Extraction of 
endogenous Rab5a with either GDIα or β were comparable. The extraction curve with GDIβ is 
smoother but both isoforms extract 70 – 90% Rab5a at saturation and reach saturation at 
around 2 μM GDI.  
One striking difference between the extraction of exogenous EGFP-Rab5a and endogenous 
Rab5a with both, GDI α and β is the high increase in “background extraction” at 0 μM GDI when 
EGFP-Rab5a is extracted. This value lies at 25 to 45% for EGFP-Rabs, while there is no 
endogenous Rab5a in the supernatant when no GDI is added (Figure 52, C and D). This indicates 
a looser interaction of EGFP-fused Rabs with the membrane. However, it could also be due to 
the high overexpression of Rabs and introducing a second washing step of the membrane 
fraction (P100) could decrease this background, especially when the extraction was performed 
on a large scale for preparative complex formation. Another difference between the extraction 
of EGFP-Rab5a and endogenous Rab5a is that EGFP-Rab5a reaches saturation of extraction at 
lower GDI concentrations. While endogenous Rab5a extraction reaches saturation around 2 μM 
GDI, EGFP-Rab5a extraction is saturated at 1 μM GDI. Saturation is slightly lower for EGFP-
Rab5a when GDIβ is used. To conclude, EGFP-Rab:GDI complex formation by Rab extraction 
from membranes was shown to be an appropriate method of complex formation. High 
extraction values were achieved, comparable to endogenous Rab extraction. However, EGFP-
Rabs exhibited a higher intrinsic solubility in buffer, which requires further optimisation. 
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Figure 52: Extraction of EGFP-Rab5a and endogenous Rab5a from COS7 membranes with GDIα and 
GDIβ. Western blot of (A) GDIα extraction and (B) GDIβ extraction (both anti-Rab5a), (C) extraction 
curve of GDIα and (D) of GDIβ (the data of extraction with 8 μM GDIβ was excluded from the graph due 
to incomplete transfer). 
 
3.3.4.2 Nickel affinity purification of the EGFP-Rab:GDI complex 
In the previous section it was shown that both GDIα and β can be used to extract EGFP-Rab5a 
into the soluble fraction, in a manner similar to endogenous Rab5a. This provides evidence, that 
a Rab:GDI complex exists, at least transiently. As a subsequent purification step, the complex 
was subjected to Nickel affinity purification. Unlike recombinant GDI, the EGFP-fusion 
constructs do not exhibit a His-tag motif. Therefore, the complex can be purified from other 
contaminants by Nickel affinity purification.  
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Complex purification was attempted with several EGFP-fused Rab proteins, including Rab1a, 
Rab5a and Rab11. Rab5a was used first in order to optimise the purification process, using 
different types and concentrations of detergent (CHAPS, TX100, NP-40). Figure 53 shows the 
resulting Western blots of the final optimised protocol with 1% TX100. High detergent 
concentrations have been reported to disrupt the Rab:GDI complex and prevent its formation 
[198], however this was not observed in these assays. Omitting GDI in the extraction step 
should ideally lead to no Rab being present in the soluble fraction. However, as it was shown in 
the previous section (3.3.4.1), EGFP-Rab5a exhibits high background levels of dissociation from 
the membranes in the absence of GDI. Hence, GDI-free samples can be used as a negative 
control to detect unspecific binding of Rab5a to the NiNTA beads. The bottom panel in Figure 
53 shows that the EGFP-Rab5a is only detected in the flow through (FT) and wash fraction (W1), 
while nothing is eluted from the beads. This shows that there is no significant unspecific binding 
of EGFP-Rab5a to the beads in these buffer conditions. The GDI-containing sample (top panel) 
shows EGFP-Rab5a elution with imidazole, providing evidence that EGFP-Rab5a is in complex 
with GDI.  
 
 
Figure 53: NiNTA affinity purification of EGFP-Rab5a:GDIβ and elution with a stepwise imidazole 
gradient (FT: flow through fraction , W1: first bead wash fraction). 
 
As a large excess of GDIβ was used in the extraction step, size exclusion chromatography was 
employed as a means of removing free, uncomplexed GDI. The fractions containing Rab5a 
(eluted with 40 mM, 100 mM imidazole) were pooled and concentrated with a 50 kDa cut off 
Vivaspin column. The sample was subjected to S200 size exclusion chromatography, but the 
EGFP-Rab5a concentration in the resulting fractions was extremely low as determined by 
immunoblotting with αRab5a antibody and no EGFP fluorescence could be detected by 
fluorescence spectroscopy. Size exclusion chromatography was hence discarded as a means of 
removing excess GDI.  
To resolve the issue of excess free GDI, Rab extractions were performed with a GDI 
concentration in the unsaturated range, while still being as high as possible to maximise the 
complex concentration. 1 μM GDIβ was chosen as it fulfils both criteria as shown in Figure 52. 
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EGFP-Rab1a and EGFP-Rab11a were thus subjected to complex formation and purification. The 
NiNTA beads were washed twice before elution was performed with a single 200 mM imidazole 
step (E1, E2, each 250 μL). Figure 54 shows the resulting Western blots. In the GDI containing 
samples Rab proteins elute in the same samples as GDI, whereas Rab proteins remain in the 
supernatant when no GDI is present. This clearly demonstrates that the GDI complex with  
EGFP-Rab1a and EGFP-Rab11a can be formed. 
 
 
Figure 54: NiNTA pull down of EGFP-Rab1a:GDIβ and EGFP-Rab11a:GDIβ complexes. Western blot 
analysis of EGFP-Rab1a and EGFP-Rab11a in complex with GDIß (S: Supernatant of beads, W: Wash 
fractions of beads, E: Elution fractions, B: Beads after elution) 
 
After demonstrating that the EGFP-Rab:GDI complex can be purified using Nickel beads, the 
complex stability was assessed. The affinity purification was repeated as before, but using 
Rab:GDI complex that had previously been frozen and stored at  -80°C. The resulting Western 
blots for EGFP-Rab5a and EGFP-Rab11a are shown in Figure 55. The majority of GDI clearly 
elutes in the imidazole containing fraction, although a small proportion remains bound to the 
beads, particularly in the case of Rab5a:GDI. However, only a faint band of the EGFP-Rabs 
indicates low co-elution with GDI, while the majority of Rab remains on the beads. This 
indicates, that some of the complex has dissociated during the freeze-thawing process and 
possibly aggregates onto the beads. For this reason, it was decided to only use freshly prepared 
Rab:GDI complex for Rab membrane binding studies.  
 
 
Figure 55: NiNTA pull down of Rab:GDI complexes after freezing (S: Supernatant of beads, W: Bead 
wash fractions, E: Elution fractions, B: Beads after elution). 
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3.3.5 Comparison of the extractability of various EGFP-Rabs with GDIα and β 
In order to assess, which Rabs are optimal for complex formation and their respective optimal 
GDI concentration, a large number of Rab proteins was systematically compared in extraction 
studies. Both isoforms of GDI were also compared for their ability to extract different Rab 
proteins. Based on the results of the complex formation and purification attempts presented in 
the previous sections, it was decided to use EGFP-Rab extraction from membranes with GDI as 
the method of choice to prepare large quantities for use in subsequent membrane-delivery 
assays, as the presence of a complex could clearly be proved and the complex concentration is 
sufficient for detection and subsequent use in membrane binding studies. Another advantage 
of the EGFP fusion is, that it allows standardisation of complex concentration, making different 
experiments comparable. 
  
3.3.5.1 EGFP-Rab extraction from membranes with increasing amounts of GDI 
This section presents extraction curves for several Rab proteins with titration of the GDI 
concentration. This study had several aims. For the Rab/membrane interaction studies it was of 
interest to find the optimal Rabs that would be good candidates to form large amounts of 
complex. As it was decided to use the “raw extracts” without further purification of the 
complex (see previous sections), it was desirable to use an optimal GDI concentration that is 
high enough to form as much complex as possible without being in excess. The optimal GDI 
concentration may vary between different Rabs. The great advantage of using EGFP-Rab fusion 
proteins rather than untagged proteins, is that it omits the need for time consuming analysis by 
immunoblotting, as the Rab concentration can be assessed by fluorescence spectroscopy. 
Furthermore, their concentration in the P100 membrane fraction can be normalised to the 
same level prior to extraction, making the assay very comparable between different Rabs.  
 
3.3.5.1.1 Slp-EGFP standard curve and P100 adjustment 
Purified Slp1(aa-1-116)-EGFP (abbreviated to Slp-EGFP) was obtained from Alistair Hume and 
was used as a standard to compare EGFP fluorescence between different Rab samples.  
Figure 56 A shows a typical standard curve of Slp-EGFP. The fluorescence is linear in the 
measured range from 0 – 0.8 mg/mL. Figure B shows the protein sample separation by SDS-
PAGE. It can be seen that the protein sample is not pure and exhibits a lot of contamination 
with other proteins. It is estimated that the concentration of Slp-EGFP is therefore at least ten 
fold lower than that of the complete protein amount determined by absorbance at 280 nm.  
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           A                     B 
                           
Figure 56: Slp1(aa-1-116)-EGFP standard curve. (A) Fluorescence emission standard curve using 0.05 – 
0.8 mg/mL Slp-EGFP, (B) Coomassie stained SDS gel (10%) of Slp-EGFP. 
 
An Slp-EGFP standard curve was produced in parallel to the P100 measurement of the EGFP-
Rab samples and used to adapt the EGFP concentration of the P100 fractions to be equivalent 
to 0.25 mg/mL Slp-EGFP. Figure 57 A and B show the fluorescence emission spectra of four 
examples of Rab P100 fractions before and after adjustment of the EGFP concentration by 
dilution.  
 
A      B 
       
Figure 57: Fluorescence emission spectra of EGFP-Rab P100 fractions. (A) Initial fluorescence of P100, 
(B) dilution of P100 fractions adjusted to a concentration equivalent to 0.25 mg/mL purified Slp1(aa-1-
116)-EGFP. 
 
3.3.5.2 GDI titration studies 
EGFP-Rab proteins were extracted with increasing concentrations of GDIß, ranging from 0 to 
2 μM, in order to compare the extraction curves between different Rab proteins. For this 
purpose, the EGFP-Rab P100 fractions were adjusted to intensities equivalent to 0.25 mg/mL 
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Slp-EGFP (section 3.3.5.1.1). Each condition was repeated in triplicate. The resulting extraction 
curves are presented in Figure 58. The data was fitted with the GraphPad Prism built in "One 
site binding hyperbola" function. Some of the data sets exhibit very high errors, while others 
are more consistent. This observation was reproducible depending on the Rab protein. Rab1a 
was found to be the most consistent Rab with respect to extraction curve reproducibility and 
was therefore always used as a positive control.  
 
A) Rab1a      B) Rab3a                 C) Rab5a 
 
D) Rab9a      E) Rab10                  F) Rab13 
 
G) Rab37      H) Rab38                  I) Rab40c 
 
Figure 58: GDIβ titration curves of EGFP-Rab extraction from HEK293 membranes. (A) Rab1a, (B)Rab3a, 
(C) Rab5a, (D) Rab9a, (E) Rab10, (F) Rab13, (G) Rab37, (H) Rab38, (I) Rab40c. 
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The calculated Bmax (maximal binding to GDIβ or percentage of extracted Rab at saturating GDIβ 
concentration) and Kd values are summarised in Table 9 and Bmax values are plotted in Figure 59. 
The Kd values are too imprecise due to high errors and insufficient resolution in the low GDI 
concentration region, and were therefore not considered further. 
 
 
Figure 59: Extractability of various EGFP-Rab proteins determined by extraction with GDIβ at 
saturating concentration. 
 
Table 9: Bmax and Kd values resulting from the GDIβ titration curves 
   
Std. Error  
 
Bmax (%) Kd (μM) Bmax (%) Kd (μM) R
2  
Rab1a 79.24 0.091 5.81 0.033 0.85 
Rab5a 68.03 0.036 3.65 0.016 0.93 
Rab9a 61.15 0.102 3.58 0.028 0.94 
Rab10 53.88 0.022 3.29 0.016 0.86 
Rab13 37.74 0.126 7.23 0.104 0.50 
Rab37 17.28 0.007 9.65 0.111 0.10 
Rab38 37.26 0.170 7.23 0.127 0.52 
 
Bmax could not be determined for Rab3a and Rab40c, as saturation was not reached and 
extraction was too low respectively. The other Bmax values however reveal that Rab proteins 
differ quite dramatically in their extractability, which ranges between 17% for Rab37 and 
almost 80% for Rab1a. Rab40c is even less extractable than Rab37 if the data point with 3 μM 
GDIβ is discarded. Due to the range of extractability displayed by the Rab proteins tested it was 
decided to further investigate and compare the extractability of different Rab proteins.  
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3.3.6 Extractability comparison of various Rabs  
It emerged from the GDI titration curves that different Rabs vary extremely between their 
extractability at saturating GDI concentration. It was therefore decided to compare the 
extraction of different EGFP-Rabs at only saturating GDI concentration. Furthermore, GDIα and 
β were employed in parallel, to assess potential preferences of Rabs for one of the two 
isoforms. The extraction experiments were performed in two different ways: 
 
Small scale (S): Extractions were performed the same way as for the GDI titration experiments, 
but only using 0 and 3 μM GDI. For each Rab the experiment was performed in three 
independent experiments.  
Large scale (L): Extractions were performed in volumes of 250 - 600 μL with 1.5 μM GDI in one 
single experiment (as a preparative complex formation step before membrane binding studies, 
see Chapter 5). 
 
Extraction on a small scale is quite unreliable and may exhibit very high background 
fluorescence without the addition of GDI. In the data analysis only experiments with low 
background fluorescence were considered. Generally, the background fluorescence is much 
lower for large scale extractions, which is due to more efficient membrane recovery and 
resuspension and less contamination from non-specific protein binding to tube walls. The 
relevant large scale extraction data with GDIα is presented in Figure 60. It shows that the 
background (using 0 μM GDI)  is reasonably low. Rab1a, 5a, 9a and 11a are highly extractable 
Rab proteins with 80% or more being extracted into the supernatant, while Rab3a extraction 
lies around 50%.  
 
 
Figure 60: Summary of large scale extractions of selected Rab proteins with 1.5 μM GDIα and the 
respective background of EGFP fluorescence without GDI.  
112 
 
Most of the Rab proteins were assessed by small scale extractions. A summary of all tested Rab 
proteins is presented in Figure 61 and Table 10. The extraction values presented are averaged 
after subtraction of the background fluorescence (0 μM GDI). Table 10 also presents the 
number of independent repeats for each experiment. It should be noted that all small scale 
extractions were repeated in triplicates. Figure 61 clearly shows that the extractability of 
different Rab proteins ranges from practically 0 to almost 100%. Furthermore, there is no 
preference for any of the assessed Rab protein for either GDIα or β. Only Rab15 shows a 
difference with a preference for GDIα, however extractability of Rab15 was measured only 
once. The tested Rabs can be divided into groups based on their extractability (Table 11).  
 
 
Figure 61: Extractability at saturating GDI concentration of various Rab proteins. 
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Table 10: Summary of extraction data for various Rabs with both GDI isoforms. N is the number of 
times the experiment was independently performed, the extraction scale was either large (L) or small (S, 
in triplicates each) (see text). 
 GDIα GDIβ  
Rab 
% in SN at 
saturation 
error N 
% in SN at 
saturation 
error N  
Extraction 
scale 
1a 80.8 3.1 9 68.4 10.8 4 L 
3a 50.0 6.0 2 n.d. - - L 
5a 87.4 6.4 5 n.d. - - L 
6 93.7 1.7 1 95.8 0.0 1 S 
7 30.0 15.7 1 29.6 7.2 1 S 
8 86.7 4.9 1 95.6 0.0 1 S 
9a 88.6 4.5 2 n.d. - - L 
10 98.6 1.4 2 99.1 0.9 2 S 
11a 79.7 2.3 2 n.d. - - L 
13 73.6 11.2 1 67.4 10.5 1 S 
15 48.1 4.9 1 28.9 2.1 1 S 
23 58.5 6.7 1 64.3 0.9 1 S 
27a 4.9 4.9 2 8.6 1.7 2 S 
27b 8.4 2.6 1 11.0 3.4 1 S 
32 0.0 0.3 1 2.1 1.3 1 S 
37 6.7 5.2 3 7.4 7.4 3 S 
40c 2.1 2.1 3 3.6 3.1 3 S 
 
 
Table 11: Categorisation of Rab proteins into high, medium and low extractability 
High extraction (>70%) Medium extraction (30-70%) Low extraction (0-30%) 
1a, 5a, 6, 8, 9, 10, 11, 13 3, 7, 15, 23 27a, b, 32, 37, 40c 
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3.4 Discussion 
This chapter presents different attempts of Rab:GDI complex formation and purification for use 
in subsequent Rab membrane delivery studies, as well as data of GDI extraction of various 
overexpressed EGFP-tagged Rab proteins from physiological mammalian membranes.  
Several strategies of Rab:GDI complex formation and purification were approached. Complex 
formation by dialysis or simple mixing of purified prenylated Rab5a and purified GDI, followed 
by size exclusion chromatography was not successful. The complex concentration was 
insufficient for further purification steps. As complex instability is observed for both 
approaches, using his-tagged Rab and his-tagged GDI, it is likely that elution from the NiNTA 
resin with imidazole or EGTA disrupts the protein interactions in the complex. Additionally, 
incorrect Rab folding during the purification of penylated Rab may be the cause for obtaining a 
relatively low amount. Several features of the Rab are crucial for formation of a stable complex, 
including the maintenance of the GDP binding pocket with the Mg2+ ion, the switch regions , 
the hypervariable C-terminal binding to GDI and correct insertion of the prenyl groups. Both 
imidazole and EGTA chelate divalent metals, but affinity for Mg2+ should be low. Furthermore, 
neither imidazole nor EGTA are known to have denaturing properties. Therefore it is unlikely 
that elution with these slightly opens the nucleotide binding pocket leading to GDP or Mg2+ 
release, leaving open the question what causes complex instability. 
MantGDP loading of Rab5a prior to complex formation was employed in order to detect the 
Rab protein by fluorescence. This showed that a small amount of complex was formed, close to 
the detection threshold of Rab5a by Western blotting. However, the separation of free GDI 
from the complex was not successful. Dialysis and simple mixing of Rab and GDI was therefore 
omitted as complex formation methods. Instead, complex formation was achieved by EGFP-Rab 
extraction from mammalian membranes  and stable complex proven by NiNTA affinity 
purification. However, the complex exhibited limited stability and NiNTA affinity purification 
was hence discarded as a means of complex purification, since imidazole elution apparently 
disrupted the complex. The instability of the GDI complex of EGFP-tagged Rab may be caused 
by increased solubility of the Rab itself, or by disruption of the Rab:GDI interacting regions, for 
example by steric hindrance between the EGFP-tag and GDI. Figure 43 shows that although the 
Ypt1 C-terminus is relatively far away from GDI, it is still on the same face of the Rab protein as 
its hypervariable C-terminus and in reach and could therefore be responsible for decreasing 
complex stability. 
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It was consequently decided, to use the Rab:GDI raw extract without further complex 
purification steps for Rab membrane binding assays. In order to avoid excess GDI, which would 
shift the equilibrium towards soluble GDI-bound Rab, titration with increasing amounts of GDI 
was employed to determine the optimal GDI concentration for different Rab proteins and to 
select Rab proteins with a high GDI extractability. The optimal GDI concentration should lie 
below extraction saturation, but at reasonably high extraction in order to obtain high complex 
concentration. For all highly extractable Rab proteins that were investigated this GDI 
concentration lies around 0.5 to 1 μM. Furthermore, freezing seemed to disrupt the Rab:GDI 
complex, therefore only freshly prepared complex should be used in subsequent Rab 
membrane binding assays. 
Using Rab membrane extraction assays with GDIα and ß, it was furthermore shown that Rab 
proteins have very different extractability potentials in vitro. For the majority of Rab proteins 
comparable extractability with GDIα and β were observed. 
In general it is accepted that Rab proteins cycle between a membrane bound and soluble GDI 
bound state, thereby regulating Rab localisation and activity. However, the data in this chapter 
indicates that there is a broad range of extractability with GDI. The question arises, what is the 
molecular and functional basis for this broad range of extractability? Summarising the 
saturation extractability and sorting it according to Rab functional groups (Table 12) it becomes 
apparent that the C-terminal prenylation motif does not determine the extractability. The 
group of highly extractable Rab proteins comprises all possible C-terminal motifs (CC, CCXXX, 
CXC, CC and monoprenylated CAAX), as well as  all tested functional groups (I, II, III, V, VI, VII 
and VIII).  Similarly, in the low extractable Rab protein group a variety of C-terminal motifs can 
be found (CXC, CCXXX, CC and CAAX). Looking at the functional groups however, it is striking 
that only Rab proteins from functional group III (Rab27a, Rab27b, Rab37) and the two 
ungrouped Rab proteins Rab40c and Rab32 exhibit low extractability. All of these Rab proteins 
share the common characteristic of being involved in secretory pathways, and localised to 
lysosome related organelles such as melanosomes (Rab 27a,Rab27b and Rab32) and mast cell 
secretory granules (Rab37) [200,201].  
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Table 12: Summary of Rab proteins used for extraction assays and their C-termini and functional 
families. The data is sorted according to extractability and functional groups. 
Rab 
C-
terminus 
C-Terminal 
motif 
Functional 
group [33] Extractability 
1a CC CC I 
High 
11a CCQNI CCXXX II 
3a CAC CXC III 
5a CCSN CCXX V 
6a CSC CXC VI 
9 CC CC VII 
8a CSLL CAAX VIII 
10 CC CC VIII 
7a CSC CXC VII 
Medium 
13 CLLG CAAX VIII 
15 CWC CXC x 
23 CSVP CAAX x 
27a CGC CXC III 
Low 
27b CAC CXC III 
37 CCSFV CCXXX III 
32 CC CC x 
40c CKIS CAAX x 
 
Table 13 summarises the localisation and function of these Rab proteins. Rab40c poses an 
exception, exhibiting the lowest extractability of all Rab proteins, and being localised to the 
perinuclear recycling compartment in oligodendrocytes. As demonstrated in Chapter 6, Rab 40c 
is palmitoylated and most likely doubly prenylated. This triple lipid motif associates tightly with 
membranes, whereas only two of these lipid groups interact with GDI, shifting Rab40c into the 
thermodynamically favourable membrane bound state.  
 
Table 13: Localisation and functions of low extractable Rab proteins 
 Localisation Function 
Rab27a,b Secretory granules , Melanosomes, 
T-cell granules 
Regulated secretion, MyosinVa recruitment 
to melanosomes and T-cell granules 
Rab32 Melanosomes, mitochondria 
 
Anchoring of PKA , post-Golgi trafficking of 
melanogenic enzymes, mitochondrial 
dynamics 
Rab37 Secretory granules (mast cells) Mast cell degranulation 
Rab40c Perinuclear recycling compartment 
(Oligodendrocytes) 
Potentially recycling of oligodendroyte 
surface components through the PRC, 
biogenesis of myelin 
117 
 
Rab extractability may be regarded as an equilibrium between the association of the Rab with 
the membrane and with GDI. The low extractability of some Rab proteins may result from a 
stronger membrane association compared to other Rab proteins, or from weaker interaction 
with GDI, or from a combination of the two factors. It may be argued that singly prenylated Rab 
proteins exhibit a weaker association with the lipid bilayer and thus require less energy to be 
extracted by GDI, however one prenyl group also confers less binding energy to GDI.  The first is 
supported by fact that the two singly prenylated Rab proteins Rab13 and Rab23 exhibit medium 
to high extractability with both GDI isoforms, with Bmax values of roughly 60-70%. In addition, it 
has been shown that some singly prenylated Rab proteins, including Rab13 and Rab23 contain a 
C-terminal polybasic stretch that facilitates membrane interaction [167]. As the membrane 
interaction of the prenylation motif does not seem to influence extractability a more plausible 
cause for the range of extractabilities are different GDI affinities for different Rab proteins. 
Rab proteins that are GTP bound cannot interact with GDI and it is therefore proposed here 
that extractability could be dependent on the nucleotide loading of the Rab protein, which 
alters the protein conformation and hence GDI affinity. The GTP loaded status results either 
from a higher affinity of the Rab for GTP relative to GDP, so that nucleotide exchange occurs 
rapidly, prior to extraction, or it results from a very low intrinsic GTPase activity, so that once 
loaded onto the Rab protein the GTP remains bound and prevents GDI association. To test the 
hypothesis that the extractability of Rab proteins is dependent on their GTPase activity, Table 
14 presents a summary of published intrinsic Rab GTPase activities. The list of Rab proteins for 
which GTPase activities have been reported is not exhaustive and the few Rab proteins that 
have been measured independently (Rab3a and Rab5a) GTPase activity values vary up to 4-fold, 
indicating that the assays used may not yield precise values but are instead relative. 
Unfortunately, the measured GTPase activities do not indicate a correlation to Rab 
extractability, but this may well be a due to the fact that GTPase activities measured 
independently may not be directly comparable. 
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Table 14: Published intrinsic Rab GTPase activities 
Rab 
GTPase activity 
[min-1] 
Reference 
Rab3a 0.082 [43] 
Rab3a 0.018 [202] 
Rab5 0.12 [31] 
Rab5a 0.164 [43] 
Rab6a 0.00035 [45] 
Ypt6 0.0002 [46] 
Rab7 0.05 [31] 
Rab27a 0.058 [43] 
EoRab11 0.0024 [44] 
 
Future work involves the comparison of the intrinsic GTPase activity of high and low extractable 
Rab proteins. Furthermore, extractability of low extractable Rabs forced into the GDP bound 
state and high extractable Rabs forced into the GTP bound state  needs to be measured and 
compared to the values measured here. In order to measure GTPase activity, Rab proteins and 
other GTPases are traditionally subjected to radioactive assays using γ- or α32P-GTP. The 
reaction products are then separated by thin layer chromatography (TLC) [203] or by 
precipitation of the proteins on nitrocellulose filters [204] or charcoal [43,44,205]. Other 
possible methods include commercially available colorimetric assays, which are based on 
malachite green forming a stable complex with liberated phosphate that has a high absorbance 
at 600 – 660 nm. These assays are very simple and quick, but lack sensitivity and require 
complete removal of free phosphate prior to the assay.  Bodipy labelled GTP has also been used 
for fluorescent based analysis of GTPase activity [206] and HPLC may be used to distinguish 
between GTP and GDP by anion exchange chromatography or reverse phase chromatography 
[194]. The established extraction assay furthermore allows the comparison of extraction with 
phosphorylated and unphosphorylated GDI, as GDI phosphorylation is believed to regulate Rab 
recycling and thereby Rab function [53,54]. 
 
3.5 Chapter summary 
Different methods of Rab:GDI complex formation were attempted. Rab:GDI complexes are 
required for Rab-membrane interaction studies performed in Chapter 5. EGFP-Rab extraction 
from cell membranes proved to be an adequate method to obtain high concentrations of the 
complex with sufficient fluorescence intensity for detection. Further purification attempts of 
the complex were not successful, which is probably due to its relative instability when exposed 
119 
 
to size exclusion chromatography and imidazole elution. However, Nickel affinity purification of 
the complex proved that stable complexes indeed exist. Using GDI at sub-saturating 
concentration circumvents the problem of excess free GDI in the complex sample, which would 
interfere in the membrane binding studies by shifting the equilibrium of membrane bound to 
GDI bound Rab.  
The second part of this chapter presents a systematic investigation of Rab extractability with 
GDIα and β. It was found that the maximum extractability of overexpressed Rab proteins from 
the cellular membrane fraction varies enormously depending on the Rab and ranges from 0 to 
almost 100%. The tested Rab proteins can be classified according to their maximum 
extractability into low, medium and high extractability. While the C-terminal motif did not 
influence the extractability, the non- and low extractable Rab proteins share the functional 
similarity  of being involved in the regulation of cellular secretion. 
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CHAPTER 4 
Phase Behaviour of Organelle Mimetic Lipid Compositions and 
Bending Rigidity of DOPC/DOPE Systems 
 
This chapter presents data on the biophysical analysis of membrane model systems. It is 
demonstrated for the first time, that the bending rigidity of DOPC membranes linearly increases 
with the quantity of DOPE added. Since Rab proteins distinguish between different organelle 
membranes, three organelle mimetic lipid compositions were selected and investigated with 
respect to phase behaviour and lattice parameters using small angle X-ray scattering (SAXS) and 
differential scanning calorimetry (DSC). It was shown that all three lipid compositions are fluid 
lamellar from 5 to 80°C and exhibit very high d-spacings in the range of 100 – 200 Å in 70% - 
80% water. The excess water point was not reached at this fraction of water, and could not be 
determined due to insufficient resolution of the diffraction patterns with higher water 
fractions. 
In order to correlate membrane properties to Rab binding, more simplified membrane models 
were considered for Rab binding experiments (Chapter 5). These were binary lipid mixtures 
composed of DOPC/DOPE and DOPC/DMPC. The lyotropic phase behaviour of these binary 
systems is well known and was therefore not further assessed. However, correlation of Rab 
membrane binding to membrane elastic parameters required their determination, as they have 
not been investigated elsewhere. The bending rigidity of DOPC/DOPE mixtures was therefore 
determined by membrane fluctuation analysis of giant unilamellar vesicles. This is the first 
study that directly investigates bending rigidity as a function of the lipid headgroup 
composition. The bending rigidity of pure DOPC was determined as 10.17 kBT, which lies in the 
same range as previously determined values. Unexpectedly, addition of DOPE leads to a linear 
increase in bending rigidity from 10.17 kBT  for pure DOPC to 24.62 kBT with 30% DOPE. This 
suggests that phospholipid headgroups have an important influence on the bending rigidity. 
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4.1 Introduction 
Biological membranes used to be regarded as fluid lakes filled with freely floating proteins for 
over two decades. This simplified model considered the lipids as mere solvent molecules 
without further structural functions. However, it is now accepted that lipid molecules 
contribute to the mechanical behaviour of the membrane on a macroscopic and microscopic 
scale, which in turn is fundamental to protein association and function (for a review see [207]). 
Knowledge of the lipid bilayer phase behaviour and parameters such as bilayer thickness, d-
spacing and curvature (see 1.6 and 1.7) is therefore important for investigating protein 
function. The lyotropic phase behaviour of membrane model systems has been extensively 
studied with simple binary and ternary lipid mixtures and the influence of bilayer and non-
bilayer phospholipids as well as sterols has been elucidated [208]. However, complex lipid 
mixtures, that mimic biological membranes with respect to headgroup composition have never 
been investigated to date and are assessed in this chapter. The applied methods will be 
discussed in the following sections. 
 
4.1.1 Differential Scanning Calorimetry 
Differential Scanning Calorimetry (DSC) of vesicles is used to determine lyotropic phase 
transitions of lipids by observing the heat flow in a sample required to linearly increase its 
temperature. The heat capacity Cp is recorded as a function of temperature. Upon phase 
transition the enthalpy and entropy change with temperature is dependent on the heat 
capacity. If for example an endothermic process occurs, such as a lipid lyotropic phase 
transition from Lβ to Lα, a higher heat flow is required to heat the sample in comparison to a 
reference sample, resulting in a peak in the heating curve.  
 
4.1.2 X-ray scattering of lyotropic materials 
Amphiphilic molecules, such as phospholipids, self-assemble into lyotropic mesophases that 
exhibit long range periodicity and short range disorder. X-ray diffraction is one of the most 
important methods employed for lipid phase identification and characterisation as a function of 
temperature, water content and pressure. The long range order of the phase may be analysed 
by X-ray scattering in the low angle regime below 3°, so called small angle X-ray scattering 
(SAXS) [111]. Wide angle X-ray scattering (WAXS) (in the region of 22°) determines the short 
range order of lipid headgroup and lipid chain packing and therefore serves to distinguish 
between the lamellar phases Lα, Lβ and Lc. 
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4.1.2.1 Principles of diffraction 
X-rays hitting a crystal cause reflection of the beams in a specific pattern that depends on the 
lattice planes and is a result of positive and negative interference of the beams. When a 
monochromatic beam of wavelength λ is diffracted on two parallel planes of a lattice (see 
Figure 62), the reflected beams will only be in phase and hence interact by constructive 
interference, when the path difference 2a of the reflected beams is a multiple of λ, i.e.  
     ., where n is an integer. From simple trigonometry it can be deduced that 
 
     
 
 
 
Eq. 17 
With       it follows that 
         , 
       Eq. 18 
which is known as Bragg’s law. 
 
 
Figure 62: Principle of diffraction on a lattice of particles. 2a equals the path distance between the two 
beams, d equals the d-spacing, Θ is the angle of the incident beam towards the sample surface and b is 
the distance between two beams diffracted on two parallel lattice layers. 
 
Lyotropic lipid phases are polycrystalline dynamic phases with randomly distributed 
microdomains, which usually results in ring shaped diffraction patterns in the small angle 
regime, unless the polycrystalline subdomains align and produce Bragg peaks at the same 
position leading to spots instead of rings. The reciprocal spacings of the Bragg peaks (shkl = 
1/dhkl) are characteristic for a set of lattice planes, defined by the miller indices hkl. Therefore, 
the type of ring pattern gives information about the type of phase, and the distance between 
the rings serves to calculate the lattice parameters. The lamellar phase is defined by sl = 1/d, 
with ratios of 1,2,3, 4 etc., leading to equally spaced peaks. The hexagonal phase yields Bragg 
peak spacing factors of 1,     2,     3 etc.  
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4.1.2.2 X-ray generation 
X-rays are generated by exposing a metal, such as copper, tungsten or molybdenum with high 
speed electrons. Upon collision with the metal, these electrons eject an electron from the inner 
shell of the metal atom. This vacancy in turn is filled by an electron from higher energy levels of 
the metal atom and the excess energy is released in the form of X-rays with wavelengths 
ranging between 1 and 2 Å. Electrons that fill the vacancy from an L shell release Kα radiation 
(e.g. CuK α = 1.54 Å) and for SAXS experiments all other rays are filtered out by a 
monochromator. 
 
4.1.2.3 SAXS Instrumentation 
SAXS is measured on linear beam lines which is schematically shown in Figure 63. X-rays are 
usually produced with a copper source. The emitted divergent beam is focussed into one 
parallel beam using focussing optics and pinholes, which decrease parasitic scattering and 
thereby improve the signal to noise ratio. The beam is aimed at the sample where a small 
fraction of the beam is reflected, but the majority of rays does not interact with the sample and 
passes straight through. In order to block the high intensity main beam from hitting the 
detector a beam stop is set in place. The diffracted X-rays are detected on a 2-dimensional flat 
detector. The flight path between the sample and the detector is under vacuum to reduce air 
scattering effects.  
 
Figure 63: General set up of a SAXS beam line.  
 
4.1.3 Giant unilamellar vesicles 
Giant unilamellar vesicles (GUVs) are widely used as membrane model systems due to their size 
which is comparable to cellular dimensions. Giant vesicles exhibit diameters in the range of tens 
of micrometers making them observable by light microscopy. Therefore, they can be used to 
study protein membrane interaction on individual vesicles. Furthermore, their size allows study 
of membrane mechanical properties, such as bending rigidity, lysis tension and compressibility 
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by micropipette aspiration and membrane fluctuation analysis,  and investigation of phase 
segregation by fluorescence microscopy [209]. The advantage of GUVs over smaller vesicles is 
that due to their large radius membrane curvature is negligible.  
 
4.1.3.1 Formation of GUVs 
Several methods exist for the formation of GUVs. Gentle hydration of thin dried lipid films on 
Teflon surfaces (originally described by Reeves and Dowben [210]) is one of the most 
conventional methods, however it yields low populations of vesicles and is very time 
consuming. Furthermore, this method is limited in the use of physiological buffers by a 
maximum of 50 mM monovalent salt. Recently, a variation of this method, swelling on low 
melting agarose gels has been reported to produce GUVs in buffers up to 150 mM salt [211]. 
Electroformation (originally described by Angelova et al. [212] ) is another widely used method 
which exhibits much higher yields of vesicles and much shorter preparation times [213]. This 
method is also very limited in the use of salts and furthermore has been shown to cause 
peroxidation of polyunsaturated lipids [214] due to the applied electric field. Even low amounts 
of peroxidation influence the physico-chemical and phase properties of membranes and 
therefore the use. Monounsaturated lipids, such as oleoyl-lipid chains, are much less prone to 
peroxidation and the effect of peroxidation is therefore negligible when saturated and 
monounsaturated lipids are used. The problem of electroformation only being applicable to low 
salt concentrations has also recently been by-passed by buffer exchange to high ionic strength 
buffer in a flow chamber post-electroformation [215].  
 
4.1.4 Vesicle fluctuation analysis 
A number of methods has been employed to determine membrane elasticity parameter, such 
as micropipette aspiration of giant vesicles and deformation of vesicles in an electric field [216]. 
Vesicle (or membrane) fluctuation analysis is the only non-invasive technique and was first 
employed as a method to determine the bending rigidity of red blood cells [217]. Membrane 
fluctuations result from thermally induced spontaneous shape fluctuations of fluid membranes. 
Curvature elastic parameters are very sensitive to temperature. The bending rigidity tends to 
decrease with increasing temperature, as the lipid chain splay increase, leading to thinner 
bilayer width and lateral expansion [216]. See section 4.2.5 for a more detailed description of 
membrane fluctuation analysis. 
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4.2 Materials and Methods 
4.2.1 Lipid handling 
All lipids were purchased from Avanti Polar Lipids as lyophilised powders. Lipids were stored at 
-20°C either as lyophilised powders or as stock solutions in chloroform/methanol 3:1. Stocks 
were prepared by dissolving powdered lipids in cyclohexane (supplemented with a drop of 
chloroform if required), lyophilisation overnight, followed by determination of the lipid mass. 
The dried lipid was then dissolved in CHCl3/MeOH 3:1 to a final stock concentration of 30 or 
40 mg/mL. These stocks were diluted according to need. Drying of CHCl3/MeOH 3:1 stocks was 
performed by evaporation of the solvent under a nitrogen stream followed by drying under 
vacuum overnight. All solvents were HPLC grade.  
 
4.2.2 Small angle X-ray scattering 
Small angle X-ray scattering was used to determine the lyotropic phase behaviour and the unit 
cell spacing of the organelle mimetic lipid mixtures. 
 
4.2.2.1 Preparation of Lipid Samples for SAXS measurements 
The lipid mixture of interest was generated from chloroform/methanol stocks, dried under 
vacuum overnight and weighed out in small glass vials. The desired volume of MilliQ water was 
added and the lipid-water mixture subjected to 5 freeze-thaw-vortexing cycles using liquid 
nitrogen and a heating block. The temperature of the heating block was adjusted to be above 
the highest phase transition temperature in the lipid mixture to ensure all lipids are in the liquid 
disordered phase. Complete mixing and rehydration to homogeneity are very important for 
sample preparation, as bilayer defects, water pockets and MLVs below the excess water point 
can occur and lead to an overestimation of the water contribution to the lattice parameters 
[218]. The homogenous, hydrated lipids were then filled into quartz glass capillaries (Capillary 
Tube Supplies Ltd,  special glass, 1.5 mm diameter) with a spatula and moved to the bottom of 
the capillary by centrifugation in a swing out rotor (Hettich EBA21 centrifuge, rotor 1115) at 
870g for 40 s. The capillaries were then flame sealed and closed air tight with silicone sealant to 
prevent evaporation of water. The capillaries were weighed after complete drying of the 
silicone and the weight controlled after data acquisition to ensure constant water content.  
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4.2.2.2  Beam lines 
SAXS measurements were performed on two in house built beam lines, the Bede and the Lyo2. 
The BEDE can detect a higher D-spacing range and measurements are much quicker, therefore 
temperature scans were typically performed on the BEDE, while the Lyo2 was used for 
stationary temperature scans with higher resolution. WAXS measurements were performed 
using the SOL beam line. 
 
4.2.2.2.1 BEDE 
The Bede beam line is based around a 80 Watts Dual port Copper target Bede Microsource 
(Durham, UK) X-ray generator with integrated XOS collimating polycapillary optics (XOS) to 
focus the beams. Kβ and white radiation are Nickel filtered, allowing only the Kα radiation (λ = 
1.542 Å) to pass. 300 μm pinholes are installed after the optics to improve signal to noise ratio 
by cutting down parasitic scattering.  The diffraction data is acquired to a CCD detector 
(Photonic Science, Gemstar, 1300x1030 pixels) with X-ray intensification. The sample holder is 
temperature controlled via a peltier control with pt-100 sensor, ranging from -20 to 110°C with 
an accuracy of 0.5°C. Control and acquisition of diffraction experiments are fully automated. 
The Bede is suitable for d-spacing values between 2.5 -150 Å. 
 
4.2.2.2.2 Lyo2 
The Lyo2 is a fully digital automated beam line, consisting of a high power Copper target nonius 
FR-591 rotating generator and Franks optics. Like the Bede it contains a Photonic Science 
Gemstar intensified CCD detector and a peltier driven temperature control with a temperature 
range from 0 -80°C (+/- 0.5°C). The Lyo2 is suitable for d-spacing values between 15 and 120 Å. 
 
4.2.2.2.3 SOL 
The SOL beam line contains a custom built Guninier X-ray camera and records both, SAXS and 
WAXS diffraction patterns, which are recorded in 1 dimension on Kodak BioMax MS film. X-rays 
are produced by a Philips PW1140 X-ray generator containing a fixed anode copper source. X-
rays are filtered by a quartz monochromator and a line focus beam is generated. The range of 
detected d-spacings is 2.5 – 150 Å. The temperature can be varied between -20 and 150°C at a 
rate of 0.003 to 3.3°C/h and continuous diffraction patterns as a function of temperature can 
be recorded via a motorised film carriage moving at a rate of 0.06 mm/min. The sample holder 
fits capillaries up to 1.8 mm. The diffraction pattern of lipid samples was measured at 25°C for 
2h.  
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4.2.2.3  Data analysis 
The diffraction patterns acquired by SAXS were analysed with respect to the phase behaviour 
and lattice parameter using the AXcess software developed in house by Dr Andrew Heron. The 
software locates the centre of the diffraction image and integrates the signals radially through a 
user defined section in order to convert the peak intensities into a plot of intensity versus pixel 
number (Figure 64). The peak pattern was used to assign them to the corresponding 
mesophase and the d-spacing was determined. Calibration was performed with silver 
behenate, which has a lamellar D-spacing of 58.38 Å. 
 
 
 
 
Figure 64: SAXS data analysis using the AXcess software developed in-house. Top panel: diffraction 
pattern of mitochondrion mix, 60% water, 25°C, bottom panel: 1D density plot and determination of the 
d-spacing values. 
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4.2.3 Differential Scanning Calorimetry  
Differential Scanning Calorimetry (DSC) was performed in a Microcal VP-DSC differential 
scanning calorimeter.  To prepare the lipid samples, lipids were lyophilised overnight. Water or 
buffer was degassed at 10°C for 35 min and added to a final concentration of 2 mM (DMPC) or 
1.5 mg/mL (organelle mimetic compositions, approximately 2 mM). Multilamellar vesicles were 
prepared by heating the lipid suspension to 52 °C for 30 min under intense stirring. 
Measurements were performed in a wide temperature range between 10 and 80°C with a scan 
rate of 1.5°C/min for the heating scan and 1°C/min for the cooling scan and a filter period of 
4 s. 14 scanning cycles were performed. 
 
4.2.4 Giant unilamellar vesicle (GUV) formation by electroformation 
4.2.4.1 ITO glass slide preparation 
Indium tin oxide (ITO) covered glass slides with a resistance of 5 – 15 Ω (Sigma-Aldrich) were 
furnished with conductive tape on the conductive side on one end of the slide (see Figure 65). 
The slides were cleaned thoroughly by consecutive washing with water/detergent, ethanol and 
chloroform and rubbed with a low lint tissue (Kimberley Clark). The slides were then dried 
under vacuum for 30 min. Lipid samples were applied in CHCl3/MeOH 3:1 in concentrations 
between 1 and 10 mg/mL. Using a Hamilton syringe 5-10 μL lipid solution was either coated 
over the whole slide in one even streak or the sample was applied drop wise in 1 μL dots.  
The solvent was evaporated under vacuum for 1 – 3 hours.  
 
4.2.4.2 Electroformation set-up and protocol 
In order to set up the electroformation chamber (Figure 65), two glass slides, one of which was 
coated with lipids, were assembled into a sandwich with the conductive sides facing each other 
and the conductive tape on opposite sides. A rectangular PDMS (polydimethylsiloxane) spacer 
separated the slides, forming the electroformation chamber. The assembly was held together 
by two mini binder clips. A needle was inserted into one corner of the PDMS spacer to allow air 
release. A second needle attached to a syringe was used to fill the electroformation chamber 
with 200 mM sterile filtered sucrose solution in MilliQ water. One crocodile clip was attached to 
the conductive tape on each side and connected to a function generator. The electroformation 
chamber was placed on a preheated heating block. A square function AC current was applied 
across the chamber with different protocols, depending on the lipid composition. The following 
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program was typically applied for pure DOPC and DOPC/DOPE mixtures (Table 15). For more 
complex lipid mixtures electroformation was unreliable and variations in voltage, frequency 
and duration were applied.  The temperature applied lay always above the highest phase 
transition temperature of the lipid mixture. 
 
Figure 65: Electroformation set-up (see text for further explanation) 
 
Table 15: Typical electroformation protocol 
Frequency (Hz) Voltage across slide (V) Time (h:min) Temperature (°C) 
10 1.6 2:00 42 
4 2.6 0:45 42 
 
4.2.5 Membrane fluctuation analysis 
Membrane fluctuation analysis was conducted in collaboration with Dr Peter Petrov at the 
University of Exeter. The fluctuation spectra of membranes are a result of the membrane elastic 
properties and thermal effects. Membrane fluctuations are dependent on the temperature and 
osmolarity of the buffer. If these two parameters are constant, the bending modulus of 
different lipid compositions can be determined and compared.  
 
4.2.5.1 Imaging of GUV fluctuations 
GUVs in 200 mM sucrose solution were visualised by phase contrast microscopy using an 
upright Leica DMLFS with a 63xPL FLUOTAR phase contrast objective. For this purpose around 
50 μL of the GUV solution were injected into an open-sided observation chamber. This chamber 
is built by separating a microscope slide and a cover slip with two thin parafilm strips which are 
then fixed by brief heating of the glass slide to 70°C on a hot plate to melt the parafilm. 
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The GUVs were recorded by a Moticam 2000 (Motic, China) digital microscope camera with a 2 
MegaPixel CMOS sensor connected to a computer. The recorded file format is Audio Video 
Interleave (AVI) and the resolution is 30 pixels per micron. A minimum number of 300 contour 
points and a minimum frame rate of 35 frames/s were required. Ideally, the number of contour 
points lay between 300 and 600 and the frame rate around 50-60 frames/s. Typically, 500 – 
1000 frames per GUV were used for data analysis and elliptical vesicles were discarded. 
 
4.2.5.2 Contour extraction of vesicles 
An ImageJ plugin written in Java by John Hale (University of Exeter) was used to determine the 
Cartesian coordinates of the GUV contour. This program recognises the edge of the vesicles as 
follows: The intensity minimum of the dark vesicle ring is detected and defined as the zero 
position. A cubic polynomial is fitted through 5 pixels on either side of the zero position 
according to the method of least squares. The minimum of this fit closest to the zero position is 
then determined and defined as the vesicle edge. In order to extract the GUV contours, AVI files 
of the GUVs were stack converted into 8-bit greyscale. A rectangular box was drawn around the 
first vesicle contour as the region of interest to facilitate contour recognition by the plugin. The 
algorithm first identifies the contour boundaries by determining the point of minimum 
intensity, starting the scan from the centre of each side of the box. These boundaries are then 
used as starting points for the algorithm to find the contour edge. The X/Y contour coordinates 
are consecutively determined for each frame and saved into a text file.  
 
4.2.5.3 Fourier analysis of contours 
The text file with the contour coordinates of each frame is further processed by Fourier analysis 
according to standard methods for quasi spherical vesicles described in [219]. Briefly, the 
Cartesian contour coordinates are transformed into polar coordinates with the centre of mass 
being the origin. With the polar coordinates, each contour is then developed in Fourier modes 
as follows, where    and    are the Fourier amplitudes and     is the mean radius of the 
contour.  
 
                                            
 
   
  
Eq. 19 
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The mean experimental values of the parameters,     ,      and      describe the mean 
vesicle shape. The time dependent membrane fluctuations around this mean shape are a result 
of the membrane elasticity and can be used to quantify the bending modulus. The mean square 
fluctuations    
   can be deduced from the mean square values of the amplitudes for each 
mode n [220].  
 
   
       
       
       
       
   
Eq. 20 
Low modes have larger amplitudes, longer wavelengths and longer fluctuation lifetimes than 
higher modes. This is important with regards to data acquisition, as it is necessary to record the 
complete mode in order to obtain statistically significant mean values. The low modes can 
range in the order of several seconds. The measurement of high modes on the contrary is 
limited by the resolution and frame rate of the camera. For the determination of the bending 
modulus         
   is plotted against           The resulting curve (see Figure 76 for a 
representative plot) exhibits a linear part for medium modes numbers. This region designates 
the bending dominated regime of membrane fluctuations.  Linear fitting of this regime with a 
slope of -3 allows the calculation of the bending modulus using the following equation: 
 
 
   
 
    
  
 
Eq. 21, 
where   is the bending rigidity, kB the Boltzmann constant, T the temperature and m the y-
intercept of the linear fit. Only data sets with  a linear regime containing at least 5 modes were 
used for determining the bending rigidity.  
 
 
 
 
 
 
 
132 
 
4.3 Results 
4.3.1 Literature review for biomimetic membrane compositions 
In order to investigate the lyotropic behaviour of organelle mimicking membranes and to study 
Rab delivery to these membranes, the literature was reviewed for published lipid compositions 
of distinct mammalian organelles. It was intended to use a broad range of phospholipid 
headgroups for the organelle mimetic lipid mixtures. Obtaining precise measurements of the 
total lipid distribution present in biological endomembranes remains difficult to date. Many 
studies focus on the analysis of total phospholipid content, lipid distribution in tissues or organs 
rather than subcellular membranes separately and often only the major phospholipids, such as 
PC, PE, PI and PS are quantified [221]. Two publications were singled out and the published 
values therein used for the organelle mimetic membranes. Zambrano et al. [222] investigated 
different organelle lipid compositions in rat liver and based on these compositions synthetic 
plasma membrane and mitochondria mixtures were generated. Evans and Hardison 
investigated the phospholipid and cholesterol composition of rat hepatic endosomes [223] and  
these published values were used for the lipid composition in the endosome mimicking lipid 
mixture. Regarding the lipid hydrocarbon chains, the majority of acyl chains in biological 
membranes are 18 carbon chains, i.e. 18:0, 18:1 and 18:2. Only organically pure dioleoyl chains 
were used for all phospholipids in the presented study for reasons of simplification and because 
dioleoyl systems are widely used as model membrane systems. Exceptions were sphingomyelin 
and phosphatidylinositol, which were physiological mixtures derived from bovine brain and 
porcine liver respectively. Table 16 summarises the compositions of the artificial organelle 
mixtures used. Interestingly, the plasma membrane mix, did not contain as much cholesterol as 
would be expected. More recent studies have revealed that the plasma membrane contains 
around 50% cholesterol [224]. However these studies did not analyse a broad range of lipids.   
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Figure 66: Chemical structures of lipids and lipid headgroups used for organelle mimetic lipid 
compositions. (A) Phosphatidic acid (PA), (B) Phosphatidylinositol (PI), (C) Phosphatidylserine (PS), (D) 
Phosphatidylglycerol (PG), (E) Sphingomyelin (SM), (F) Cardiolipin (CL), (G) Cholesterol (Chol). DOPC and 
DOPE are shown in Figure 15. 
 
Table 16: Organelle mimetic synthetic membrane compositions (in % (w/w)) 
  Plasma membrane Endosome Mitochondrion 
DOPC 34.55 49.90 40.61 
DOPE 20.48 15.55 34.86 
PI (bovine brain)  6.77 - 4.63 
DOPS 7.91 2.35 0.71 
SM (porcine liver)  14.07 11.02 0.50 
Chol 12.88 19.00 0.15 
DOPG 0.88 - 17.93 
LPC 0.88 - 0.60 
LPE 1.14 - - 
DOPA 0.44 - - 
CL - 0.81 - 
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4.3.2 Differential Scanning Calorimetry of biomimetic membrane mixtures 
Differential Scanning Calorimetry (DSC) was employed to investigate the phase behaviour of 
fully hydrated membranes consisting of the organelle mimicking lipid compositions (section 
4.3.1). Study of the phase behaviour of such complex lipid compositions has not been 
undertaken and cannot be predicted, as the effect of the interplay between the lipids is 
unknown. As a positive control pure DMPC was used, in order to show that the assay conditions 
were correct. The lipids were dried, rehydrated under intense stirring at a concentration of 
2 mM or 1.5 mg/mL respectively, which leads to the formation of multilamellar vesicles. Each 
suspension was scanned between 10°C and 80°C for 14 cycles with scanning rates of 1.5 K/min 
for heating and 1 K/min for cooling. Each sample was reproduced at least once. One 
representative DSC curve for each sample is shown in Figure 67. Panel A shows the DSC heating 
(black) and cooling (red) curves of DMPC, confirming the transition from gel to liquid crystalline 
phase at 41°C and the pretransition at around 35°C [225]. None of the organelle mimicking 
mixtures exhibit a phase transition in the investigated temperature range.  
 
A. DPPC              B. Plasma membrane mix 
           
C. Mitochondrion mix                              D. Endosome mix 
          
Figure 67: DSC thermograms of (A) DPPC, (B) plasma membrane mix, (C) mitochondrion mix, (D) 
endosome mix. Red curves present heating cycles, black curves represent cooling cycles. 
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4.3.3 Small Angle X-Ray scattering of biomimetic membrane mixtures 
Small angle X-ray scattering (SAXS) was performed to determine the lyotropic phase behaviour 
of the organelle composition mimicking membranes with different water contents. Swelling 
curves were determined by SAXS on the Lyo2 beam line at 25°C with 60, 70 and 80% (w/w) 
water. Due to very high noise, each sample was measured a multitude of times for a short 
period (in the range of minutes, see Table 17). A large number of randomly occurring high 
intensity artefacts (so-called zingers) were observed, which would impair the integration of the 
diffraction pattern with the AXcess software. Using the white-point filter tool of the software 
these zingers were thus removed from each diffraction image separately. The resulting images 
were then superimposed and added followed by intensity integration of the diffraction pattern. 
As the diffraction pattern consists of concentric circles, integration was performed as a function 
of the radial distance from the centre.  
The superimposed SAXS diffraction patterns are presented in Figure 68 and the respective 
integrated intensities in Figure 69. All three compositions are lamellar at the investigated 
temperature and due to the high d-spacing it can be assumed that they are fluid lamellar, which 
were confirmed by wide angle X-ray scattering (see section 4.3.5). The resulting lattice 
parameter values are summarised in Table 18 and plotted over the water content (Figure 70). 
The diffraction patterns show a drastic increase in noise with increasing water content which 
could not be resolved with the available beam lines for the plasma membrane mix containing 
80% water and above 80% for all compositions. Furthermore, a clear decrease in ring distance is 
observed, hence an increase in lamellar d-spacing, for all three lipid compositions.  
 
Table 17: Number of superimposed SAXS diffraction images and respective duration of measurement 
on Lyo2 (or *BEDE) for organelle mimicking lipid compositions 
Water (%) PM Endosome Mitochondrion 
60 50 x 1 min Total of 47 min* 46 x 1 min 
70 36 x 2 min 50 x 2 min* 50 x 2 min 
80 43 x 2 min 43 x 3 min 36 x 4 min 
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Figure 68: SAXS diffraction patterns measured on the Lyo2 and Bede (Endosome 60% and 70% water) 
beam lines.  
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Figure 69: Integrated SAXS diffraction pattern using the AXcess software. The X-axis is shown in 1/d-
spacing [1/Å], y-axis shows the intensity (A.U.). 
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Comparison of the lamellar d-spacing values of the three compositions at different water 
contents (Table 18 and Figure 70) shows that they exhibit a comparable trend of increasing d-
spacing with increasing water content. At 80% the swelling has not yet reached the excess 
water point, which is very high, as is the d-spacing in the range of 100 – 200 Å. As a comparison, 
the repeat lattice parameter of fully hydrated DOPC is 63.1 Å at 30°C [226]. As already 
mentioned these high swelling properties can be explained by a high percentage of charged 
lipids PI, DOPS and SM [110,227]. The high extent of noise in the diffraction patterns may be 
caused by the high swelling. At such high distances between the different lamellar sheets the 
membranes potentially exhibit a higher degree of undulation, leading to broadening of the 
diffraction peaks [228]. The increase of d-spacing of the endosomal and mitochondrion mix is 
not linear, but exhibits a slightly steeper increase with increasing water content. For the PM mix 
only two data points were determined.  
 
Table 18: D-Spacing [Å] of different organelle mimetic lipid compositions at 25°C and the standard 
error (s.e.) 
Water [%] Plasma Membrane +/- s.e. Endosome +/- s.e. Mitochondrion +/- s.e. 
60 98.665 0.112 81.626 0.623 96.326 0.121 
70 142.596 0.588 126.831 5.630 132.975 0.498 
80 - - 195.827 1.332 183.783 0.861 
 
 
 
Figure 70: D-Spacing values of different organelle mimetic lipid mixtures at 25°C as a function of the 
water content at 60, 70 and 80% (w/w). PM (plasma membrane mix), Endo (Endosome mix) and Mito 
(Mitochondrion mix). 
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4.3.4 SAXS temperature scans of endosome mimetic lipid composition 
Different organelle mimetic lipid compositions were subjected to temperature scans in steps of 
5°C ranging from 5 to 70°C on the Bede beam line. The resulting diffraction patterns were stack 
analysed in AXcess in order to determine the d-spacing and phase behaviour at each 
temperature.  
 
4.3.4.1 SAXS of organelle mimetic lipid mixtures in water 
D-spacing of endosome mimicking lipid composition in 60% and 70% (w/w) water is shown in 
Figure 71. Panel A shows an example of a resulting stackplot created in AXcess of the endosome 
mimetic mixture in 70% water. The diffraction pattern is clearly lamellar throughout the whole 
temperature range, without undergoing any apparent phase separation. This was also the case 
in 60% water. These results are in agreement with the DSC data (section 4.3.2) where it was 
shown that none of the three organelle mimetic lipid compositions undergo any phase changes 
in the temperature range between 10 and 80°C. Analysis of the d-spacings of the endosome mix 
in 60 and 70% water at each temperature yields the graph in Figure 71, panel B. As expected, 
the d-spacing decreases with increasing temperature, and increases with increasing water 
content. 
 
A           B 
    
Figure 71: Temperature scans of endosome mimetic lipid mixtures. (A) Stackplot of endosome mix in 
70% water created in AXcess. White regions indicate the position of SAXS peaks. (B) Temperature 
dependence of d-spacing of endosome mix in 60 and 70% water. 
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4.3.4.2 SAXS of buffered organelle mimetic lipid compositions  
Membranes behave differently in pure water than under physiological conditions, therefore the 
phase behaviour was investigated in the presence of 50 mM Tris pH 7.5, 150 mM NaCl and 
5 mM MgCl2, as this buffer is typically used for Rab protein purification. The resulting d-
spacings in dependence of temperature are shown in Figure 72. As expected, the inter-bilayer 
distance increases  with increasing water content for both mixtures from 50% to 60% water. 
70% water was only investigated for the PM mix and the d-spacing values are slightly lower 
than at 60% water, up to 60°C, when they exhibit a steep increase for the 70% water PM mix. 
This indicates, that below this temperature the excess water point is achieved at or below 60% 
water. Above 60°C the excess water point increases, accompanied by a steep increase of the 
inter-bilayer water capacity. 
 
 
Figure 72: D-spacing values of PM and Mitochondrion mimicking membranes in the presence of salt 
and buffer depending on temperature determined by SAXS on the Bede beam line. 
 
Comparison of PM and Mitochondrion mix in water and buffer at 25°C (Figure 73) interestingly 
reveals, that the d-spacing of PM mix in 60% water and buffer is identical.  A slight decrease of 
PM d-spacing in 70% water suggests that the excess water point has been reached. However, 
further measurements are required to confirm this.  
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Figure 73: Comparison of swelling behaviour of PM and Mitochondrion mix at 25°C in water and 
buffer containing salt.  
 
4.3.5 Wide angle X-ray scattering of organelle mimetic lipid mixtures 
SAXS and DSC have shown that all three organelle mimetic lipid mixtures are lamellar 
throughout the investigated temperature range. However, it remained unclear which type of 
lamellar phase they exhibit, Lα, Lβ or Lc. For this reason WAXS measurements of endosome and 
plasma membrane mimetic lipid compositions in 60% water were performed on the SOL beam 
line. Lipid samples were diffracted for 2 h at 25°C. The resulting diffraction patterns (Figure 74) 
were recorded by film exposure followed by film development. Silverbehenate (AgBe) serves as 
a calibration standard and positive control. The observed multiple sharp peaks in the wide 
angle regime are a result of the crystalline phase of AgBe. The two lipid mixtures do not exhibit 
any peaks in the wide angle regime, suggesting that both are fluid lamellar phases. These WAXS 
measurements complement the previously shown DSC and SAXS experiments. In combination it 
can be concluded, that the organelle mimetic lipid mixtures are fluid lamellar, without phase 
separation between 5 and 80°C. 
 
 
Figure 74: WAXS diffraction patterns of AgBe, endosome (60% water) mix and PM mix (60% water) at 
25°C. AgBe is a positive control exhibiting sharp peaks in the wide angle regime, which gives evidence 
for crystallinity. Both lipid mixtures are fluid lamellar, as they exhibit no diffraction peaks in the wide 
angle regime. 
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4.3.6 Membrane fluctuation analysis of DOPC/DOPC mixtures to determine the 
bending rigidity 
A number of methods have been reported for the formation of giant unilamellar vesicles 
(GUVs). In the course of this study, GUV formation was attempted by agarose swelling [211] 
and gentle hydration on Teflon surfaces [229], and electroformation [212]. The latter proved to 
be the most reliable method in our hands and was therefore chosen as the standard method. 
GUVs made from DOPC supplemented with 0/10/20 and 30 mol% DOPC were recorded over 
several seconds in phase contrast as described in section 4.2.5.1 and fluctuations extracted as 
described in 4.2.5.2 and 4.2.5.3. A representative DOPC GUV is shown in Figure 75 with images 
extracted in 0.5 s steps, clearly showing the movement of the membrane.  
 
 
Figure 75: Series of DOPC GUV in 0.5 s intervals (filmed in phase contrast) 
 
Contour extraction and conversion to polar coordinates, followed by Fourier transformation 
enabled the extraction of the Fourier amplitudes an and bn, which were converted to the mean 
fluctuations cn using equation Eq. 20 in the provided Java code. The logarithmical plotting of the 
mean square fluctuations         
   vs. the logarithm of the mode number      (n) leads to a 
graph as shown in Figure 76. The resulting curves exhibit a linear, bending dominated regime, 
which was fitted by linear regression. Modes 1 to at least 4  and above 19 were always 
disregarded. The number of modes fitted linearly in-between these bounds depended on each 
individual data set. Less than 50% of the recorded GUVs were suitable for further data analysis, 
possibly due to multilamellarity and not being spherical. 
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Figure 76: Data analysis of membrane fluctuations to determine the bending rigidity. The linear region 
is the bending dominated regime, which is linearly fitted with a slope of -3. The resulting y-intercept of 
the linear fit (m) is used to determine the bending rigidity according to Eq. 21. 
 
Using Eq. 21, the bending rigidity was calculated for each vesicle measured. The resulting 
separate bending moduli are shown in Figure 77. The number of individual GUVs analysed for 
each composition was 11 for 30 mol% DOPE (panel A), 9 for 20 mol% DOPE (panel B), 1 for 
10 mol% DOPE (not plotted) and 10 for pure DOPC (panel C). Only a fraction of the measured 
vesicles was unilamellar, many were bi-, tri- or oligo-lamellar. The bending rigidity is 
proportional to the number of lamellar layers, therefore the measured bending rigidity of each 
vesicle is a multiple of the unilamellar bending modulus, i.e. 
 
        
Eq. 22, 
 
where      is the measured bending rigidity,   is the unilamellar bending modulus and n is a  
positive integer, equal to the number of bilayers present in the measured vesicle. As a 
consequence, it was crucial to assign each experimentally determined bending rigidity to the 
correct lamellarity in order to determine the unilamellar bending modulus. The horizontal lines 
in Figure 77 indicate the average values calculated from the data starting at unilamellar vesicles 
at low bending rigidity and increasing with increasing lamellarity. 30 mol% and 20 mol% DOPE 
mixtures consisted of only uni- and bilamellar vesicles. Pure DOPC consisted of bi-, tri- and 
penta-lamellar vesicles. The red line in Figure 77 panel C indicates the unilamellar bending 
modulus, which was derived from the average weighted values of the experimentally 
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determined multi-lamellar bending rigidities, shown as black horizontal lines and separately in 
panel D.  
 
        A. DOPC/DOPE 7:3    B. DOPC/DOPE 8:2 
 
           
 
        C. Pure DOPC     D. Average values for pure DOPC 
 
                    
Figure 77: Bending rigidity of DOPC/DOPE GUV membranes. (A) DOPC/DOPE 7:3, (B) DOPC/DOPE 8:2, 
(C) pure DOPC and (D) average values for pure DOPC. Vesicles were sorted according to increasing 
bending rigidity. The horizontal lines indicate the average values for increasing lamellarity, with the 
lowest line representing the unilamellar bending rigidity. The red line in panel (C) represents the 
unilamellar bending rigidity calculated from the bi-, tri- and penta-lamellar values.  
 
The unilamellar bending rigidities for each lipid composition are tabulated in Table 19 and 
presented in Figure 78. They were calculated as averages of all experimentally determined uni- 
and multi-lamellar values and weighted according to lamellarity. Interestingly, the bending 
rigidity exhibits a linear decrease with decreasing mol% of DOPE. Extrapolation of the linear fit 
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leads to a bending rigidity of 59.4 kBT for pure DOPE.  This is the first self consistent study 
measuring the bending rigidity of a binary mixture of DOPC and DOPE. 
 
 
Table 19: Summary of bending moduli determined for different DOPC/DOPE compositions 
Mol% DOPC κ (kBT) S.E. 
70 24.62 1.07 
80 20.34 2.09 
90 17.71 (1.22) 
100 10.17 0.62 
 
 
Figure 78: Bending moduli of binary DOPC/DOPE mixtures. The line represents the linear fit of the data 
points. 
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4.4 Discussion 
4.4.1 Lyotropic phase behaviour of organelle mimetic lipid compositions 
This chapter presents the investigation of the phase behaviour of complex lipid compositions 
that mimic organelle compositions of the plasma membrane, endosomes and the 
mitochondrion by SAXS and DSC. Furthermore the bending rigidity of binary DOPC/DOPE 
mixtures was determined. While the phase behaviour of  binary and ternary lipid mixtures has 
been widely investigated, there is a lack of studies on the phase behaviour of more complex 
lipid compositions and the contribution of proteins. In physiological membranes containing 
cholesterol and sphingolipids, membrane microdomains have been visualised with fluorescence 
microscopy, atomic force microscopy and two-photon fluorescence microscopy [112,230,231]. 
Such microdomains have also been created in low component lipid mixtures [115,232], but no 
studies on complex, organelle mimetic lipid mixtures have been reported.  
The use of organelle mimetic lipid mixtures is limited by the lack and imprecision of data 
regarding the lipid composition of subcellular membranes. This is due to the fact that the 
separation of organelles by gradient ultracentrifugation remains imprecise to date. 
Furthermore, before the introduction of mass spectrometry as a means of lipid identification 
only those lipids were identified, that were specifically searched for using chromatographic 
methods. Many of the early publications in the field only looked at bulk lipids such as PC, PE, PI, 
PS and Cholesterol, leaving out less abundant lipids such as lysolipids, cardiolipin and 
sphingolipids, which have an important effect on membrane properties. The aim of this study 
was to use complex headgroup mixtures, while keeping the lipid chain composition as uniform 
as possible by using oleoyl chains. The majority of lipids in mammalian membranes are C18 
chains, therefore parameters such as the membrane thickness should be physiologically 
relevant in the used artificial compositions. The presented studies on complex membrane 
compositions neglect the fact that in vivo, asymmetry of the two lipid leaflets is another factor 
that modulates overall membrane phase behaviour. The preparation of membrane model 
systems with asymmetric leaflets remains one of the big challenges in studying the function of 
biomembranes. 
The studies on three organelle mimetic lipid compositions reported here reveal that they are all 
lamellar phases with high d-spacing (see Table 18 and Figure 70) reaching almost 200 Å with 
80% water for the endosome and mitochondrion mixtures without yet having reached the 
excess water point. Temperature scans of the endosome mix in 60% and 70% water from 5-
147 
 
80°C showed that both are lamellar over the complete temperature range measured (Figure 
71). A mild, monotonous decrease in d-spacing is observed with increasing temperature for all 
samples. This observation is caused by a decrease in lipid chain order with increasing 
temperature, accompanied by an increase in chain splay that decreases the bilayer thickness. 
No phase segregation is observed, which is interesting considering the complexity of the lipid 
compositions. Furthermore, it may indicate an important role of proteins on membrane phase 
separation, as endosomes and PM mix were shown to exhibit phase segregation into liquid 
disordered (Lα) and ordered (Lß) domains in vivo [233,234]. This indicates that the in vivo 
membrane lipid composition alone does not exhibit lateral phase segregation, but membrane 
proteins are required to induce these. A number of proteins have been shown to influence 
phase behaviour of lipid mixtures, for example by inducing non-bilayer phases, even at low 
mole fractions, such as gramicidin A and other amphipathic alpha helical peptides [235-237]. It 
is difficult however to extrapolate from these simple lipid mixtures with low protein 
concentration to in vivo conditions, where the lipid composition is far more complex and a 
multitude of membrane proteins interact with the membrane. 
Conversely to the results presented above, a study investigating the phase behaviour of natural 
lipid extracts from bovine liver, brain and heart [238] found that these lipid compositions are 
lamellar at physiological conditions, with relatively high d-spacings (89 - 99 Å), but convert to 
non-lamellar phases at near-physiological (40 - 50°C) conditions. There may be a number of 
reasons for the differences to the findings in this thesis. While in [238] SAXS was performed on 
samples in excess water (50 μg/mL, equal to 95% (w/w) water) using a synchrotron beam line, 
the data presented here was derived from samples below the excess water point and on 
conventional SAXS beam lines. Addition of water above the excess water point may induce 
phase transitions. However, the d-spacings reported in this study are lower compared to the 
data presented here. This is especially surprising considering that they contain more water. 
Therefore, it is possible that the observed differences in d-spacing are due to a considerably 
higher complexity of the lipid extracts compared to  the organic lipid compositions in terms of 
lipid species variety. Furthermore, lipid extracts were obtained from Avanti Polar Lipids and 
may contain remaining traces of protein, which may change the phase behaviour. 
 
Calculation of structural parameters other than the d-spacing, such as the average area per lipid 
and the average thickness of the bilayer, are important for estimating the hydrophobic 
mismatch between protein and membrane, and the protein insertion energy [141]. However, 
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calculation of these parameters requires knowledge of the excess water point, which could not 
be determined at such high observed d-spacings due insufficient resolution of the diffraction 
patterns. The high d-spacing and swelling observed for the organelle mimetic membranes is not 
surprising, and most likely results from the high content of charged lipids in the compositions. It 
is well known that charged lipids induce unlimited swelling of the lamellar phase [227,239], and 
studies of quaternary systems of SM/DOPC/DOPE with increasing amount of PI or DOPS 
showed that PI induces unlimited swelling of the lamellar phase [110] due to electrostatic 
repulsion of the headgroups [240]. The swelling curves of endosome and mitochondrion 
mimicking compositions (see Figure 70) do not exhibit a linear increase but can be fitted to an 
exponential or quadratic function. This observation has been explained by Costigan et al. [141]. 
The first water molecules release stress caused by electrostatic and steric interaction between 
headgroups, by intercalating between the headgroups and thereby not contributing much to 
the bilayer distance. A further increase in water leads to a constant increase in contribution to 
the bilayer distance, once the intra-bilayer repulsion is relieved by hydration with water.  
 
Figure 72 visualises the influence of near physiological salt concentration at pH 7.5 on two 
organelle mimicking lipid mixtures, PM and mitochondrion, in 50, 60 and 70% water. They show 
a very similar trend of increasing d-spacing with water content and decreasing d-spacing with 
temperature. Direct comparison of d-spacing values in water and buffer at 25°C (Figure 73) 
shows that the buffer has a tendency to decrease the d-spacing. Addition of salt is expected to 
decrease the d-spacing of lipid mixtures containing charged lipids in comparison to samples in 
pure water. This is due to the fact that the presence of charged molecules, such as salt ions and 
buffer molecules dramatically decreases the length of coulomb interaction between charges. 
The limit of distance where coulomb interactions can be ignored is the Debye screening length 
   which is given by [241]: 
    
    
          
 
 
 
 
  
 
Eq. 23 
 
where   is the dielectric constant (78.5 for pure water at 25°C), kB is the Boltzmann constant 
(1.38·10-23 JK-1), T is the temperature (K), k is the Coulomb constant (8.99·109 Nm2C-2), e is the 
charge of an electron (1.6·10-19 C),    is the number density for each charged particle species 
per volume and zi is the charge. For an aqueous solution containing 50 mM Tris pH 7.5, 150 mM 
NaCl and 5 mM MgCl2 the Debye screening length amounts to 6.98 Å. This is relatively short in 
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comparison to the determined d-spacings values of 60 – 200 Å of the investigated lipid 
mixtures. Shielding the lipid headgroup charge therefore has the effect of decreasing inter-
bilayer repulsion and hence the lattice parameter. The mitochondrion mimetic mixture in 60% 
water and the PM mimetic mixture in 70% water exhibit much lower d-spacing in the presence 
of salt, but surprisingly, in 60% water the d-spacings of PM mix in water and buffer are 
identical. 
 
4.4.2 Bending rigidity of binary DOPC/DOPE mixtures 
Micropipette aspiration of giant vesicles was employed to determine the bending rigidity of 
DOPC containing 0/10/20 and 30 mol% DOPE. It is found that addition of DOPE to DOPC leads 
to a monotonous increase of the bending rigidity. The dependence of bending rigidity on the 
lipid chain length, degree of unsaturation and bilayer thickness has been shown previously in a 
comprehensive study using micropipette aspiration [96]. However, much less is known about 
the influence of the lipid headgroup. It was shown for mixtures of DOPE/DOPS/tetradecan that 
the bending rigidity is not a function of the DOPE/DOPS ratio [242]. Furthermore, it was 
postulated by Marsh [97,243], that lipid headgroups do not influence the bending rigidity, 
because similar bending moduli of around 10 kBT (per monolayer) had been reported for DOPC, 
DOPE and DOPS. However, the data reported here shows that the headgroup does have an 
influence on bending rigidity.  
Previously reported bending rigidities for DOPC and DOPE are summarised in Table 20. It is 
obvious, that the values are subject to variations, depending on the method of determination 
and study. The bending rigidity of pure DOPC determined in this work was 10.17±0.62 kBT, 
which lies between the values of 6.1 kBT and 21.2 kBT determined previously by vesicle 
fluctuation analysis [216] and micropipette aspiration [96]. Pure DOPE has previously been 
determined to 11 – 23.1 kBT and therefore lies in the same range as DOPC. However, 
comparison of the values is difficult, as they were measured with completely different 
methods, as pure DOPE does not form bilayers. Furthermore, both lipids have never been 
measured in combination. The results presented here are therefore the first study investigating 
the influence of the headgroup on the bending rigidity in lipid mixtures with homogenous lipid 
chains. 
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Table 20: Previously reported bilayer bending rigidity values of DOPC, DOPE and DMPC. Originally 
reported values are printed in black, conversion to different units are printed in grey. 
Lipid κ (kBT) κ [10
-19 J] Temp.(°C
) 
Method Ref. 
DOPC 21.2 ± 2.7 0.85±0.11 21 MA [96] 
DOPC 6.1 ± 1.3 0.24±0.05 23 VFA [216] 
DOPE 12.2 0.48 22 X-ray diffraction [244] 
DOPE 11 
(monolayer) 
- 
- 
 
X-ray diffraction and 
osmotic stressing 
[245] 
DOPE 
 
23.1 ± 1.0 
 
0.94±0.04 
 
22 
dual-solvent stress 
experiments on HII-phases 
[246] 
DMPC 13.4 ±1.4 0.56±0.06 29 MA [96] 
 
4.5 Chapter Summary 
This chapter presents studies on the phase behaviour and lattice parameters of organelle 
mimetic synthetic lipid mixtures and data on the bending rigidity of DOPC/DOPE bilayers. 
Between 5 and 80 °C the organelle mimicking membranes were all lamellar without phase 
segregation and exhibited very high d-spacings and swelling behaviour in water. These 
observations are due to a high amount of charged lipids (DOPG, PI, DOPS, SM) in the presented 
compositions. The bending rigidity of DOPC/DOPE mixtures was shown to increase 
monotonously with increasing mole fraction of DOPE. This is the first self-consistent study 
investigating the influence of the phospholipid headgroup on membrane rigidity .  
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CHAPTER 5 
Rab Delivery to Membrane Model Systems 
 
In this chapter the influence of membrane properties on Rab targeting is investigated. Rab 
protein targeting to intracellular membranes is highly specific with respect to the compartment 
they associate with. Elucidating the molecular mechanism that enables different Rab proteins 
to distinguish between subcellular compartment membranes is of high interest as it remains 
one of the open questions regarding Rab function. Membrane targeting factors and other 
mechanisms have been proposed to convey specificity to the process of Rab membrane 
association (see section 1.5), but no general mechanism has been uncovered and Rab 
membrane targeting may not be strictly dependent on protein factors.  In this work, the role of 
biophysical membrane properties for Rab membrane binding are investigated for the first time. 
This is an important topic considering the function of Rab proteins in membrane traffic and the 
fact that other Ras related GTPases have been shown to specifically recognise global membrane 
properties and single lipid species.  
A number of methods were developed in this study to address these issues and to study Rab 
membrane delivery. EGFP-Rab proteins in complex with GDIα were incubated with different 
membrane systems and the amount of membrane-bound Rab was determined by immuno-
blotting. The artificial membrane mixtures could not be separated by ultracentrifugation, 
therefore a new method was developed. A biotin-streptavidin pull down approach was 
optimised and applied for separating the vesicles. In order to investigate Rab membrane 
binding, different membrane systems were employed, ranging from physiological cellular 
membranes to artificial binary lipid mixtures. By means of this top-down approach, 
implementing a stepwise reduction of membrane complexity, the requirement of 
proteinaceous targeting factors and physiological membrane composition could be determined. 
Experiments with binary lipid mixtures of DOPC/DMPC and DOPC/DOPE correlated Rab 
membrane targeting to stored curvature elastic stress in membranes. 
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5.1 Introduction 
Rab targeting to membranes is generally assumed to involve interaction with other proteins 
that act as specific targeting factors for Rab proteins (see Chapter 1, section 1.5). Rab protein 
targeting to physiological membranes has been studied in vitro in a number of experiments 
([177,247-250] , see section 5.1.1). However, none of the investigations used artificial 
membrane systems and thus cannot decouple which biomechanical properties of the 
membrane may regulate protein binding. Using completely synthetic lipid mixtures has crucial 
advantages. The composition of the model membrane systems can be controlled precisely a 
priori and this in turn allows the systematic exploration of the biomechanical properties 
involved in the regulation of protein binding. Another advantage of synthetic lipid mixtures 
over cellular membranes is that they are completely free of membrane proteins, allowing the 
investigation of the role of protein targeting factors for selective binding process. Removal of 
membrane proteins, for example by proteolysis or membrane extraction is not quantitative and 
using organic lipid mixtures makes the experiments more reliable. For these reasons, the 
investigation of Rab delivery to simple lipid mixtures that are completely protein free and with 
known biophysical parameters is of high importance.  
 
5.1.1 Rab delivery to membrane systems  
The molecular mechanism of Rab targeting to specific membranes remains an open question. 
Recruitment of several Rab proteins (Rab3a, Rab5a, Rab9a) to physiological membranes has 
been investigated in a number of studies, where Rab proteins were correctly targeted to 
subcellular membranes. A summary of these studies will be given here. Purified Rab5 in 
complex with GDIα has been shown to correctly target to membranes in permeabilised cells 
[247]. Furthermore, membrane association of Rab5 with a photoactivatable GGPP analogue 
was investigated with the intention of identifying membrane bound targeting factors that 
interact with the prenyl groups [177]. However, only protein interacting membrane associated 
factors were detected, but not identified in this study. Rab5 and a Rab5 mutant binding the GTP 
analogue XTP (xanthosine 5’- triphosphate) were correctly targeted to early endosome 
membranes [249] after in vitro prenylation using a REP1:Rab5 complex, reaching saturation 
after around 5 to 20 min incubation time. In another study, Rab9 was shown to be selectively 
recruited to MPR (mannose phosphate receptor) enriched late endosomal membranes 
compared to ER-enriched membranes and red blood cell ghosts [248]. Rab9:GDI complexes 
were isolated from the cytosol of CHO (chinese hamster ovary) cells overexpressing Rab9a by 
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size exclusion chromatography. Recruitment to membranes was assessed at different time 
points and it was revealed that Rab9 specifically binds to MPR-enriched membranes with 30% -
50% membrane association after 40 min. Membrane binding was accompanied by association 
of an equimolar amount of GTP, indicating that GDP is exchanged for GTP upon membrane 
association of Rab9. Furthermore, it was shown that the non-hydrolysable GTP analogue 35S-
GTPγS enhances membrane association of Rab9 as compared to GTP. This was explained by the 
fact that GDI cannot extract GTP bound Rab9. It was furthermore shown in this study, that GDP 
inhibits membrane recruitment of Rab9, as does free GDI. In addition, the study revealed that 
membranes have an extremely high capacity for Rab9 that is only saturated at a 50-fold excess 
of Rab9 relative to endogenous levels. This finding is supported by the correct targeting of 
highly overexpressed Rabs [251-253]. Studies of Rab3a membrane binding in vitro [250] 
showed that Rab3a preferentially binds to membrane fractions enriched in synaptic vesicles, 
but cross-binding to ER-enriched membranes was also observed over a 30 min timeframe. 
Furthermore, membrane interaction increased linearly with the quantity of membrane used 
and Rab3a binding was saturable at 100 nM Rab3a per 10 μg membrane protein containing 
membrane fraction. In general membrane binding lay roughly around 50% of added Rab 
protein at saturation. Investigation of the nucleotide status of Rab3a upon membrane binding 
revealed that binding is nucleotide independent and nucleotide exchange occurs during 
membrane association, but at a slower rate than the binding process. Re-extraction from 
membranes with GDI is possible as long as Rab3a remains GDP bound. Interestingly, Rab3a 
binding was sensitive to proteolysis of membrane proteins prior to Rab3a binding, indicating 
the involvement of membrane associated protein targeting factors for Rab3a binding. These 
studies indicate that Rab binding in vitro is membrane selective and saturable, reaching 
saturation after approximately 30-40 min with binding yields of 30 – 50%. In the case of Rab3a 
membrane binding was revealed to be dependent on membrane  associated protein factors, 
however physiological membrane fractions were used and membrane proteins removed by 
proteolysis. Comparison of the results of the described studies also reveals some ambiguities. 
For example, membrane binding of Rab9 is more sensitive to the presence of GDP and 
nucleotide exchange occurs at a faster rate than compared to Rab3a. This may suggest 
differences in membrane and nucleotide affinity of different Rab proteins, which possibly 
serves as a means of regulating and differentiating Rab activity.  These discrepancies in Rab 
function are in accordance with the observed GDI extraction results in Chapter 3, where it was 
shown that GDI exhibits a broad range of affinity for different Rab proteins. 
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5.2 Materials and Methods 
5.2.1 Preparation of native HEK293A membranes 
For the preparation of native membranes for Rab-delivery assays, HEK293A cells were 
harvested from a 10 cm dish at confluency as described (section 2.1.2.1), frozen in liquid 
nitrogen and stored at -80°C until use. The pellet was resuspended in 750 μL lysis buffer (see 
section 3.2.7) and sonicated for 30 s at 5 μm using a titanium tip sonicator (MSE Soniprep 150). 
The PNS was prepared by centrifugation at 2000g for 5 min at 4°C. The resulting supernatant 
contains soluble protein and cellular membranes. The membranes are separated by 
ultracentrifugation at 100000g for 45 min at 4°C to yield the P100. The membrane pellet is 
resuspended in 350 μL extraction buffer (3.2.7) by 30 s sonication at 5 μm. 
 
5.2.2 Folch extraction of HEK293 lipids 
The standard method for protein free purification of total lipid from tissues and organs was 
developed by Folch and Lees half a century ago [254]. It is based on two steps. First, lipids are 
extracted from the cell homogenate by solubilisation in Chloroform/Methanol 2:1 followed by 
extraction of proteins into the aqueous phase by addition of water or aqueous buffer.  
In detail, the cell pellet was resuspended 20-fold in Chloroform:Methanol 2:1, vortexed and 
incubated at room temperature for 10 min. One fifth of the volume of PBS was added at room 
temperature and extensively vortexed. The sample was then centrifuged at 200g for 2 min to 
enhance separation of the solvent and aqueous phase. The aqueous phase (top – containing 
proteins) was carefully removed including the white precipitate at the interface. The solvent 
was then evaporated under a nitrogen stream and lyophilised overnight. The lipid film was 
rehydrated in 350 μL extraction buffer by 5 vortexing-freeze-thawing cycles using liquid 
nitrogen and a heating block at 70°C. 
 
5.2.3 Vesicle preparation 
Vesicles are most commonly prepared by extrusion through a polycarbonate membrane or by 
sonication. Extrusion is very reproducible with respect to size distribution of the vesicles, but is 
more time consuming. Sonication generally produces a broader distribution of vesicles in the 
range of 5 to 50 nm and is less reproducible. When the vesicle size is equivalent both methods 
produce biophysically comparable vesicles with respect to their molecular scale environment 
[255]. The sonication time dependence of the particle size distribution of DMPC was 
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investigated by Maulucci et al. [256]. They report that with increasing sonication time vesicle 
size decreases, reaching a plateau after 1 h. Vesicles were either prepared by extrusion using 
the Avanti Mini extruder according to the manufacturer’s instructions or by sonication. 
Extrusion was performed by pushing the lipid suspension 19 times through a polycarbonate 
membrane with 100 nm pores (Whatman). For Rab delivery assays organic lipid mixtures where 
prepared at a lipid concentration of 2 mM and sonicated in a water bath sonicator (Fisher 
Brand FB1021) for 45 min. For DMPC containing mixtures it was ensured that the water 
temperature was between the main phase transition temperature (Pβ – Lα) of 23.6°C [256] (or 
23.9°C [257]) and 37°C. 
 
5.2.4 EGFP-Rab:GDI complex formation 
Formation of the Rab:GDI complexes used in the membrane binding assays was based on 
scaling up the previously developed Rab extraction assays (3.2.9). Briefly, the Rab containing 
P100 fraction was used at a final assay concentration corresponding to 0.5 mg/mL Slp1-1-116-
EGFP (see section 3.2.8 for the preparation of a Slp1-1-116-EGFP fluorescence standard curve) 
and GDIα was used at a final concentration of 1.5 μM. Typically, 250 μL EGFP-Rab P100 (0.5 
mg/mL Slp1-1-116-EGFP equivalent) was mixed with 250 μL 3 μM GDIα and incubated at 37°C 
for 20 min, followed by immediate ultracentrifugation at 100000 g for 45 min at 4°C. The 
supernatant was removed and the membrane pellet resuspended in 500 μL extraction buffer 
(see section 3.2.7) by 30 s tip sonication at 5 μm (MSE Soniprep 150). In order to distinguish 
background EGFP signal in the supernatant from EGFP-Rab in complex with GDI, controls 
without GDI were always performed in parallel. The complexes were stored on ice until use and 
were used the same day or within 24 hours. 
 
5.2.5 EGFP-Rab membrane binding assays 
Freshly prepared EGFP-Rab:GDI complex (section 5.2.4) was mixed 1:1 (v/v) with membranes 
(1x HEK293A membranes (5.2.1), 1x Folch extract (5.2.2) or 2 mM for artificial membrane 
compositions (see 5.2.3) and incubated for 30 min at 37°C. Typically the total assay volume was 
60 μL. Subsequent steps to separate the membranes and membrane bound Rab proteins 
differed depending on the use of HEK293A membranes (section 5.2.5.1) or organic lipid 
mixtures (section 5.2.5.2). 
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5.2.5.1 Native HEK293A membrane and Folch extracts 
Native HEK293A membranes and HEK293 Folch extracts could be separated from the aqueous 
solution by ultracentrifugation for 45 min at 100000g and 4°C. The resulting pellet was 
resuspended in SDS-PAGE loading buffer and the supernatant and the corresponding volume of 
membrane fraction were analysed by immunoblotting with αGFP and αCalnexin antibody. 
 
5.2.5.2 Organic lipid mixtures 
Synthetic membranes composed of organic lipids could not be pelleted by ultracentrifugation. 
For this reason an assay was developed to capture the membranes onto streptavidin agarose 
beads. 1 mol% Biotin-Cap-PE and 0.05 mol% Lissamine Rhodamine PE was incorporated into 
artificial lipid compositions and vesicles prepared by sonication as described previously (see 
5.2.3). After incubation of the vesicles with Rab proteins for Rab-membrane association, the 
samples were transferred into new tubes containing 37 μL streptavidin agarose beads that 
were previously thoroughly equilibrated in extraction buffer (EB, section 3.2.7). In order to 
inhibit unspecific binding of Rab proteins to the tube walls, the tubes were previously blocked 
with an aqueous solution of 5% skimmed milk for 2 hours at room temperature. The tubes were 
then washed three times with water to completely remove the milk. The lipid-protein-bead 
mixture was incubated at 4°C for 4-5 hours under gentle agitation to capture the membranes 
onto the beads. The beads were then centrifuged gently at 200g for 1 min followed by 
transferring the supernatant into new tubes. The beads were washed in 400 μL EB and the 
membranes solubilised in 60 μL extraction buffer supplemented with 1.5% CHAPS by incubating 
at room temperature for 10 min with 3x vortexing. The beads were removed by centrifugation 
at high speed (14000g, 1 min). In order to determine the membrane capture yield, the 
fluorescence emission intensity of the supernatant and bead fractions at 590 nm was 
determined. A 384-well plate (white flat bottom NBS, Corning, #3574) was employed. The NBS 
(non-binding surface) plate was used to minimise non-specific protein binding. The 
fluorescence spectra of 60 μL of 3-fold diluted supernatant and bead fractions were measured 
at an excitation wavelength of 557 nm and the emission was recorded between 570 nm and 
610 nm. All fluorescence measurements were performed in a Varian Cary Eclipse Fluorescence 
Spectrophotometer with microplate reader. The pull down efficiency was determined by 
comparing the fluorescence intensity of corresponding fractions at 590 nm. 
The remaining sample volumes of supernatant and bead fractions were supplemented with 
SDS-PAGE loading buffer and analysed by immunoblotting with αGFP antibody. 
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5.3 Results 
The advantage of using EGFP-labelled Rab proteins in the Rab-membrane binding assay is the 
direct detection and quantification of Rabs in the soluble and membrane fractions by 
fluorescence detection, without the requirement for immunoblotting. However, initial  Rab 
membrane  binding assays indicated that GFP fluorescence was not a reliable readout as the 
sensitivity of the fluorimeter was limiting and the resulting fluorescence spectra were very 
noisy (see Figure 79). Additionally, the intensity of EGFP fluorescence in the membrane fraction 
is below zero; a possible explanation is fluorescence dispersion due to scattering effects 
created by small membrane particles such as vesicles. The corresponding immunoblot analysis 
(Figure 81, 80 min) clearly showed binding of Rab proteins to the membranes. Due to these 
inadequacies, immunoblotting and densitometry was employed for all quantifications of EGFP-
Rab delivery to membranes described henceforth. 
 
 
Figure 79: Exemplary fluorescence spectra of the supernatant and membrane fractions after Rab 
delivery assays, showing that the fluorescence is too noisy and low for quantification. S represents 
supernatant fractions, P membrane pellets. The data is corresponding to the samples shown on the 
Western blot in Figure 87 (+ Lipids). 
 
5.3.1 Optimisation of the Rab-membrane binding assay conditions 
In initial binding experiments several observations were made, leading to changes in the 
original protocol. Firstly, it was observed that centrifugation left up to 50% of Calnexin in the 
supernatant, suggesting that the membranes were not pelleted efficiently. The percentage of 
membrane pelleted was not improved by extending the centrifugation time. However, in the 
initial protocol 200 mM sucrose was included in the extraction buffer and also present in the 
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Rab delivery assay, as a means of stabilising the membranes [258]. This concentration of 
sucrose increases the density of the buffer and may affect the recovery of membranes. 
Omission of sucrose was shown to improve the yield of membrane recovery while not 
interfering with the quality of extraction (i.e. complex formation) or subsequent Rab membrane 
binding assay.  Figure 80 presents two immunoblots showing the calnexin distribution with and 
without sucrose in the buffer. According to analysis by densitometry, the membrane recovery 
lies around 60% in the presence of 200 mM sucrose and is increased to above 90% when 
sucrose is omitted.  
 
 
Figure 80: Effect of sucrose on the recovery of membranes by ultracentrifugation. Western blots of the 
supernatant (S) and pellet (P) fractions with (+) and without (-) 200 mM sucrose after ultracentrifuation. 
 
Another problem observed in initial Rab delivery assays was that a large proportion of the 
EGFP-Rabs was detected in the “pellet” fraction, even when no membranes were added in 
control samples. These proteins either precipitate or non-specifically bind to the walls of the 
tubes. Pre-treatment of the tubes with 5% skimmed milk powder in water for 80 min was 
shown to decrease the extent of non-specific binding by over 50% (determined by 
densitometry, Figure 81). It was therefore concluded that the proteins were non-specifically 
binding to the tube walls rather than precipitating and milk treatment of the tubes was 
included as a standard procedure in further experiments. In addition, negative controls 
containing EGFP-Rab but no membrane were implemented in every Rab membrane delivery 
assay. In addition to milk treated tubes, commercially available low-binding microspin tubes 
were also utilised, but those did not decrease the level of non-specific binding. 
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Figure 81: Tube treatment with 5% skimmed milk powder (in water) significantly decreases unspecific 
binding of Rab proteins to the tube walls (MT= Milk treated tubes, UT=untreated tubes). The times 
indicate the incubation time of the milk treatment. No membrane was present in this experiment. 
 
5.3.2 Mechanical separation of membranes 
Separation of membranes from the surrounding solution after Rab membrane binding is 
essential for the quantification of membrane bound Rab protein and Rab remaining in solution. 
While cellular membranes (native HEK293 and HEK293 Folch extracts) could be pelleted by 
ultracentrifugation, this was not possible for synthetic lipid mixtures, due to their increased 
buoyancy. Attempts to increase sedimentation by using sucrose filled vesicles were not 
successful either. An alternative method for mechanically separating membranes from the 
surrounding solution was therefore established. Two possible mechanical membrane 
separation approaches were considered, filtration (5.3.2.1) and a biotin-streptavidin pulldown 
approach (5.3.2.2). 
 
5.3.2.1 Membrane separation by filtration  
The first method tested for membrane separation from surrounding buffer utilised microcon 
filters (Millipore) which were also applied to study membrane partitioning of CCT 
(CTP:phosphocholine cytidylyltransferase, section 1.8.2.1) derived peptides [151,259].  These 
tubes are commercially available with filters of pore sizes of at least 0.2 μm, making them 
unsuitable for the separation of small vesicles in the range of 50 - 200 nm diameter. Hence, 
these filters were exchanged with polycarbonate membranes (Whatman) with pore sizes of 30 
or 50 nm. Extruded vesicles with 0.05% incorporated Lissamine Rhodamine PE were sized by 
DLS and spun through these filters until approximately 10% of the starting volume remained in 
the top chamber. The flow through and the remaining lipid suspension in the top chamber were 
analysed by fluorescence spectroscopy. The results showed that no concentration increase was 
achieved and that the membranes were able to pass through the filters. This method was 
therefore dismissed.  
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5.3.2.2 Biotin-Streptavidin membrane separation 
The second approach for separating the membranes involved the incorporation of a small 
fraction of biotinylated lipids into the membranes and capture of the membranes onto 
streptavidin beads via the strong interaction between biotin and streptavidin. This approach 
has increasingly been employed in the field of lipid research [260,261]. Figure 82 schematically 
shows the principle of membrane separation purification process. 1 mol% of Dioleoyl Biotinyl 
Cap PE (Avanti, BCPE, Figure 83) is incorporated into the membrane mixtures. In addition, 
0.05% of the fluorescent headgroup labelled Lissamine Rhodamine PE (Avanti, LissRhod PE or 
LRPE, Figure 84) is incorporated in order to allow quantification of the pull down efficiency. 
 
 
Figure 82: Schematic representation of membrane capture to streptavidin agarose beads. The 
membranes are mixed with streptavidin beads and allowed to incubate for the biotin-streptavidin 
interaction to take place till saturation. The beads are then separated by gentle centrifugation and the 
supernatant is removed. The beads are washed carefully and the membranes bound to the beads are 
then solubilised into solution by adding buffer containing detergent. The Lissamine Rhodamine PE 
remaining in the supernatant and captured onto the beads is quantified by fluorescence spectroscopy.  
 
The excitation of Lissamine Rhodamine PE at 557 nm and its emission maximum at around 
590 nm does not interfere with the EGFP fluorescence. Furthermore, both incorporated lipids 
are headgroup modified DOPE lipids and therefore should only have a negligible influence on 
the biophysical properties of the membranes. 
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Figure 83: Chemical structure of Biotinyl Cap PE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-
(cap biotinyl). R represents a dioleoyl chain. 
 
Figure 84: Chemical structure of Lissamine Rhodamine PE (1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt)) 
 
Two commercially available types of beads were tested for the pull down assay, Pierce 
Neutravidin agarose beads and the high capture Pierce Streptavidin Plus UltraLink resin. Figure 
85 shows the results for Neutravidin agarose. Incorporation of 0.5% and 1.2% Biotin Cap PE 
leads to an increase of LissRhod PE fluorescence on the beads compared to samples without 
incorporated biotinylated lipids (panel A). However, incorporation of 1.2% rather than 0.5% 
does not further increase the vesicle capture yield. Furthermore, saturation is not reached 
which indicates that a large fraction of the membranes remains in the supernatant. This is 
further supported by the fact that there is no decrease of fluorescence intensity of the 
supernatant with increasing amount of incorporated biotinylated lipid (Figure 85, panel B). It 
needs to be noted that the values of fluorescence intensity are arbitrary units and cannot be 
compared between the graphs in panel A and B.  
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        A       
 
        B 
 
Figure 85: Pull down of Biotinyl Cap PE containing membranes (DOPC:DOPE 70:30) onto Neutravidin 
agarose beads. (A) Lissamine Rhodamine PE fluorescence on beads, (B) Lissamine Rhodamine PE 
fluorescence in supernatant (BCPE = Biotinyl Cap PE). 
 
As the application of Neutravidin Agarose beads did not achieve a high pull down yield, the 
more expensive Streptavidin Plus UltraLink agarose was tested with incorporation of 0%, 0.2% 
and 1% (mol%) Biotin Cap PE (Figure 86). 100 nmol lipids were incubated with increasing 
amounts of beads ranging from 0 – 50 μL in a total volume of 150 μL. Membrane binding to the 
beads increases with increasing quantity of incorporated Biotinyl Cap PE and beads (panel A). 
With 1% Biotinyl Cap PE and 50 μL beads saturation of binding is almost reached. Furthermore, 
a strong decrease of fluorescence of the supernatant fraction is observed with increasing 
amount of Biotinyl Cap PE and beads (panel B). For the actual Rab membrane binding assays, 
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the sample volumes were scaled down. Instead of 100 nmol lipids only 60 nmol were used and 
it was therefore decided to use 35 μL streptavidin agarose beads for 60 nmol of lipids (60 μL 
1mM lipids) and 1% incorporated Biotinyl Cap PE for further experiments.  
 
    A 
 
B                         
                          
Figure 86: Pull down of Biotinyl Cap PE containing membranes (DOPC:DOPE 70:30) onto Streptavidin 
agarose beads. (A) Lissamine Rhodamine PE fluorescence on beads, (B) Lissamine Rhodamine PE 
fluorescence in supernatant (BCPE = Biotinyl Cap PE).  
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5.3.3 Rab delivery to HEK293 total cell membranes 
Native HEK293 membranes embody the most physiological in vitro membrane system, as they 
contain all endogenous HEK293 lipid species and membrane proteins. Since it is known that the 
EGFP-Rabs bind to these membranes in vivo and furthermore, the Rab:GDI complexes used in 
the binding assays were initially formed by extraction of Rabs from native HEK293 membranes, 
it should be possible to re-deliver the Rab proteins to these membranes. Native HEK293 
membranes could be pelleted after Rab delivery by ultracentrifugation and binding to HEK293 
cell membranes was monitored for Rab1a and Rab9a by immunoblotting followed by 
densitometry (Figure 87). The percentage of EGFP detected on the membrane (       ) is 
calculated from the detected signal intensities of the membrane fraction (   ) and the 
supernatant (  ) as follows: 
            
   
      
 
    Eq. 24 
 
The data clearly shows binding of EGFP-Rab to the membranes (+Lip). This binding is much 
more pronounced for Rab1a compared to Rab9a, but both are considerably higher than 
unspecific binding of EGFP-Rab to the tubes (-Lip). The majority of calnexin is detected in the 
membrane fraction, indicating that the recovery of the membranes by ultracentrifugation 
worked well. The anti-His immunoblot shows that only a very small fraction of GDI is detected 
on the membranes, which is possibly due to contamination or unspecific binding to the 
membranes and tube walls. Alternatively, GDI may transiently associate with the membrane 
during the Rab delivery process [248]. 
 
                A         B 
  
Figure 87: Delivery of Rab1a and Rab9a to HEK293 membranes. (A) Western Blot, (B) quantification of 
membrane binding by densitometry 
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In order to maximise Rab binding, the amount of membrane was titrated in the following 
experiment using Rab5a (Figure 88, panel A), to determine the optimal amount of membrane 
added in this assay. The anti-GFP blot clearly shows increasing signal intensities in the 
membrane fraction with increasing quantity of membrane added in the assay.  
As observed in the previous experiment (Figure 87), binding of GDIα to membranes is negligible 
and this was assumed to be the case for all following experiments, omitting the need for αHis 
probing. The majority of calnexin is detected in the membrane fraction, suggesting sufficient 
recovery of the membranes.  
Figure 88, panel B presents the ratio of EGFP-Rab5a bound to the membrane, quantified in two 
ways: densitometry (black squares) and EGFP fluorescence at 509 nm (excitation at 488 nm) 
(red dots). Both curves start off with a comparable slope and show the same trend of increasing 
binding, reaching saturation. However, the curve determined by fluorescence spectroscopy 
reaches saturation much quicker and with a much lower degree of Rab protein binding. 
Furthermore, at large membrane amount of 40 μL no fluorescence is detected anymore. This 
clearly demonstrates the unsuitability of fluorescence intensity as a means of quantification 
probably caused by fluorescence scattering due to small membrane particles. Consequently, for 
future experiments only densitometry was applied for quantifying the fraction of EGFP-Rab 
bound to the membrane fraction. 
 
 A           B 
        
Figure 88: Rab5a binding to HEK293 membranes with increasing amount of membrane. (A) Western 
blots, (B) binding to membranes determined by densitometry of the Western blot  (black squares) or by  
fluorescence intensity (stars).  
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5.3.4 Rab delivery to protein free HEK293 total lipid extracts 
The previous section showed that Rab proteins bind to native mammalian membranes 
containing proteins. In order to assess the requirement of proteinaceous targeting factors in 
this process, protein free membrane fractions were prepared and used for Rab protein 
targeting. The Folch extraction is the most commonly used and classical method for preparing 
protein free total membrane extract and was therefore used in the experiments presented 
here. Rab1a and Rab5a were used in the binding assay to the Folch membranes (Figure 89).  
Panel A shows the successful complex formation of both Rabs with GDIα. Two different 
volumes of Folch membranes (8 and 24 μL) were used to study Rab membrane binding (Figure 
89, panel B) and the same Folch extract was used for both, the Rab1a and Rab5a experiments.  
No “membrane binding” is observed for Rab1a and Rab5a without the addition of lipids, but 
with 24 μL Folch extract there is clear binding of Rab5a to the lipids. Membrane binding of 
Rab1a is not as clear. As a positive control native HEK293A membranes were added and the 
negative control contained no lipids at all. The volume of HEK293 membranes was chosen to be 
⅚ of the Folch membrane volume, assuming that during the Folch extraction approximately 15-
20% of the lipids are lost. This assumption is based on the fact that the organic phase is partially 
removed during the Folch extraction, in order to ensure complete removal of the aqueous 
phase and interface precipitates. Another negative control contained either the maximum 
amount of Folch membranes or native membranes, but instead of EGFP-Rab:GDIα complex 
Slp1-1-116-EGFP was used at a final concentration of 0.05 mg/mL. Unfortunately, Slp1-1-116-
EGFP could not be detected in neither the supernatant nor membrane fraction for the Folch 
control, but in the native membrane sample clearly all of the protein is localised in the soluble 
fraction, showing that there is no unspecific binding of EGFP to the membranes.  
The anti-Calnexin immunoblot of Rab5a shows that in the Folch extracts the calnexin was not 
completely removed, which indicates that the removal of membrane proteins was not 
quantitative. Therefore, membrane bound targeting proteins may still be present and no clear 
conclusion can be made on the requirement of such proteins in the Rab-membrane binding 
mechanism.  
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   A               B 
    
Figure 89: Complex formation and delivery to Folch extract and native HEK293 membranes of Rab1a 
and Rab5a. (A) Extraction of EGFP-Rab1a and EGFP-Rab5a with 1.5 μM GDIα determined by 
fluorescence spectroscopy, (B) Binding of EGFP-Rab1a and EGFP-Rab5a to native HEK293 membranes 
(N) and Folch extract (F).  
 
The membrane binding experiment was repeated using Rab1a and Rab5a with new Folch 
extract and native HEK293 membranes and additionally supplementation of 10 mM GDP and 
10 mM GTP was compared to investigate the necessity for these nucleotides in the membrane 
binding process. During the Folch extraction a larger fraction of lipids was lost, due to an 
attempt to maximise protein removal from the interface between the aqueous and solvent 
phase. As a consequence, the volume of Folch extract compared to HEK293 membranes used in 
the Rab membrane binding assay was further increased (20 μL Folch lipids vs. 15 μL native 
membranes) in order to compensate for the loss of lipids during the Folch extraction. GTP was 
added to the HEK293 native membrane samples, as this serves as a positive control and the 
presence of GTP was assumed to enhance Rab binding (Figure 90). Both Rab proteins, Rab1a 
and Rab5a visibly bind to native membranes and the Folch extract under both nucleotide 
conditions. However, the Folch extraction again did not remove calnexin and presumably other 
membrane proteins quantitatively and the membrane separation was not quantitative, as 
calnexin is present in both, the soluble (S) and membrane fraction (P) for the Rab5a samples.  
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Figure 90: Binding of Rab1a and Rab5a to native HEK293 membranes (N) and Folch extract (F) with 
10 mM GDP and 10 mM GTP. 
 
The relative amount of EGFP-Rab  bound to the membrane was quantified by densitometry 
(Figure 91). As the membrane separation was not quantitative, the values for Rab5a were 
corrected using the calnexin distribution as a reference. The correction factor fc was calculated 
with the percentage of calnexin in the membrane fraction Calmb (P) as determined by 
densitometry with the following equation: 
 
                ,   Eq. 25 
with 
                                                                               
   
      
 ,     Eq. 26,    
 
where Ds and Dmb stand for the signal intensity of the supernatant and membrane fractions as 
determined by densitometry. In both cases, the background binding of the Rabs to the tube 
wall is clearly lower than the Rab binding to membranes. An increase in Rab1a membrane 
binding is observed when GDP is added instead of GTP. The reverse can be seen for Rab5a for 
the Folch extracts. However, densitometry on Western blots is generally quite imprecise and no 
conclusion can be made without a sufficiently high number of repeat experiments and 
statistical significance.  
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       A. EGFP-Rab1a membrane binding 
 
 
   B. EGFP-Rab5a membrane binding                         C. EGFP-Rab5a corrected membrane binding 
 
                               
Figure 91: Rab1a and Rab5a binding to HEK293 native membranes and Folch extract in the presence of 
1 mM GDP or GTP. (A) EGFP-Rab1a and (B) EGFP-Rab5a binding to Folch and native HEK293A 
membranes with GDP and GTP determined by densitometry from Western blots in Figure 91. (C) EGFP-
Rab5a membrane binding with corrected values using the calnexin distribution into the membrane and 
soluble fraction. Control reactions without lipids were performed to ensure that signals detected in the 
membrane fractions are specific and not caused by protein precipitation or protein attachment to the 
tube walls. In the case of –lipid controls the y-axis should more appropriately be labelled “% EGFP in 
pellet fraction”. 
 
 
5.3.5 Rab delivery to organelle composition mimicking membranes 
In the previous sections Rab proteins were shown to be able to bind to membranes derived 
directly from mammalian cells. The next step in the top-down approach was to test Rab binding 
to artificial lipid mixtures, mimicking the complexity of physiological membranes. Complex 
organelle mimicking compositions (section 4.3.1, Table 16) were chosen in case Rab proteins 
require specific lipid species for membrane association. The two negative controls of Slp-EGFP 
(final concentration 0.13 mg/mL) instead of Rab and Rab without lipids were performed in 
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parallel. Rab1a and Rab11a were delivered to endosome- and plasma membrane mix in 
duplicates, followed by analysis by immunoblotting and densitometry (Figure 92). High 
membrane binding in the range of 35 – 50% was observed for both Rab proteins to both 
membrane compositions. The negative controls clearly exhibit low non-specific binding of the 
EGFP-Rabs to the tube walls (-Lipids), which was quantified to approximately 3% by 
densitometry. Furthermore, very low background binding (8%) of Slp-EGFP to the membranes is 
observed.  
     A                     B 
            
Figure 92: Binding of EGFP-Rab1a and EGFP-Rab11a to Endosome (Endo, E) and Plasma membrane 
(PM) mimetic lipid compositions. (A) Western Blot: Top panel shows Rab binding to the membranes, 
bottom panel shows the controls. (B) Quantification of Rab1a, Rab11a and Slp-EGFP (negative control) 
membrane association by densitometry. 
 
The membrane pull down efficiency for each sample was determined by measuring the 
Lissamine Rhodamine PE fluorescence at 590 nm (λex = 557 nm) (Figure 93 A) and the Rab 
membrane binding values corrected correspondingly (Figure 93 B). In vivo, Rab1a is targeted to 
the Golgi and ER, while Rab11a cycles between recycling endosomes and the plasma 
membrane. Consequently, Rab11a is expected to exhibit higher partitioning into the used 
organelle mimetic lipid mixtures. However in this study, both Rab proteins bind to the 
endosome and PM compositions to a comparable extent, with membrane partitioning of 
around 60%. It is desirable to repeat this assay with Rab proteins that distinguish between 
plasma membrane and endosomal membranes in vivo, for example Rab9 and Rab23,  in future 
experiments, in order to evaluate the physiological relevance of the synthetic organelle mimetic 
lipid compositions. 
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  A                       B 
                   
Figure 93: Corrected binding of Rab1a to organelle mimetic lipid compositions followed by 
Streptavidin-biotin membrane purification. (A) Membrane pull down yield quantified by Lissamine 
Rhodamine PE fluorescence and (B) corrected values of Rab1a binding to the membranes. 
 
The experiments in this study were performed in a completely membrane protein free 
environment, assuming that contaminating proteins from the Rab:GDI complex formation 
process can be neglected. It is concluded that Rab1a and Rab11a can bind to membranes 
without the need for targeting factors. These results therefore complement the previous 
experiments using Folch extracts, where it could not be ensured that all endogenous HEK293 
membrane proteins were removed.  
 
5.3.6 Rab delivery to vesicles of different lipid compositions 
In the previous sections several Rab proteins were shown to bind to membranes in vitro, Rab1a 
even in the absence of membrane proteins, suggesting that targeting factors may not be strictly 
required for the facilitation of membrane association. The investigation of membrane 
properties as Rab targeting factors requires the decoupling of lipid species and biophysical 
membrane properties. In Chapter 4 the elastic properties of binary DOPC/DOPE mixtures were 
investigated and a linear correlation between the DOPE content and bending rigidity was 
shown. For this reason, very simple binary lipid mixtures with known elastic properties were 
used in the following Rab-binding experiments. DOPC is a type 0 lipid and was used as the base 
lipid. DMPC is a type I lipid and DOPE a type II lipid. These lipids with opposing intrinsic 
curvatures were used as the second lipid species in the binary lipid compositions. Mol fractions 
0.6 and 0.8 of DOPC were supplemented with either DOPE or DMPC and binding of Rab1a to 
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these binary DOPC/DMPC and DOPC/DOPE mixtures was monitored. If Rab protein targeting is 
influenced by membrane mechanics, Rab1a is expected to preferentially bind to the DOPE 
containing mixtures to release the stored curvature elastic stress therein. 
The membrane delivery assay of Rab1a was performed in duplicates (Figure 94). The 
immunoblots clearly show very low membrane binding for the DMPC containing compositions 
and a clear increase for pure DOPC and the DOPE containing mixtures.  
 
                            
Figure 94: Rab1a binding to binary lipid compositions of DOPC/DMPC and DOPC/DOPE. Western blots 
of the supernatant (S) and bead (B) fractions resulting from the membrane separation by biotin-
streptavidin pull down. The two Western blots show data from two separate experiments. 
 
Omitting the lipids in the assay allows the assessment of background binding of the Rabs to the 
tube walls. As shown in the immunoblots in Figure 95 A, there is an insignificantly low amount 
of background binding of Rab protein to the tube walls and a very low degree of unspecific 
binding of Slp-EGFP to the lipids. Quantification of the signals by densitometry is presented in 
panel B. The unspecific binding of Slp-EGFP is reproducibly below 10% for all lipid compositions. 
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Figure 95: Controls of the binding assay. (A) Western blots of control samples, Rab:GDI complex 
without lipids and Slp-EGFP, (B) Slp-EGFP binding as determined by densitometry after correction using 
the LissRhod PE pull down efficiency. 
 
Quantification of Rab1a partitioning into membranes by densitometry (Figure 96) surprisingly 
reveals a linear dependence on the mol fraction of DOPE. Panel B presents the membrane pull 
down yield determined from the Lissamine Rhodamine PE fluorescence. The efficiency of 
membrane capture varies considerably between each sample and ranges from approximately 
13 to 48%. Correcting the proportions of membrane bound EGFP with these pull down yields 
for each sample according to the following formula (Eq. 27) does not change the overall trend 
of the binding curve, see panel C. 
 
                       
          
   
           
Eq. 27 
 
 
 
 
174 
 
A. LissRhod PE Pulldown yield 
 
    B. EGFP-Rab1a membrane binding         C. Corrected EGFP-Rab1a membrane binding 
        
Figure 96: Binding of Rab1a to binary DOPC/DMPC and DOPC/DOPE mixtures. (A) Quantification of 
membrane pull down yield by fluorescence emission of LissRhod PE, (B) quantification of Rab1a 
membrane binding by densitometry (error bars represent SEM from two experiments), (C) 
quantification of Rab1a membrane binding, corrected with pull down yield correction factors. 
 
Linear fitting the membrane binding data (Figure 97) reveals a linear correlation between 
membrane binding and mol fraction of DMPC and DOPE, with the exception of the 80 mol% 
DMPC/DOPC data point. The remaining data points however fit the following fitting curve (Eq. 
28) extremely well, with R2 = 0,9992.  
 
             
Eq. 28 
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Figure 97: Linear fit of Rab1a membrane binding to DMPC/DOPC and DOPE/DOPC mixtures. The data 
point of 0.2 mol fractions DMPC was excluded from the fit. 
 
This is the first time that Rab membrane targeting has been investigated using synthetic lipid 
mixtures with defined biophysical properties. The linear dependency of Rab membrane 
partitioning on the molar fraction of the lipid mixtures strongly suggests a correlation between 
Rab membrane binding and biophysical membrane properties. Plotting Rab1a membrane 
binding over the bending modulus, by combining the linear fit functions determined here and in 
section 4.3.6, illustrates the linear dependency of increasing Rab1a membrane binding with 
increasing membrane bending rigidity, in the investigated range.  
 
 
Figure 98: Rab1a membrane binding as a function of the bending rigidity. The graph was obtained by 
combining the linear fits of the data obtained for the bending modulus  and Rab1a membrane binding as 
a function of the DOPC/DOPE composition. The two separate data points represent data points that 
were measured for the same lipid composition (100% DOPC and 80% DOPC respectively). 
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5.4 Discussion 
A summary of the results presented in this chapter is shown in the flow chart below (Figure 99). 
 
Figure 99: Flow chart summarising the experimental strategy and results presented in this chapter 
 
Rab1a, Rab5a and Rab9a were used for membrane binding studies. All three proteins were 
shown to bind to HEK293 membranes in vitro and Rab5a was shown to bind with a linear 
increase to an increasing amount of membrane, reaching saturation. Using HEK293 Folch 
extracts, Rab1a and Rab5a were shown to bind to membranes that contained a substantially 
reduced amount of membrane protein and for Rab1a this binding was shown to be 
independent of the presence of GTP and GDP. Up to this point, previously obtained results on 
Rab delivery to physiological membranes [247-250] could be confirmed. Using natural total lipid 
extracts is not very physiological, considering the high amount of effort that cells put into fine 
tuning the lipid composition of each of their separate sets of subcellular membranes. Mixing up 
the subcellular membrane compartments, as it is the case for the use of native HEK293 
membranes and Folch extracts, may lead to quite different membrane properties, which are 
not representative for the in vivo membrane behaviour. To test binding to entirely protein free, 
artificial membranes, vesicles of endosome and plasma membrane mimetic lipid compositions 
were prepared and subjected to Rab1a binding.  A clear and reproducible binding of Rab1a to 
both membrane compositions was observed, with a preferential binding to endosome mixture 
of 65% of added EGFP-Rab1a versus binding to the plasma membrane composition of around 
45%.  
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Rab1a is localised to neither of these membranes in vivo. Instead it is localised to Golgi and ER 
membranes [262] and therefore it would be interesting to investigate Rab1a binding to 
organelle mimetic membrane systems of these organelles. Nevertheless, the observed data 
supports the hypothesis that Rab proteins are able to distinguish between different membranes 
based on their lipid composition and physical properties resulting thereof without the presence 
of membrane bound protein targeting factors. However, this only indicates a preference for 
specific membranes, as cross-binding to other membranes clearly occurs. For this reason, 
targeting factors may still be required to enhance specificity of membrane binding.  
There are some major differences between the lipid compositions of the PM and Endosome 
mixture (see Table 16, section 4.3.1). While the PM mix contains almost all the lipids apart from 
cardiolipin, the endosome mixture lacks PI, DPG, LPC, LPE and PA. These lipids are only present 
in the PM mix in very small fractions (0.4 -0.9 % (w/w) and 6.8% (w/w) for PI). Another 
difference is the PC and PE content. Endosome mix contains around 50% PC and only 15.6% PE, 
while PM contains 34.6% PC and 20.5% PE. Several factors could be responsible for the 
preference of Rab1a for the endosome mix. The Rac1:RhoGDI complex has been reported to 
require PI(3,4,5)P3 for dissociation and membrane binding [165] but this does not seem to be 
the case for Rab1a, as PI lipids are completely absent from the Endosome mix. The only lipid 
present in the Endosome mixture that is lacking in the PM mixture is cardiolipin which may 
possibly have an influence on protein binding and activity, as cardiolipin was shown to enhance 
activity of membrane reconstituted cytochrome c [263]. 
Rab membrane binding may possibly be regulated by differences in the lipid ratios between the 
two compositions, which in turn affect the global elastic membrane properties, rather than the 
presence of specific lipids regulating membrane association. In Chapter 4 the PM and 
endosome mixtures were shown to be fluid lamellar phases with comparable lattice parameters 
and swelling properties, however, the stored curvature elastic stress might vary between the 
two mixtures. In order to decouple Rab binding from the presence of specific lipids and to look 
at the influence elastic membrane parameters, Rab1a binding to binary mixtures containing 
DOPC and either DMPC or DOPE was investigated. Using non-ionic lipids avoids the influence of 
electrostatic effects, which are difficult to distinguish from curvature elastic effects. Both lipid 
systems have also been studied extensively and are known to be homogenously miscible 
without phase separation. Furthermore, a number of studies has employed these binary lipid 
systems to investigate the modulation of protein activity, folding and partitioning in correlation 
to membrane curvature elasticity (for a review see [97] and section 1.7). 
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Figure 97 shows the binding of Rab1a to binary lipid vesicles consisting of DOPC/DMPC and 
DOPC/DOPE. Rab1a clearly binds preferentially to DOPE containing membranes. Binding to 
DMPC containing vesicles is only slightly higher than the background binding of Slp-EGFP and 
reaches 15-20%. A perfectly linear increase in binding is observed with increasing amount of 
DOPE reaching 70% binding. It could be argued, that the membrane binding of Rab1a to the 
DMPC containing binary mixtures is comparable to the Slp-EGFP control and therefore within 
the background, hence no binding occurs. This may be true as the detected level of Rab1a 
membrane binding to the DMPC mixtures is only slightly higher than that of the Slp-EGFP 
control and may lie within the error of measurement. However, in that case the linear 
dependency of Rab1a binding to the DOPC/DOPE mixtures still holds true.  
One drawback of the reported data is that the vesicle diameters were not determined. In order 
to exclude membrane curvature effects caused by small vesicle diameters,   |c1 + c2|<< |2c0| 
needs to be ensured. However, the method of preparation was equal for all lipid compositions 
used in the experiment and therefore comparable vesicle diameters can be assumed. 
Nevertheless, the experiment needs to be reproduced to confirm the results.  
The obtained observations are comparable to modulation of CCT activity [153] and opposite to 
the behaviour of Alamethicin [157] in DOPC/DOPE mixtures (see section 1.8.2). While CCT 
activity was shown to increase with increasing mole fraction of DOPE in DOPC membranes, the 
partitioning of Alamethicin decreases. Similarly to CCT, which inserts a hydrophobic alphahelical 
domain into one lipid monolayer, Rab proteins insert a hydrophobic part of the molecule (i.e. 
the prenyl group) into one monolayer of the membrane. However, not much is known about 
the molecular basis of membrane association. For example, in order to allow stored curvature 
elastic stress relief, the Rab proteins would be required to not only insert the prenyl groups, but 
a substantial part of the protein itself into the lipid headgroup plane, allowing membrane lipid 
molecules to splay into the newly created space (see Figure 100). 
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Figure 100: Schematic depiction of splay relief mechanism of proposed Rab membrane insertion. If the 
Rab protein inserts, for example with a cone shaped geometry as shown here, neighbouring lipid chains 
are allowed to splay (adapted from [153]). 
 
MAS (magic angle spinning) NMR  revealed that N-Ras membrane anchoring is enabled by 
vertical insertion of the two lipid chains (farnesyl and palmitate) into one monolayer while the 
peptide backbone resides in the headgroup area [161] (see Figure 101). This is reminiscent of 
amphipathic helices relieving membrane stress and supports  the splay relief hypothesis for Rab 
proteins.  
 
 
  
Figure 101: Schematic representation of the insertion of the Ras peptide modified with a hexadecyl 
and palmitoyl chain into the lipid/water interface of the membrane (from [161]). 
 
Membrane association may be very dependent on the type of lipid modification. Aequorea 
derived fluorescent proteins were shown to partition into lipid raft microdomains when they 
were palmitoylated or myristoylated, but not when they were prenylated [264], indicating a 
distinct molecular mechanism of membrane association. As a conclusion, it is emphasised that 
for the first time a correlation has been found between Rab protein membrane binding and 
membrane mechanical properties, which potentially assists in Rab targeting to their correct 
subcellular localisation and may even regulate their activity. 
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5.4.1 Future work 
The separation of vesicles with the biotin-streptavidin approach lacks consistency and efficiency 
and seems to be dependent on the lipid composition used. Therefore alternative methods 
should be considered for separating membranes after Rab delivery experiments. A flotation 
assay for separating vesicles with high buoyancy from soluble protein has been reported by 
Lacey and Haimo [265]. The vesicle protein mixture in sucrose is overlaid with a decreasing 
sucrose gradient. Upon ultracentrifugation the buoyant membranes migrate towards lower 
sucrose concentration, while soluble protein remains in the bottom of the tube. This method 
would be applicable for Rab-membrane delivery assays, assuming that Rab binding to the 
vesicles does not change their sedimentation behaviour.  Separation of liposomes for the 
purpose of protein-lipid binding assays has also been reported  by size exclusion on Superose 
12 FPLC-column [166], making this another alternative method to employ in Rab membrane 
binding studies.  
Having shown that Rab1a is able to distinguish between membranes with differing elastic 
properties, the major question of targeting specificity remains. Are other Rab proteins also able 
to sense membrane rigidity and do different Rab proteins have different preferences regarding 
the extent of rigidity? A broad comparison study is required using a number of different  Rab 
proteins with different cellular localisations and assessing their binding to simple membrane 
systems with defined elastic membrane properties. In addition, extending the binding studies 
to organelle mimetic lipid compositions will help to elucidate the requirement of targeting 
factors for binding specificity. An elegant way of correlating Rab targeting to membrane 
curvature elastic stress would be a flow cytometry based assay as proposed in [266]. In detail, a 
set of vesicles with a broad diameter distribution may be subjected to binding of fluorescently 
labelled Rab proteins, followed by analysis of Rab binding as a function of vesicle diameter. 
Smaller vesicles exhibit a higher curvature and higher curvature elastic stress, thus increased 
Rab targeting to smaller vesicles would indicate their sensitivity to these biophysical properties. 
Another aspect of Rab membrane binding is the modulation of the Rab activity. Investigation of 
nucleotide exchange rates and GTP hydrolysis rates as a function of membrane composition 
and elastic properties would be desirable in order to study this matter. 
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5.5 Chapter Summary 
This chapter presents the investigation of Rab protein binding to different membrane systems. 
The first part of the chapter describes the optimisation of the Rab membrane binding assay 
including the implementation of a membrane separation method using biotinylated lipids and 
streptavidin beads. The influence of protein content and membrane composition on Rab 
delivery was assessed. The data provides evidence that Rab proteins can bind to protein free 
membranes in a lipid composition dependent manner. Binding to binary compositions of non-
ionic lipids DOPC with either DMPC or DOPE suggests that Rab1a preferentially binds to 
membranes with increasing bending rigidity. Based on previous work on CTT a membrane 
binding model for Rab proteins is proposed, that explains membrane selectivity caused by 
stored curvature elastic stress.  
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CHAPTER 6 
Identification of a Palmitoylated Rab GTPase 
 
This chapter presents data supporting Rab40c to be palmitoylated. Recently, a number of Rab 
proteins have been identified as potential candidates for palmitoylation in proteomic 
screenings. Several of these Rab proteins were tested in this chapter, but only mouse Rab40c 
was shown to be positive. Mouse Rab proteins for which no evidence of palmitoylation was 
found were Rab1a, Rab1b, Rab2a, Rab3a, Rab5a, Rab5c, Rab7, Rab10, Rab14, Rab27a, Rab27b 
and Rab38. In order to investigate palmitoylation of Rab proteins, metabolic labelling of 
HEK293A cells overexpressing EGFP-Rabs with tritiated palmitic acid was employed. The Rab 
proteins were purified by immunoprecipitation and analysed by Western blotting and 
fluorography. The palmitate groups of Rab40c were shown to be cleavable with hydroxylamine, 
indicating that they are bound to a cysteine residue via a thioester bond. The amino acid 
sequence of Rab40c suggests that the penultimate cysteine residue, C273, could be 
palmitoylated. This was assessed by site directed mutagenesis, substituting this residue to 
serine (C273S) and subsequent metabolic labelling. However, the mutated protein still 
appeared palmitoylated, leaving open the question of the acylation site.  
 
6.1 Introduction 
6.1.1 Lipid modifications of proteins with acyl chains 
Lipid modification of proteins plays a very important role. It provides proteins with a sufficiently 
hydrophobic character to associate with membranes [267]. Two major types of protein 
lipidation are isoprenylation and acylation with fatty acids. Often proteins are dually modified 
by both of these moieties. Acylation with fatty acid chains mainly involves the saturated C16 
chain palmitate and the saturated C14 chain myristate, but other chain lengths and saturated 
chains are possible too. Myristoylation occurs specifically on N-terminal glycine residues and 
myristic acid is attached irreversibly via an amide bond. Typically, this reaction occurs co-
translationally when the N-terminal glycine becomes accessible after removal of the initiator 
methionine. However, it can also occur post-translationally when a glycine becomes accessible 
by proteolytic cleavage [268].  
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Palmitoylation always occurs post-translationally. N-palmitoylation is the irreversible formation 
of an amide linkage to an N-terminal cysteine [269]. An important example for N-palmitoylation 
is Sonic hedgehog [270], for which this type of modification was first discovered. Oxyester 
formation with palmitate is also possible but the physiological relevance is unclear. S-
palmitoylation is the major type of palmitoylation and hereafter called palmitoylation. This type 
of lipidation mediates protein trafficking and has recently been shown to regulate protein 
stability [268]. Palmitoylation also helps in localising proteins to lipid ordered microdomains 
(rafts). The palmitate forms a thioester bond with a cysteine residue. Thioester bonds are much 
more labile making S-palmitoylation reversible, acting as a means of controlling protein activity, 
similar to phosphorylation. Some palmitoylated proteins contain transmembrane domains and 
are permanently membrane associated. Most palmitoylated proteins discovered to date 
however, associate with membranes only peripherally and transiently, depending on their state 
of palmitoylation. Palmitoylation can occur in two ways: enzymatically by protein 
acyltransferases (PATs), or alternatively via autoacylation which may also be a common form of 
modification [271]. Although palmitoylation was the first post-translational lipid modification to 
be identified over 30 years ago, PATs were discovered only about 10 years ago in S. cerevisiae 
[257] and more recently in mammalian cells (e.g. [274]). PATs contain a characteristic Asp-His-
His-Cys (DHHC) motif within a cysteine rich domain (CRD) which is functionally required.  
 
6.1.2 Structural requirements for palmitoylation 
Prenylation and myristoylation require specific sequence motifs, facilitating the prediction and 
identification of potential sites of lipidation. Palmitoylation however has no such consensus 
sequences, apart from the presence of a cysteine residue. This makes the prediction of the 
localisation of a palmitate group much more difficult and usually identification requires 
mutational analysis of all candidate cysteine residues. Study of known palmitoylation sites of 
proteins reveals a common structural context. Proteins may be exclusively palmitoylated, but 
often palmitoylation occurs as a second lipid modification after prenylation or myristoylation. 
Cysteine residues slightly upstream of prenylation motifs are likely targets for palmitoylation.  
Rat-adeno-sarcoma (Ras) GTPases are mutated in 30% of all human cancers [275]. There are 
three isoforms of Ras proteins, H-Ras, N-Ras and K-Ras. Apart from their C-termini, which are 
hypervariable regions and serve as lipid anchor motifs, they share very high sequence identity. 
H-, N- and K(A)-Ras are modified by two different lipid groups (Table 21). They are farnesylated 
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at the C-terminal cysteine, and exhibit one or two further S-palmitoylated cysteines in close 
proximity [276]. In contrast, K(B)-Ras is only farnesylated, but contains an upstream polybasic 
region with six lysine residues. This positively charged stretch promotes membrane association 
by interaction with the negatively charged phospholipid headgroups As a consequence, K(B)-
Ras is directly targeted to the plasma membrane, whereas N- and H-Ras require a functional 
Golgi apparatus and the classic secretory pathway to undergo palmitoylation and to be 
targeted to the plasma membrane [277,278]. K-Ras plasma membrane binding was shown to 
depend on -AAX proteolysis and methylation. Figure 102 shows a summary of the sequential 
CAAX processing steps of H-, N- and K-Ras and their subsequent intracellular trafficking 
pathways. 
 
Table 21: Lipidation of Ras proteins. Underlined cysteines are palmitoylated, bold cysteines are 
farnesylated [279] 
Ras C-terminus 
H-Ras GCMSCKCVLS 
N-Ras GCMGLPCVVM 
K(B)-Ras KKKSKTKCVIM  
 
 
Figure 102: Membrane trafficking of mammalian Ras proteins [280]. CAAX processing starts with 
farnesylation of the C-terminal cysteine with FPP. Ras is then localised to the ER membrane, where 
proteolytic cleavage of the –AAX motif by Rce1 (Ras and a-factor converting enzyme) takes place 
followed by methylation of the prenylated cysteine by Icmt (isoprenylcysteine carboxyl 
methyltransferase) using SAM (S-adenosylmethionine). K-Ras is then directly localised to the PM and 
binds to the membrane via the farnesyl anchor and a polybasic region slightly upstream. N- and H-Ras 
are palmitoylated on one or two cysteine residues by an ER-localised palmitoyltransferase (RPT) and 
then traffic via the classical secretory pathway through the Golgi to the PM.  
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6.1.3 Functions of palmitoylation 
Palmitoylation significantly increases the ability of any given protein to interact with 
membranes, particularly in combination with other lipid modifications such as prenylation or 
myristoylation. For dually lipidated proteins farnesylation is a prerequisite for palmitoylation 
[281]. This is explained by the kinetic membrane trapping model proposed by Silvius [282], 
where the assessment of membrane partitioning of peptides with different dual-anchor motifs 
showed a strong increase in affinity compared to mono-lipidated peptides.  
The first lipid modification, farnesylation or myristoylation, only promotes weak, transient 
membrane interaction. This interaction is necessary for the palmitoylation reaction to be 
conducted by the respective PAT. The attachment of the palmitoyl group leads to a much 
stronger association with the membrane, thereby retaining the protein on the membrane 
where it was palmitoylated. For this reason it is the localisation of the respective PAT that 
determines the membrane targeting of palmitoylated proteins. PATs are integral membrane 
proteins and it has recently been shown that each PAT exhibits a characteristic membrane 
localisation [283]. 
Ras protein activity and localisation has been shown to be regulated by a constitutive de-
/reacylation cycle [284,285] . Depalmitoylated N- and H-Ras proteins are distributed over all 
endomembranes, binding transiently. Re-palmitoylation traps the Ras proteins on the Golgi, 
where the respective PATs are localised. Intracellular vesicle traffic transfers the Ras proteins to 
the plasma membrane, where they are eventually depalmitoylated and the cycle restarts.  
Palmitoylation not only promotes membrane binding in general, it has also been shown to 
target proteins specifically to membrane microdomains. Membrane microdomains are enriched 
in sphingolipids and cholesterol and are predominantly present in the plasma membrane 
[286,287]. The lipids present in membrane microdomains are in the liquid ordered state and 
therefore have higher affinity for saturated acyl chains, such as palmitic or myristic acid, than 
for unsaturated and branched chains, such as prenyl groups. The reversibility of S-
palmitoylation may furthermore be another mechanism for dynamic raft association, and serve 
the regulation of interaction with other raft targeted proteins. Palmitoylation in neurons is 
significant for targeting proteins for transport to nerve terminals and regulating trafficking at 
synapses (for Reviews see [288] and [289]). An example is PSD-95, which is localised to 
dendrites. Palmitoylation of PSD-95 is required for targeting to perinuclear vesiculotubular 
structures, where transport intermediates bud off to travel to postsynaptic sites [290]. 
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6.1.4 Palmitoylation of Rab GTPases 
Rab proteins are known to be post-translationally modified by one or in most cases two 
geranylgeranyl groups, but no other lipid modifications have been identified. Initially, in early 
studies evidence was found that the yeast Rab analogues YPT1 and YPT3 are palmitoylated 
[291,292]. Nevertheless, these studies were performed prior to identification of 
geranylgeranylation as a possible lipidation motif and it was later assumed that the apparent 
palmitoylation of these Rabs was an artefact and Rab protein modifications other than GG 
groups were not followed up. 
Recently, ABE and click chemistry have been used in large scale profiling of palmitoylation in 
mammalian cells, and among the hundreds of newly identified candidate proteins for 
palmitoylation a number of Rab proteins were found in two different studies. Kang et al. [293] 
investigated rat neural palmitoyl-proteomics using cultured rat embryonic cortical neurons and 
purified synaptosomal membrane fractions extracted from whole adult rat brain tissues. They 
found Rab10 as a high confidence candidate and Rab1b, Rab2b, Rab5c, Rab7 and Rab14 as low 
confidence candidates. Furthermore, they identified a brain specific splice variant of the Rho 
GTPase Cdc42 that is palmitoylated instead of prenylated, due to a different C-terminus. It is 
known that raft-like membrane microdomains are enriched in dendritic spines, supporting the 
hypothesis that palmitoylation plays a distinct role in neuronal cells. In another study, Martin et 
al. [294] employed click chemistry with 17-ODYA to identify palmitoylated proteins from human 
Jurkat T cells. Rab1b and Rab38 were among the high confidence candidates, while Rab5c was 
among the medium confidence ones. See Table 22 for a summary of the candidate Rab proteins 
found in the two studies. Both methods of large scale screenings suffer from false positives and 
are not very reliable. All proteins identified in these screenings can only be regarded as 
potential candidates until palmitoylation is verified by metabolic radiolabelling. 
 
Table 22: Summary of potentially palmitoylated Rab proteins found in proteomic screenings 
Method 
High 
confidence Rabs 
Medium/low confidence 
Rabs 
Reference 
ABE chemistry Rab10 Rab1b, 2b, 5c, 7, 14 [293] 
Click chemistry 
with 17-ODYA 
Rab1b, 38 5c [294] 
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6.1.5 Methods for detecting and analysing palmitoylation 
6.1.5.1 Metabolic labelling with radio labelled palmitate 
Traditionally, palmitoylation was investigated using metabolic labelling with radio labelled 
palmitic acid. 3H-palmitate is the most commonly used compound, however for higher 
sensitivity 125I-IC16 palmitate (16-iodohexadecanoic acid, a palmitate analogue) may be used 
[269]. The principle of metabolic labelling with fatty acids is as follows: The protein of interest is 
overexpressed in mammalian cells. Before the radiolabel is added, pyruvate is added to the 
medium. Pyruvate acts a source of acetyl-CoA and minimises interconversion of the added fatty 
acid to other metabolites [267]. It can also be decreased by minimising the labelling time. This 
effect of label metabolism depends on the cell line and can vary significantly. In general, the 
elongation to longer chain lengths is much more common than the catabolism to shorter 
chains. Radiolabel is then added to the medium and allowed to act for a set amount of time, 
usually 2-8 hours. The cells are then harvested, lysed and the protein of interest is purified by 
affinity purification or immunoprecipitation. The purified protein is then resolved 
electrophoretically and the resulting gel is processed by fluorography. The fluorograph is then 
left to expose high sensitivity films at -80°C. Due to very weak signals, the exposure time is 
quite long and can vary from 1 week to 8 weeks.  
 
6.1.5.2 Hydroxylamine Treatment 
The two types of palmitoylation – N- and S-palmitoylation – can be distinguished based on their 
chemical bond. Since S-palmitoylation is relatively unstable and reversible, it can be cleaved off 
the protein using hydroxylamine, which selectively cleaves thioester bonds. The cleavage of N-
palmitoylation requires much harsher conditions, for example acid hydrolysis or basic 
hydrolysis using KOH/methanol. This method however additionally cleaves all types of ester 
bonds [267]. If treatment of palmitoylated proteins with hydroxylamine removes the radiolabel, 
it can be assumed that the protein is S-palmitoylated via a thioester bond.  
 
6.1.5.3  Acyl-biotinyl exchange (ABE) chemistry 
Green and Drisdel have recently developed a new non-radioactive, proteomic technology for 
detecting palmitoylated proteins [295]. This method involves three chemical steps in which the 
palmitate is substituted for biotin (Figure 103).  
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(1) Unmodified cysteine thiols in the protein mixture are blocked with N-ethyl-maleimide 
(NEM) (or with iodoacetamide) 
(2) Existing palmitate thioester bonds are cleaved with hydroxylamine (NH2OH) leading to 
the exposure of free sulfhydryl groups. 
(3) The newly created sulfhydryl groups are marked with a thiol specific biotinylation 
reagent. 
 
These resulting biotinylated proteins can then easily be affinity purified using streptavidin 
resins and subsequently identified by a number of methods. If a specific protein is investigated 
it can simply be analysed by SDS-PAGE and Western blotting. In proteomic screenings for 
unidentified proteins mass spectrometric methods, such as MudPIT (multidimensional protein 
identification technology) can be applied. The drawbacks the ABE method is that nearly 1/3 of 
identified proteins are false positives [296]. To avoid false positives, complete blockage of free 
thiol groups in step (1) is crucial.  
 
 
Figure 103: Principle of ABE method for the detection of S-palmitoylated proteins (modified from 
[297]). Free thiol groups are blocked by NEM (N-ethyl-maleimide), followed by cleavage of thioester 
bonds to remove palmitate thioesters. Newly exposed sulfhydryl groups are then coupled to biotin via a 
disulfide bond and the labelled molecules are pulled down onto streptavidin beads. If required, 
captured protein may be eluted from the beads by breaking the disulfide bonds with β-
mercaptoethanol. 
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6.1.5.4  Click chemistry 
Another recent development in the field of non-radioactive protein labelling with acyl groups is  
the application of bioorthogonal ligation chemistry, or click chemistry [298,299]. Instead of 
radioactively labelled acyl chains, acyl chain analogues with small chemical tags are added to a 
cells expressing the protein (or proteins) of interest. Azide, alkyne or aldehyde groups are 
suitable as such chemical tags, as they are robust, and react selectively in water compatible 
reactions. Once the proteins are modified with the label, these tags react with a capture 
reagent that may be conjugated to reporter groups or beads for mechanical separation.  
17-ODYA (octadecynoic acid), a palmitic acid analogue, has recently been employed in a click 
chemistry based approach for detecting the palmitoylome of mammalian cells [294]. Figure 104 
shows a schematic presentation of the labelling principle. It should be noted, that recently click 
chemistry has been extended to investigate the prenylome [300,301]. 
 
 
Figure 104: Principle of using click chemistry with 17-ODYA to identify palmitoylated proteins 
(modified from [294]). The molecule is incorporated into proteins by metabolic labelling of cultured 
cells. After cell lysis, the alkyne group of 17-ODYA is conjugated to an azide group linked to a reporter 
group, allowing detection or capture of the protein. 
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6.2 Materials and Methods 
6.2.1 Transfection of HEK293A cells 
97 μL Optimem (Gibco) were mixed with 3 μL Fugene6 (Roche) and incubated 5 min at room 
temperature. 1.6 μg plasmid DNA (0.5 μg for EGFP mock plasmid) was then added and 
incubated 30 - 45 min. The DNA-lipid complex was carefully pipetted to HEK293A cells at 70 – 
80% confluency in 2 mL supplemented DMEM (Gibco). 
 
6.2.2 Metabolic labelling with 3H-Palmitic Acid 
Transfected HEK293 cells were metabolically labelled with 3H-palmitic acid 24 h post-
transfection. This was performed by exchanging DMEM to 1.0 mL labelling medium, in order to 
reduce post-translational modification with endogenous (unlabelled) palmitic acid.  
1 h after medium exchange, 3H-palmitic acid in ethanol was added to the cells to a final 
concentration of 125 μCi/mL, followed by incubation for 3 h at 37°C. The cells were harvested 
by removing the radioactive medium, followed by washing them once in 2 mL ice cold PBS and 
scraping them in 1.5 mL PBS. The cells were centrifuged at 800g for 2 min at 4°C, followed by 
two washing steps in 1 mL ice cold PBS and spinning at 800g for 1 min at 4°C. The cell pellet was 
then lysed in 200 μL immunoprecipitation buffer (IPB) by incubating on ice for 5 min while 
repeatedly vortexing for a few seconds. The total cell lysate was centrifuged at 16000g for 
15 min at 4°C to remove cell debris and large DNA fragments.  
 
Labelling Medium 
DMEM 
5% FBS 
5 mM Na-Pyruvate 
 
 
 
IPB: 
50 mM Tris, pH 7.5 
150 mM NaCl 
1% IGEPAL 
0.1% SDS 
1 mM DTT 
1x PI (Roche) 
 
6.2.3 Immunoprecipitation of EGFP-Rab proteins 
1.3 μL rabbit αGFP antibody (abcam, ab290) was added to 90 μL of total lysate (see 6.2.2). 
Sheep anti-Rabbit IgG conjugated Dynabeads® (Dynal, Invitrogen) were equilibrated in IPB and 
resuspended to a 50% slurry. 50 μL of this slurry were added to each sample of total lysate. The 
mixture was allowed to immunoprecipitate under gentle agitation overnight at 4°C. In parallel a 
control sample without primary antibody was performed in order to quantify nonspecific 
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binding to the beads. The supernatant was removed and the beads washed twice in 900 μL IPB 
and once in 900 μL detergent free IPB.  
Since β-mercaptoethanol can cleave the reversibly attached palmitoyl groups off the protein, 
DTT was used instead in the SDS loading buffer, and SDS samples were only briefly heated to 
80°C instead of boiling them for 10 min. 1x DTT-SDS loading buffer was added to the beads and 
6x DTT-SDS loading buffer was added to the supernatant fraction to a final concentration of 1x 
SDS loading buffer. Equivalent volumes of supernatant and bead samples were 
electrophoretically separated on 10% SDS polyacrylamide gels. Two identically loaded gels were 
prepared, one of which was used for immunoblotting with rabbit αGFP antibody and the other 
for fluorography.  
 
DTT-SDS loading buffer 
20 mM DTT 
0.02% (w/v) Bromophenol blue 
40% (v/v) Glycerol  
10% (w/v) SDS  
0.3 M Tris, pH 6.8 
 
6.2.4 Fluorography 
The SDS gels were immersed in DMSO for 2 x 30 min under slight agitation, followed by 1 - 2 h 
in DMSO supplemented with 22.5% PPO (2,5-diphenyloxazole). The gels were washed 2x 30 min 
in ddH2O. The gels were dried between cellophane for 1 - 2 days until completely dry. Kodak 
BioMax Ms Film (Sigma) was pre-flashed to increase sensitivity and the pre-flashed side was 
exposed to the gels at -80°C for 2 – 6 weeks.  
 
6.2.5 Hydroxylamine treatment 
In order to examine the reversibility of palmitoylation, the SDS gels of the immuno 
precipitations were treated with 1 M hydroxylamine pH 7.5 overnight. As a control, 
corresponding gels were treated with 1 M Tris, pH 7.5 in parallel. All gels were processed by 
fluorography.  
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6.2.6 Site directed mutagenesis of pENTR Rab40c C273S 
Site directed mutagenesis of pENTR-Rab40c was performed as described in the QuikChange II 
XL-Site-Directed Mutagenesis kit from Stratagene. Briefly, the plasmid DNA was amplified by 
PCR using complementary oligonucleotides. The original template DNA without the restriction 
site was digested after the PCR using the endonuclease DpnI, an enzyme that selectively digests 
the parental methylated and hemimethylated DNA. The mutated plasmids were transformed 
into E. coli XL10-Gold ultracompetent cells. PfuTurbo DNA polymerase and the following 
temperature profile were used for amplification.  
 
Table 23: Temperature profile used for the site directed mutagenesis PCR  
Temperature [°C] Time [min:s] Cycles 
95 1:00 1 
95 0:50  
60 0:50 18 
68 8:00  
68 7:00 1 
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6.3 Results 
6.3.1 Metabolic labelling of EGFP-Rab proteins 
A large number of different Rab proteins were tested for palmitoylation by metabolic labelling 
with tritiated palmitic acid. All of them apart from one were negative for palmitoylation. The 
resulting Western blots of the immunoprecipitations and corresponding fluorographs are 
presented in Figure 105. The top row of blots and fluorographs shows the control samples. 
HRas was used as a positive control, while EGFP and YFP-Src10 were used as negative controls. 
YFP-Src10 is known to be myristoylated. Therefore, if it comes up as positive for palmitoylation, 
it indicates a fault in the assay conditions as palmitic acid can be degraded to myristic acid if the 
labelling time is too long. Furthermore, a radioactive signal of this negative control could 
indicate substrate promiscuity of N-myristoyl transferases (NMTs). 
The immunoblots of the controls show that the immunoprecipitation for HRas and EGFP 
worked very well. The fluorograph of HRas also shows a band in the + primary antibody (+1° AB) 
bead fraction, showing that it is palmitoylated. Even though the immunoprecipitation was 
nearly quantitative, the corresponding signal on the fluorograph is much stronger in the 
supernatant compared to the beads. It can be assumed that the fluorograph signal in the 
supernatant results from overexpressed HRas, as it is not present in samples of EGFP-Rabs that 
were negative for palmitoylation. The presence of the strong supernatant signals at 50 kDa on 
the HRas fluorograph suggests that palmitoylation interferes with the immunoprecipitation, 
possibly caused by aggregation due to increased hydrophobicity. To resolve this problem the 
assay conditions need to be adjusted to more stringent conditions. 
The fluorographs of the EGFP and YFP-Src10 controls show that there is no unspecific binding of 
EGFP to the beads and that the added palmitic acid is not metabolised to myristic acid. 
 
The Rab protein samples in Figure 105 are all negative for palmitoylation. The immunoblots 
show, that in almost all cases the immunoprecipitation was not quantitative and a large 
fraction of the EGFP-Rabs remains in the supernatant. This is especially pronounced for Rab1b, 
3a, 10 and 14, where 50% or more remains in the supernatant. However, this does not interfere 
with the assay as all signals in the bead fraction are strong enough to be detected by 
fluorography in case of palmitoylation. Furthermore, a strong signal around 50 - 55 kDa would 
be expected in the supernatant fraction resulting from remaining palmitoylated EGFP-Rab, as it 
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can be seen on the HRas fluorograph. None of the negative Rab proteins exhibit such a signal. 
Wild type Rab40c however was found to be palmitoylated (Figure 106).  
 
 
 
Figure 105: Metabolic labelling of EGFP-HRas, YFP-Src10 and various EGFP-Rabs. For each protein the 
top panel shows the Western blot of the immunoprecipitation and the lower panel shows the 
corresponding fluorograph of the same sample. +/- denotes the use of primary antibody (αGFP) in the 
immunoprecipitation, in order to check for unspecific binding of protein to the beads. S and B represent 
supernatant and bead fraction of the immunoprecipitation reaction. 
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Figure 106: Western blot and fluorograph of immuno precipitated EGFP-Rab40c wt. +/- denotes the 
presence of αGFP antibody in the immunoprecipitation, S and B represent supernatant and bead 
fractions. It was ensured that there was no spill over of sample from adjacent lanes. 
 
Hydroxylamine cleavage showed that the palmitoyl group is reversibly bound (Figure 109), 
indicating that it is attached to a cysteine residue via a thioester bond. Analysis of the amino 
acid sequence of Rab40c shows 8 cysteines, which is quite a large number compared to other 
Rab proteins, the majority of Rabs having 3-5 cysteine residues. As palmitoyl groups are often 
found at the C-terminus, proximal to prenylated C-terminal cysteines, C273 (underlined in the 
sequence below) was regarded as a potential site of palmitoylation. This would imply that 
Rab40c is only singly prenylated at the last cysteine residue. Site directed mutagenesis was 
employed to mutate C273 to a serine. This is the ideal substitution, since serine closely 
resembles cysteine, but cannot form thioester bonds or any other bond with palmitic acid.  
 
 
Figure 107:  Mouse Rab40c sequence. Highlighted residues are the prenylation motif (green), cysteine 
residues (yellow), GTP binding domains (red), effector domain (blue). The potential palmitoylation site 
C273 is underlined (from [197]. 
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The following primers were used for site directed mutagenesis (the mutated bases are shown in 
red and the respective codon is underlined): 
 
Forward 
5’-GCCCACCTCAGAACAGCTCTCGGAGCAAC-3’ 
Reverse 
5’-GTTGCTCCGAGAGCTGTTCTGAGGTGGGC-3’ 
 
The resulting mutated plasmid was confirmed by sequencing and used for overexpression and 
subsequent metabolic labelling, revealing that the C273S mutant is still palmitoylated (Figure 
108). The signals in the bead fraction of the primary antibody containing samples (+) are very 
faint, but visible on the films. Additionally, the strong bands at around 60 kDa support the fact 
that both samples are palmitoylated.  
 
 
Figure 108: Western blot and Fluorograph of mouse EGFP-Rab40c wt and C273S. +/- denotes the 
presence of αGFP antibody in the immunoprecipitation, S and B represent supernatant and bead 
fractions. 
 
The experiment was repeated with hydroxylamine treatment (Figure 109) and the results were 
confirmed. The fluorographs furthermore show that the palmitoylation is reversible and thus 
assumingly bound to a cysteine residue via a thioester bond, as already mentioned above.  
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Figure 109: Hydroxylamine pH 7.5 and Tris pH 7.5 treated fluorographs of immunoprecipitation of 
EGFP-Rab40c wt and the C273S mutant and EGFP-HRas control. +/- denotes the presence of αGFP 
antibody in the immunoprecipitation, S and B represent supernatant and bead fractions. 
 
6.4 Discussion and Summary 
The classical method of metabolic labelling with radioactively labelled palmitic acid was 
employed to analyse a number of Rabs for palmitoylation, some of which have recently been 
found in proteomic screenings as putative palmitoylated proteins [293,294]. Most of these Rabs 
could not be confirmed with this more reliable method of metabolic labelling; only mouse 
Rab40c was shown to be palmitoylated. It was furthermore observed that the palmitoyl group 
is reversibly attached using hydroxylamine treatment of the fluorographs. Site directed 
mutagenesis of C273S, a suggested position of a palmitoyl group, indicated that the mutant 
protein retained the ability to be palmitoylated. This may indicate that this cysteine is 
prenylated, meaning that Rab40c is doubly prenylated with geranylgeranyl groups and at least 
singly palmitoylated. If this is the case, it would explain the particularly strong association with 
membranes, shown in Chapter 3. Alternatively, palmitoylation may be retained in the mutant 
due to a shift of the palmitoylation site to an upstream position. 
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6.4.1 Rab40c function and possible implication of palmitoylation 
Rab40c function was first investigated in 2004 [197] when it was cloned from a rat 
oligodendrocyte cDNA library. It has only been cited in one other paper on a Xenopus Rab40 
homolog, Xrab40, where it was shown to be required for normal gastrulation [302]. Human 
Rab40c shares 75% and 80% sequence identity with Rab40a and b, respectively [188], and has 
281 amino acids with a molecular weight of 31.5 kDa. Analysis of different types of rat tissue 
showed a tissue specific expression of Rab40c. It exhibits high expression in brain, heart, kidney 
and testis, low expression in lung and liver and is completely absent from spleen and skeletal 
muscle.  Rab40c is structurally quite distinct from other Rabs in that it contains a predicted 
palmitoylation motif in addition to the prenylation motif in its C-terminus, and some of the 
more conserved residues of the GTP binding regions are exchanged. This has an effect on the 
GTP binding properties of Rab40c, as Rodriguez-Gabin et al. [197] showed with a nitrocellulose 
filter binding assay using [35S+GTPγS . Rab40c binds GTP with a Kd of around 21 μM and has a 
higher affinity for GTP than GDP. This is quite different to other Ras like proteins which 
generally have Kd values in the range of 10
-8 M and bind GTP and GDP with comparable 
affinities. This shift of GTP affinity from the nanomolar to the micromolar range is typical for 
the observed exchange of D by H in the GTP binding motif [303]. Rodriguez et al. predicted that 
due to these distinct properties Rab40c does not alternate between the GDP and GTP bound 
state, reversibly interacting with different membrane compartments. Instead, due to its higher 
affinity for GTP, it remains mainly in the GTP bound active state. This prediction is in 
accordance with observations made in Chapter 3, that Rab40c is not extractable by GDI. 
Further studies on endogenous expression of Rab40c in primary cultures of oligodendrocytes 
and oligodendrocyte progenitors showed a fourfold higher expression in oligodendrocytes. The 
myelin sheath that surrounds axons in neurons is derived from oligodendrocytes. This suggests 
that Rab40c plays a role in myelin biogenesis in oligodendrocytes. Furthermore, overexpression 
of EYFP-Rab40c in HeLa and HOG cells showed localisation to the perinuclear recycling 
compartment (PRC), and on vesicles budding from the PRC. Together, these two observations 
lead to the hypothesis that Rab40c plays a key role in myelin biogenesis, for example in the 
vesicular transport of its components from the PRC to the cell surface and in recycling of cell 
surface molecules such as receptors. The PRC functions in the regulation of recycling cell 
surface molecules. Firstly, it serves as a reservoir for receptors and other plasma membrane 
components [304], and secondly it is a sorting centre [305], as from here the receptors are 
either targeted to the plasma membrane domain from where they endocytosed or to other 
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plasma membrane domains. Oligodendrocytes may take advantage of such reservoirs to wrap 
myelin around several axons simultaneously.  
 
6.4.2 Future work 
It would be interesting to investigate palmitoylation in Rab40 isoforms a and b and compare 
their extractability with Rab40c. However, the mouse genome does not contain Rab40a and an 
EGFP-Rab40b construct was not available at the time of study. Therefore, a comprehensive 
comparison of the three Rab40 isoforms will require the use of the human genes. The three 
human Rab40 isoforms are aligned below (Figure 110). All isoforms have an untypically high 
number of cysteine residues (yellow), but there are a few striking differences between the 
three isoforms.  
 
RAB40A   MSAPGSPDQAYDFLLKFLLVGDRDVGKSEILESLQDGTAESPYSHLGGIDYKTTTILLDG 60 
RAB40B   MSALGSPVRAYDFLLKFLLVGDSDVGKGEILASLQDGAAESPYGHPAGIDYKTTTILLDG 60 
RAB40C   MGSQGSPVKSYDYLLKFLLVGDSDVGKGEILESLQDGAAESPYAYSNGIDYKTTTILLDG 60 
         *.: *** ::**:********* ****.*** *****:*****.:  ************* 
 
RAB40A   QRVKLKLWDTSGQGRFCTIFRSYSRGAQGVILVYDIANRWSFEGMDRWIKKIEEHAPGVP 120 
RAB40B   RRVKLQLWDTSGQGRFCTIFRSYSRGAQGVILVYDIANRWSFDGIDRWIKEIDEHAPGVP 120 
RAB40C   RRVKLELWDTSGQGRFCTIFRSYSRGAQGILLVYDITNRWSFDGIDRWIKEIDEHAPGVP 120 
         :****:***********************::*****:*****:*:*****:*:******* 
 
RAB40A   KILVGNRLHLAFKRQVPREQAQAYAERLGVTFFEVSPLCNFNIIESFTELARIVLLRHRL 180 
RAB40B   KILVGNRLHLAFKRQVPTEQAQAYAERLGVTFFEVSPLCNFNITESFTELARIVLLRHGM 180 
RAB40C   RILVGNRLHLAFKRQVPTEQARAYAEKNCMTFFEVSPLCNFNVIESFTELSRIVLMRHGM 180 
         :**************** ***:****:  :************: ******:****:** : 
 
RAB40A   NWLGRPSKVLSLQDLCCRTIVSCTPVHLVDKLPLPIALRSHLKSFSMAKGLNARMMRGLS 240 
RAB40B   DRLWRPSKVLSLQDLCCRAVVSCTPVHLVDKLPLPIALRSHLKSFSMANGLNARMMHGGS 240 
RAB40C   EKIWRPNRVFSLQDLCCRAIVSCTPVHLIDKLPLPVTIKSHLKSFSMANGMNAVMMHGRS 240 
         : : **.:*:********::********:******::::*********:*:** **:* * 
 
RAB40A   YSLTTSS---THKRSSLCKVKIVCPPQSPPKNCTRNSCKIS 278 
RAB40B   YSLTTSS---THKRSSLRKVKLVRPPQSPPKNCTRNSCKIS 278 
RAB40C   YSLASGAGGGGSKGNSLKRSKSIRPPQSPPQNCSRSNCKIS 281 
         ***::.:     * .** : * : ******:**:*..**** 
Figure 110: Alignment of human Rab40 isoforms a, b and c. Cysteine residues are highlighted in yellow. 
 
Rab40c contains a sequence insert of three glycines slightly upstream of the C-terminus, which 
may affect flexibility of the prenylated part of the protein. Interestingly, Rab40a has two 
additional cysteine residues close to the C-terminus. Rab40c exhibits a cysteine at position 149 
that does not exist in the other two isoforms. These could be potential sites of palmitoylation. 
Furthermore, there is an unusual double cysteine motif in all three isoforms at positions 196 
and 197, which could be a target of internal palmitoylation. A number of neuronal proteins are 
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doubly palmitoylated at an internal double cysteine motif, such as Rhodopsin, the 5-HT4A 
receptor, GRK6 and KChIP2b (see [288] for a review).  
Future work involves confirmation of Rab40c palmitoylation using more stringent 
immunoprecipitation conditions in order to increase the bead signal compared to the 
supernatant signals on the fluorographs. The localisation of palmitoylation has to be 
determined by further site directed mutagenesis of the remaining cysteine residues for use in 
metabolic labelling. The double cysteine motif is a favoured palmitoylation site and should 
therefore be investigated with priority. Furthermore, the type and number of prenyl groups on 
Rab40c needs to be determined, as it has never been confirmed to be doubly prenylated.  
If Rab40c is largely in the GTP bound state, interaction with REP would be inhibited and as a 
consequence geranylgeranylation by RGGTase impaired. Instead, Rab40c may be a substrate for 
FTase or GGTase I, which is supported by the presence of a CAAX box. Knock down experiments 
of the three types of prenyltransferases (FTase, GGTase I, and RGGTase) using siRNA may be 
employed to determine which one facilitates prenylation of Rab40c. 
 
As a conclusion, Rab40c is the first mammalian Rab protein shown to be palmitoylated. This 
palmitoylation is reversible and therefore attached via a thioester bond to a cysteine residue. 
The position of palmitoylation remains undetermined, as the most likely position, C273, could 
not be confirmed. However, this indicates that Rab40c is doubly prenylated at the C-terminus 
and exhibits a third lipid modification in addition, leading to stronger membrane association 
than other Rab proteins. In addition, Rab40c has been predicted to bind GTP with much higher 
affinity than GDP, thereby inhibiting interaction with GDI. Both these assumptions are 
supported by observations made on membrane extraction of Rab40c with GDI (Chapter 3). 
Furthermore, permanent GTP association of Rab40c may impair prenylation by RGGTase and 
render Rab40c a substrate for other prenyltransferases. 
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CHAPTER 7 
Conclusions  
 
Rab GTPases exhibit specificity in targeting to organelle membranes. Several structural features 
of Rab proteins, such as the RabF and RabSF regions have been shown to be required for 
correct localisation [37], however the molecular mechanism of membrane targeting remains 
obscure. It has been proposed that membrane bound proteins with characteristic membrane 
localisations function as Rab targeting factors [64], but this has not been confirmed as a general 
mechanism conveying targeting specificity. As Rab proteins are involved in membrane 
trafficking events, such as vesicle budding, fission and fusion, they may exploit membrane 
biophysical properties to distinguish between different membranes. Sensitivity towards stored 
membrane curvature elastic stress and specific lipid species has been shown for other small 
GTPases of the Arf, Rho and Ras families. The Arf GTPases Arf1 and Sar1p bind to membranes 
by inserting their N-myristoylated N-terminal amphipathic helix into the membrane, thereby 
modulating membrane curvature according to the bilayer couple hypothesis [105,133,134,136]. 
Furthermore, membrane recruitment of the Rho GTPases Rac1 and 2 was shown to be 
regulated by anionic phospholipids, particularly  PtdIns(3,4,5)P3, caused by a polybasic amino 
acid stretch within these proteins [165,166]. This was revealed to be a common principal in 
many plasma membrane targeted small GTPases, including evidence for some Rab proteins, 
most of which are monoprenylated [167].  For these reasons, the aim of this thesis was to 
investigate the sensitivity of Rab membrane targeting to membrane biophysical properties. A 
combination of biochemical and biophysical technologies was applied, in order to conduct 
these studies. 
 
Chapter 4 establishes the biophysical properties of the membrane systems used. Two types of 
model systems were utilised in the Rab binding studies. These were complex lipid compositions 
mimicking protein free organelle compositions, and binary lipid mixtures with defined 
biophysical properties. Three synthetic organelle mimetic lipid compositions (plasma 
membrane, endosome and mitochondrion mixtures) were selected and subjected to SAXS, 
WAXS and DSC to establish their phase behaviour in water and buffered solution. These studies 
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revealed fully lamellar, homogenous phase behaviour of all three lipid mixtures over a broad 
temperature range (5-80°C) and in 50-80% water or buffer. This is interesting in two aspects. 
First, such complex synthetic lipid headgroup compositions have not been investigated with 
respect to phase behaviour to date. The lamellarity of all investigated lipid mixtures without 
phase segregation in the absence of protein indicates that in vivo proteins may play an 
important role by inducing membrane microdomains and transient non-lamellar structures, for 
example during membrane fusion and fission. However, the lipid mixture with the highest 
quantity of cholesterol and sphingomyelin was the plasma membrane mix, containing 13-14% 
(w/w) of each. This is most likely an underestimation and phase segregation would be expected 
at higher contents. Therefore, the properties of the used synthetic mixtures used may not 
represent the reality in physiological conditions. 
The second important feature - and advantage - of the observed lamellarity of the three 
organelle mimetic mixtures is that they were applicable for the Rab binding experiments, since 
vesicles were used as model membrane systems, requiring lamellar lipid mixtures. 
Furthermore, differences in Rab binding are then decoupled from the phase behaviour of the 
lipids and can be correlated to differences in other biophysical properties such as curvature 
elastic stress or bending rigidity.  
The bending rigidity of DOPC/DOPE mixtures containing 0/10/20 and 30% DOPE was 
established by membrane fluctuation analysis. The bending rigidity had previously been 
suggested to be largely independent on the lipid headgroup [97]. However, this suggestion 
derived from comparison of bending rigidity values determined in separate studies that applied 
different measurement methods. Here, for the first time a set of comparable measurements is 
presented, allowing the direct comparison of the bending rigidity of different lipid 
compositions. A linear dependency of membrane bending rigidity on the fraction of DOPE 
present was observed, suggesting that the headgroup in fact does have a significant effect on 
bending rigidity.   
Having established that DOPC/DOPE mixtures exhibit defined and distinguished biophysical 
properties, these compositions were used in Rab membrane delivery studies, in order to 
correlate Rab targeting to these properties. In addition to binary DOPC/DOPE mixtures, 
DOPC/DMPC mixtures were also used, as DMPC was expected to induce the opposite effect on 
Rab binding. DMPC is a well described type I lipid which induces positive curvature. In contrast 
DOPE is a type II lipid, inducing negative curvature. Furthermore, DMPC has a lower bending 
rigidity than DOPC, due to its reduced chain length [96,306]. Rab binding to DMPC containing 
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compositions was indeed very low, while a linear increase of membrane binding was observed 
for increasing mol fractions of DOPE. These findings strongly suggest sensitivity of Rab proteins 
towards membrane rigidity and stored curvature elastic stress. These properties may therefore 
form the basis of Rab membrane selectivity or act as additional features to convey targeting 
specificity. Considering the finding that differential Rab membrane binding was observed on 
synthetic lipid compositions lacking any other protein factors, may indicate a more important 
role of membranes for Rab recruitment than previously thought.  
Another aspect of Rab membrane binding is their extraction into the cytosol by GDI. Chapter 3 
presents the first broad study comparing the extractability of different Rab proteins in vitro, 
using 17 different EGFP-tagged overexpressed Rab proteins. It has been shown for the first time 
that there is a significant difference in extractability, ranging from non-extractable (Rab40c) to 
almost full extractability (e.g. Rab 11a). Direct comparison of GDIα and β resulted in 
comparable values for each Rab with both GDI isoforms, leaving open the question whether 
they fulfil discreet functions or are redundant. 
The fact that different Rab proteins exhibit such high differences in extractability may be a 
fundamental mechanism of controlling the amount of Rab protein that is membrane bound. As 
only membrane associated Rab proteins can be activated [9,76], this also regulates the pool of 
Rab proteins available for activation. A possible cause for the differences in extractability may 
be the nucleotide state of Rab proteins, as only Rab proteins binding GDP are able to interact 
with GDI [42]. Two properties may be responsible for enhanced GTP binding: preferential 
binding of GTP compared to GDP and a low GTPase activity. Rab40c is an example of a Rab 
protein exhibiting a higher affinity for GTP than for GDP [197]. The observation that Rab40c 
extractability converges towards zero supports the hypothesis that the nucleotide state 
regulates GDI extractability. However, Rab40c membrane affinity may also be caused by its 
second type of lipid modification, palmitoylation, which was uncovered in Chapter 6.  
Chapter 6 presents a study of Rab palmitoylation for a broad selection of different Rab proteins. 
Until recently Rab proteins were assumed to solely be prenylated, but two large scale 
palmitoylation profiling studies gave evidence that some Rab proteins may be modified by 
palmitoylation [293,294]. This lipidation motif would be an additional mechanism of regulating 
membrane association and selectivity, especially as S-palmitoylation is reversible, hence 
functioning as a membrane association switch. Therefore a number of potentially palmitoylated 
Rab proteins were subjected to a metabolic labelling study. 11 Rab proteins were screened 
negative for palmitoylation, but Rab40c was positive and hydroxylamine cleavage confirmed 
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reversible S-acylation. The C-terminus of Rab40c is unusual among Rabs and has been predicted 
to be a palmitoylation site. However, mutation of the putative palmitoylated cysteine residue, 
C273S, resulted in Rab40c still being palmitoylated, suggesting that a different cysteine residue 
is subjected to palmitoylation. In that case, the C-terminus of Rab40c would be doubly 
prenylated and additionally palmitoylated at a different position, thereby enhancing its 
membrane affinity. This may be supported by the observed extremely low extractability of 
Rab40c (Chapter 3). Furthermore, Rab40c contains unusually many cysteine residues compared 
to other Rab proteins, therefore a triple lipidation would not be surprising.  
Alternatively, the mutational deletion of the palmitoylated cysteine residue may render Rab40c 
a substrate for palmitoylation at a different position. This may be supported by the fact that 
Rab40c is largely in the GTP bound state [197], thereby inhibiting interaction with REP and 
accordingly inhibiting geranylgeranylation by RGGTase. As a consequence, interaction with 
other prenyltransferases and PATs may be facilitated. Farnesylation is often accompanied by 
palmitoylation, e.g. as in HRas and NRas. Recently, palmitoylation has been shown to be 
particularly important in the nervous system and physiological function of Rab40c 
palmitoylation may therefore be related to its function in neurons.  
 
7.1 Concluding remarks 
Several aspects of Rab membrane interaction have been addressed in this thesis, in order to 
explore the question of membrane targeting specificity. Study of GDI extraction into the cytosol 
using a broad range of Rabs for the first time revealed that each Rab exhibits a different 
extraction potential. The C-terminal motif could not be correlated to extractability, but 
evidence was obtained that it may have a functional purpose, as very low extractability was 
observed on a group of Rabs that are localised to lysosome related organelles and involved in 
the exocytic pathway. It is hypothesised that extractability is based on the ability to interact 
with GDI, which in turn is regulated by the nucleotide state of Rab proteins. Further studies 
correlating the intrinsic GTPase activity of Rab proteins to their extractability will help to 
answer this question.  
Another aspect of membrane association is the lipidation motif. Rab 40c was shown to be 
palmitoylated and exhibited the lowest extractability with GDI of all tested Rab proteins. 
Further study of the proteins involved in Rab40c post-translational modification and Rab40c 
function is required to elucidate the function of this unusual Rab protein. 
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Most importantly, Rab membrane interaction was for the first time revealed to correlate to  
membrane biophysical properties. It was furthermore shown that Rab proteins are delivered to 
synthetic membranes in an environment that was in principal free from proteins other than 
those contained in the Rab:GDI complex raw extracts, thus putting into question the role of Rab 
targeting factors hypothesised elsewhere. 
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